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Zusammenfassung 
Das Interesse an Raumstrukturen glykosylierter Proteine hat in den letzten Jahren stetig 
zugenommen, da diese Moleküle Schlüsselfunktionen im menschlichen Körper 
wahrnehmen und unter ihnen viele wichtige pharmakologische Zielstrukturen sind. 
Aufgrund ihrer Fähigkeit zur posttranslationalen Modifikation und komplexen Faltung 
stellen stabile Zellinien ein hervorragendes System für die Produktion rekombinanter 
Glykoproteine dar. Obwohl die Proteinproduktion in Säugerzellen schon wesentlich 
weiterentwickelt wurde, bleibt die Etablierung stabiler Zelllinien kompliziert und 
zeitaufwendig. Die zufällige Transgenintegration ins Wirtsgenom erfordert ein 
aufwendiges Überprüfen sehr vieler Zellklone. Ein weiteres Problem, insbesondere für 
die Röntgenstrukturanalyse, ist die Heterogenität und Flexibilität der Protein-
Glykosylierungen, die häufig die Bildung von gut streuenden Kristallen verhindern. 
Mutierte Zelllinien wie CHO Lec3.2.8.1  produzieren Glykoproteine mit verkürzten 
Kohlenhydrat-Seitenketten vom mannose-reichen Typ (high mannose). Diese 
Glykoproteine können deglykosyliert und effizient kristallisiert werden. Um zu gut 
kristallisierbaren Proteinkonstrukten zu gelangen, müssen oft unterschiedliche 
Varianten von einem Protein hergestellt werden. Daher ist ein schnelles und flexibles 
Expressionssystem gerade für die Strukturbiologie von großem Interesse. 
Diese Arbeit beschäftigt sich mit gezielter Genmanipulation mit Flp Rekombinase-
vermittelten Rekombinationsstrategien, um die Zelllinienentwicklung in CHO Lec3.2.8.1 
Zellen im Hinblick auf einen höheren Durchsatz und vorhersagbare Expressionsstärke 
zu optimieren. Zuerst wurden genetisch stabile Loci mit starker Genaktivität im 
Wirtszellgenom mit GFP Kassetten markiert, die von Flp-Erkennungssequenzen (FRT) 
flankiert waren. Zwei aufeinander folgende Fluoreszenz-aktivierte Zellsortierungsschritte 
(FACS) ermöglichten die Isolierung und Klonierung der am stärksten fluoreszierenden 
Zellen. Zellen, die GFP über mehrere Wochen stabil exprimierten, wurden 
Masterzellklone genannt. Je nach Strategie wurde das GFP entweder über 
Rekombinase-vermittelten Kassettenaustausch (RMCE) gegen ein anderes Gen 
ausgetauscht oder es wurde über ortsgerichtete Rekombination ausgeschnitten (FLEx). 
Im letzteren Fall war das zu exprimierende Gen schon hinter das GFP-Gen kloniert 
worden. Durch Entfernen des GFPs wurde das zu exprimierende Gen unter die 
Kontrolle des Promoters gebracht und damit aktiviert. Ein Vergleich der beiden 
Rekombinationssysteme zeigte die höhere Flexibilität und Schnelligkeit des RMCE 
Systems. Etablierte RMCE Masterzellen können in einem Schritt innerhalb von 2 
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Monaten umgewandelt werden, um beliebige Proteine zu produzieren. Auf diese Weise 
wurden 10 unterschiedliche Produktionszelllinien aus den Masterzellen generiert. Die 
rekombinanten Produkte umfassten hauptsächlich sekretierte Glykoproteine, aber auch 
ein intrazelluläres Protein und ein GPI-Anker-Protein. Drei der Zelllinien wurden in 2,5 L 
Bioreaktoren kultiviert, wobei das jeweilige rekombinante Protein reproduzierbar im 
Milligramm-pro-Liter Maßstab produziert wurde.     
Eines der Zielproteine, eine Domäne des humanen LAMP-3/DC-LAMP, ein Mitglied der 
Familie der lysosomal-assoziierten Membranproteine, wurde gereinigt, deglykosyliert 
und für die Röntgenstrukturanalyse kristallisiert. Schwermetallionen-Derivate der 
Kristalle wurden verwendet, um das Phasenproblem über anomale Dispersion mit 
multiplen Wellenlängen (MAD) zu lösen. Diese Experimente ermöglichten es, die 
Proteinstruktur aufzuklären.     
Zusammengefasst ermöglicht die Kombination aus FACS und ortsspezifischer 
Rekombination eine schnelle und robuste Klonierung von Zelllinien, die das 
rekombinante Protein ohne ständige Antibiotika-Selektion stabil produzieren. Aufgrund 
der kurzen Etablierungszeit ist das RMCE System in CHO Lec3.2.8.1 Zellen das ideale 
System, um Glykoproteine für die Strukturaufklärung zu produzieren.      
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Summary 
Structures of mammalian glycoproteins attracted increasing interest in recent years, as 
these proteins have key functions in the human body and include important drug 
targets. Due to their capability of post-translational modification and complex folding, 
stable cell lines are an excellent expression system for their recombinant production. 
Though considerable enhancements improved the production in mammalian cell lines, 
their development remains difficult and time-consuming. Transfections leading to 
random transgene integration require exhaustive clone screening. Another challenge, in 
particular for X-ray structure analysis, is the heterogeneous and flexible nature of 
protein glycosylation which often hampers the formation of well diffracting crystals. 
Glycosylation mutant cell lines such as CHO Lec3.2.8.1 produce glycoproteins with 
truncated carbohydrate chains of high-mannose type. These glycoproteins can be 
deglycosylated and crystallized efficiently. To find well crystallisable protein constructs, 
structural projects often necessitate the production of a variety of different constructs 
per protein. Thus, a fast and flexible expression system in CHO Lec3.2.8.1 cells is of 
essential interest for structural biology.  
This work describes defined genome engineering by Flp-mediated recombination 
strategies in order to optimise cell line development in CHO Lec3.2.8.1 towards higher-
throughput and predictable expression strength. Firstly, stable and high-producing loci 
in the host genome were tagged by FRT-flanked GFP cassettes. Two subsequent 
rounds of preparative fluorescent activated cell sorting (FACS) enabled high-throughput 
selection by isolating and cloning the top fluorescent cells. Cells stably expressing GFP 
over several months were termed master cell clones. Depending on the strategy, the 
GFP gene of these cells was either exchanged against another gene by recombinase-
mediated cassette exchange (RMCE) or excised by site-specific recombination (FLEx). 
In the latter case, the gene of interest was already located downstream of GFP. Upon 
deletion by recombination, the gene of interest was put under control of the promoter 
and thus expressed. A comparison of both recombination systems proved a higher 
flexibility and speed of RMCE. Once established, RMCE master cell lines can be 
converted to produce any protein of interest in about two months. Thus, 10 different 
production cell lines were successfully established from selected master cells. The 
recombinant products include glycoproteins, an intracellular protein and a GPI-anchored 
protein. Three cell lines were cultivated in 2.5 L bench top bioreactors and reliably 
produced recombinant protein in mg per litre scale.     
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As an example, one of these proteins, a domain of human LAMP-3/DC-LAMP, a 
member of the lysosome associated membrane protein family, was purified, 
deglycosylated and crystallized for X-ray structure analysis. Highly diffracting heavy-
atom derivative crystals were used to obtain phase information by multi-wavelengths 
anomalous dispersion (MAD) experiments. This information enabled the determination 
of the protein structure. 
In conclusion, the combination of FACS and site-specific recombination facilitates rapid 
and robust cloning of cell lines that stably produce recombinant proteins without 
continuously adding antibiotics. Due to its short development timeline, RMCE in CHO 
Lec3.2.8.1 cells is the ideal system to produce glycoproteins for structure determination. 
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1 Introduction 
 
1.1 Mammalian expression systems in structural biology 
Three-dimensional structures at atomic resolution are indispensable for a thorough 
understanding of protein function. In particular, the identification of functional sites and 
binding partners of proteins involved in diseases facilitates pharmaceutical drug 
development (Buchanan, 2002; Zhang & Kim, 2003). The first bottleneck for structure 
determination is the availability of sufficient amounts of soluble, high-quality protein. 
According to structures deposited in the Protein Data Bank (PDB), bacteria remain the 
most common expression hosts, assigned to 88% of the PDB entries, followed by 
insects/baculovirus systems (4%), fungi/yeasts (2.6%) and mammalians (2.4%) 
(Nettleship et al., 2010). Although constituting a valuable high-throughput system, 
bacteria lack critical eukaryotic post-translational modifications like glycosylation and 
certain chaperones to ensure a proper folding of many mammalian proteins including 
glycoproteins, membrane proteins and large multi-protein complexes. The demand for 
eukaryotic expression systems capable of dealing with the production of these 
challenging proteins is further underlined by the estimation that about 50% of all human 
proteins are glycosylated (Apweiler et al., 1999). Due to authentic biosynthesis and 
folding, mammalian expression systems are favoured for proteins of the same origin 
(Wurm, 2004). However, in comparison to other eukaryotic expression systems 
mammalian cells are generally regarded as a time- and cost-intensive choice. Their 
cultivation is characterized by slow growth kinetics, low cell densities, high sensitivity to 
mechanical stress and the need for specialized media (Sandig et al., 2005). Progress in 
high-throughput techniques and in genetic engineering has made mammalian cell 
culture more attractive in terms of speed, ease and yield (Andersen & Krummen, 2002). 
Hence, the number of protein structures based on mammalian expression systems has 
progressively increased each year and is poised to get ahead of fungi/yeast expression 
systems (Fig. 1-1). Insect/ baculovirus expression systems remain the most abundant in 
eukaryotic systems. Comparative studies on the performance of baculovirus- and 
mammalian cell based systems stated that their expression abilities complement one 
another (Aricescu et al., 2006). While cytosolic proteins were favourably produced in 
baculovirus expression systems, secreted proteins were obtained in higher yields in 
mammalian cells.   
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Figure 1-1: Plot of cumulative total number of protein chains deposited in the PDB 
whose expression system was identi fied as mammalian, insect, baculovirus, fungi or yeast 
by year of deposition. Expression data were parsed from the set of PDB files available in  
August 2010. Chains were counted rather than PDB entries as expression information is  
recorded by chains in the PDB. 
The most common mammalian expression hosts for structural studies are human 
embryonic kidney (HEK293) cells (Graham et al., 1977) and Chinese hamster ovary 
(CHO) cells (Tjio & Puck, 1958) (Fig. 1-2). Transient expression is distinguished from 
stable cell lines. Transient expression is characterized by a straightforward process 
from DNA delivery to protein harvest within a few days. By the introduction of 
suspension cultures and improvements in large-scale transfection techniques, transient 
expression systems have gained new advantages regarding speed and throughput 
(Baldi et al., 2007; Derouazi et al., 2004; Durocher et al., 2002; Girard et al., 2002; 
Meissner et al., 2001; Pham et al., 2003). Due to their high transfection rates, HEK293 
cells are valuable hosts for transient expression and have successfully delivered protein 
for various X-ray structure determinations (Bishop et al., 2009; Carafoli et al., 2008). To 
enhance protein expression further, two genetic variants, HEK293T and HEK293E, 
were developed. While HEK293T cells constitutively express the simian virus 40 (SV40) 
large T-antigen (Lebkowski et al., 1985), HEK293E cells express the Epstein-Barr virus 
(EBV) nuclear antigen 1 (EBNA1) (Cachianes et al., 1993). Both gene products enable 
the episomal amplification of plasmids containing the corresponding viral SV40 
(HEK293T) or EBV (HEK293E) origin of replication (Van Craenenbroeck et al., 2000). 
Recently, a comparable system for episomal replication and plasmid retention was 
developed in CHO cells (Kunaparaju et al., 2005). This so-called Epi-CHO expression 
system consists of CHO-K1 cells stably producing polyomavirus (Py) large T-antigen 
(PyLT) and a transfection vector bearing the Py origin of replication for autonomous 
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amplification. The transfection vector additionally encodes the EBNA1 gene and the 
EBV origin of replication for plasmid retention. Despite these enhancements, large DNA 
quantities have to be prepared regularly for each transfection. Thus, low-yield 
recombinant proteins are better expressed by stable cell lines which can be scaled up 
more easily. Moreover, their cultivation can be repeated indefinitely without the need of 
large DNA quantities. In pharmaceutical industry, stable mammalian cell lines are the 
dominant system for the production of recombinant therapeutic proteins by supplying 60 
to 70% of these products (Wurm, 2004). CHO cells are the most popular hosts for 
efficient integration of exogenous DNA in their genome (Hoeijmakers et al., 1987).   
 
Figure 1-2: Electron scanning microscopy of HEK293 and CHO cells.  (A) HEK293 cells 
on silicon surface (http://www. fz-juelich.de). (B) Non-adherent CHO cells (Porter et al. , 
1973).  
 
1.2 Conventional cell line development 
 
1.2.1 The general strategy for cell line development 
The development of a production cell line is conventionally based on random integration 
of a transgene into the host cell genome (Fig. 1-3). In addition to the transgene, a 
selectable marker gene is co-transferred into the cells, either encoded on the same 
vector or on a separate vector (Gurtu et al., 1996). The selection procedure depends on 
the marker which includes, for instance, the bacterial neomycin phosphotransferase, 
conferring resistance to the drug G418 (Southern & Berg, 1982), dihydrofolate 
reductase (DHFR) (Urlaub & Chasin, 1980) and glutamine synthetase (GS) (Cockett et 
al., 1990). The DHFR and GS selection systems are based on the complementation of a 
deficient nucleotide metabolism and the glutamine synthesis pathway, respectively. 
Host cells are available for both systems that have a defect in the respective enzyme. 
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However, such a host is not necessarily needed for the GS system. Non-transformed 
cells are prevented from growth in the absence of the appropriate metabolites 
hypoxantine and thymidine (DHFR system) or glutamine (GS system). These metabolic 
selection systems are also suitable for gene amplification leading to increased 
transgene expression. To this end, the cells are cultured with an inhibitor of DHFR 
(methotrexate, MTX) or GS (methionine sulfoximine, MSX). Consequently, only cells 
with enhanced enzyme expression survive due to a transcriptionally active integration 
locus or increased vector copy numbers. A stepwise increase of the inhibitor can result 
in several hundred to thousand copies (Wurm et al., 1986). The enhanced DHFR or GS 
production is usually accompanied by enriched product yields (Kim et al., 2001). Since 
the specific productivity varies among individual clones, repeated selection and analysis 
cycles are necessary, making this procedure laborious and not suitable for all cell lines.  
Following selection and eventual gene amplification, single cells are isolated, subcloned 
and screened for homogenous high-producers. Suitable cell clones are expanded, 
characterised and used for the process development destined to optimise cultivation 
conditions for higher productivity. Altogether, developing a cell line from gene transfer to 
larger-scale production can take more than a year and has to be repeated for each 
novel recombinant product (Wurm, 2004). In particular, the screening for stable high-
producers is laborious, as expression abilities can vary essentially among transformed 
subclones (Gellissen, 2005). Only a minor part expresses the transgene in high 
concentration over a long time. Thus, many clones have to be analysed over a long time 
to find an ideal producer.  
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Figure 1-3: Conventional strategy for stable  cell line development.  Initially, a 
transgene and a selection marker are introduced to the host cell line by gene transfer 
methods. Cells having integrated the exogenous DNA in their genome are selected and 
cloned as individual cell l ines. After freezing cell banks in liquid ni trogen, cell lines are 
screened for stable and high producers. For stable high -producers a process development 
confers efficient cultivation.  
 
Factors influencing the transgene expression on genomic level are the number of 
integrated transgene copies and the genetic environment of the integration site which is 
known as position effect variegation (Bestor, 2000; Kito et al., 2002). While integration 
into a heterochromatic locus leads to transcriptional down regulation culminating in 
complete transgene silencing, loci that can mediate transcriptional stabilization are rare 
(Pikaart et al., 1998; Walters et al., 1996). In addition, removing antibiotic selection 
pressure during cell propagation frequently results in mosaic gene silencing and 
diminishing protein yields (Liu et al., 2006). Although an increased vector copy number 
upon gene amplification coincided with higher expression levels, gene copies at 
different loci tended to recombine and thus caused chromosomal aberration (Derouazi 
et al., 2006). Tandem-repeat integrations are similarly problematic, as they may induce 
epigenetic inactivation as a consequence of a natural defence against retroviruses 
(McBurney et al., 2002). Another defence strategy to protect the mammalian genome 
from foreign DNA sequences was described by Scrable and Stambrook (Scrable & 
Stambrook, 1997). While a lacI gene from E. coli was inactivated by methylation in 
transgenic mice, a synthetic version of the same gene that followed human codon 
usage was relatively resistant to methylation and silencing. Thus, prokaryotic features of 
the transfection vector which are required for plasmid replication and selection during 
cloning procedures may also influence transcriptional activity of the integration locus 
due to their divergent nucleotide composition.  
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1.2.2 Epigenetic strategies to augment transgene expression 
The growing understanding of the molecular network that drives transcription of 
recombinant proteins gave rise to a variety of approaches employing epigenetic 
knowledge to increase product yield of stable cell lines. With regard to the position 
effect, one of the oldest strategies to create and maintain a favourable chromatin 
conformation is based upon the differences in histone modifications between the active 
and repressed status. While euchromatin is generally associated with histone 
acetylation, repression involves the removal of acetyl groups by histone deacetylases 
(HDACs). Hence, blocking HDACs by adding sodium butyrate to the cultured cells 
enhances transcriptional activity (Palermo et al., 1991). A disadvantage of sodium 
butyrate is the inhibition of cell growth and induction of cellular apoptosis (Davie, 2003). 
Further strategies involve genetic engineering of the host cells. The incorporation of cis-
acting DNA sequences into the transgene vector was found to create transcriptional hot 
spots independent of the site of integration. Common examples of these regulatory 
elements are scaffold/matrix attachment regions (S/MARs) (Girod et al., 2005; Kim et 
al., 2004), which affect chromatin structure, and ubiquitous chromatin opening elements 
(UCOEs) (Antoniou et al., 2003; Benton et al., 2002) derived from housekeeping genes. 
Both were applied in cell line development and resulted in an increased number of 
stable high-producers in CHO host cells.  
A third approach involves improved selection strategies using preparative FACS 
(Mattanovich & Borth, 2006). Cell sorting can isolate transgene integration events into a 
rare genomic locus where high-level expression is possible and silencing does not 
occur (Bestor, 2000; Kito et al., 2002). The cell sorting approach requires a fluorescent 
readout that is correlated to the expression of the recombinant product of interest. 
Internal ribosomal entry sites (IRES) can be used to couple the expression of the gene 
of interest to a marker that can be readily detected by FACS, such as GFP, or a cell 
surface antigen (Gaines & Wojchowski, 1999; Mancia et al., 2004). Alternatively, the 
product itself can be captured on the cell surface by a polymer matrix or low 
temperature (Pichler et al., 2009). Kaufman et al. (2008) describe the repeated isolation 
of the highest fluorescent cells by FACS to increase specific cellular productivity. Cell 
clones isolated like this provided highly homogenous and stable gene expression. 
Besides FACS selection, there is the possibility to dilute and grow cells in a semi-solid 
methylcellulose medium until colony formation. The secreted recombinant product 
immobilised by the medium can be detected by fluorescence labelled antibodies as a 
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halo around the colony (Caron et al., 2009). Cell colonies surrounded by the biggest 
halo were either picked up manually after microscopic identification or automatically by 
colony pickers resulting in a higher throughput (Caron et al., 2009).  
The exploitation of endogenous hot spots for transgene expression was further 
facilitated by targeting transgenes directly to such hot-spots instead of random 
integration. Site-specific recombination enables such targeting. It can improve 
predictability in cell line development with regard to the position effect. Moreover, time 
and effort to identify high and stable producers can be remarkably reduced.  
 
1.3 Site-specific recombination systems in cell line development 
 
1.3.1 Recombination systems 
Recombination describes the physical exchange of DNA sequences based on their 
homology. In eukaryotes, recombination naturally occurs as a general DNA repair 
mechanism in mitosis or as chromosomal crossover in meiosis to provide genetic 
diversity. Depending on the degree of homology between the exchanged DNA 
sequences, homologous recombination requiring extensive sequence homology, site-
specific recombination requiring short specific sequences and illegitimate recombination 
requiring only a few identical nucleotides are distinguished.  
While homologous recombination is a popular tool for the modification of murine 
embryonic stem cells (Glaser et al., 2005), it is hampered in differentiated cells by low 
frequency and is masked by more frequent illegitimate recombination (Puttini et al., 
2005). To enhance the frequency of homologous recombination, artificial zinc finger 
nucleases (ZFNs) have been evolved (Moehle et al., 2007). ZFNs consist of a DNA 
cleavage domain fused to an engineered zinc finger binding domain. The binding 
domain is homologues to a known expression locus and directs the ZFN to its target. 
The cleavage domain stimulates the host cell‟s DNA repair mechanism by a site-specific 
double-strand break followed by the integration of donor sequences in the host cell 
genome using homology-directed repair mechanism (Liang & Garrard, 1999). However, 
this method suffers from cytotoxicity which is caused by illegitimate DNA cleavage 
(Porteus & Baltimore, 2003). Although an increased recognition and cleavage specificity 
of ZFNs is under investigation (Pruett-Miller et al., 2008; Urnov et al., 2005), this method 
has still to be developed further for the generation of production cell lines. Another 
challenge is the identification of appropriate chromosomal sites which are currently not 
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known for CHO production cell lines. In human cell lines a genomic locus was identified 
that allows stable long-term expression of transgenes (Smith et al., 2008). It is referred 
to as AAVS1 (on chromosome 19, within gene PPP1R12C) and has already been used 
for ZFN transgenesis in different cell lines including HEK293 (DeKelver et al., 2010). 
However, it has not been analysed yet, if this locus is also a high expression hot spot.   
The technology that currently might be the best choice for targeted mammalian cell line 
development is based on site-specific recombination (SSR) systems of heterologous 
origin. SSR systems consist of the recombinase enzyme and two, double-stranded DNA 
recognition target (RT) sites that can recombine in a sequence dependent manner. The 
most common used recombinases in mammalian cell culture are the E. coli P1 phage-
derived Cre (Cyclization recombination) (Sternberg & Cohen, 1989), the 
Saccharomyces cerevisiae-derived Flp (Flippase) (Buchholz et al., 1996b) and the 
bacteriophage ΦC31-derived integrase (Thorpe & Smith, 1998). The corresponding 
recognition target sites are loxP (locus of cross-over P1) sites for Cre, FRT (Flp-
recognition target) sites for Flp and a combination of attP/attB sites for ΦC31.  
Both, Cre and Flp belong to the family of tyrosine recombinases, which share a 
common recombination mechanism based on a double-reciprocal crossover between 
an identical set of sites. While the sites of the two systems differ in their sequence, their 
overall structure is similar (Fig. 1-4). Each 34 bp long FRT and loxP site comprises an 8 
bp asymmetric spacer sequence which is involved in DNA-DNA base pairing and 
determines the orientation of the recombination target (RT) site. In case of FRT and 
loxP, the spacers are flanked by two 13 bp long inverted repeats containing Flp and Cre 
binding sites, respectively (Abremski et al., 1983; Senecoff & Cox, 1986). The natural 
48 bp FRT site bears an additional base pair and another 13 bp direct repeat which is 
located upstream of the rest. While the third repeat is not necessarily needed for simple 
excision reactions, it can mediate improved recombination efficiency for other 
applications and serves together with the spacer region as determinant for the 
orientation of the FRT site.   
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Figure 1-4: Composition of a 48 bp wild-type FRT site.  DNA breaking and rejoining 
occurs at the asymmetric 8 bp spacer (light blue). It is flanked by three 13 bp inverted  
repeats representing three binding sites for Flp (horizontal arrows).  Only two inverted 
repeats directly flanking the spacer sequence are required for a minimal FRT site with 
partial function (34 bp). The third repeat is located behind an isolated base pair. The 
vertical arrows illustrate the DNA cleavage sites of Flp. The cone r epresents a FRT site 
with its orientation.   
 
Two RT sites are bound by four protein monomers for the recombination of two DNA 
sequences (Chen & Rice, 2003). Two active protomers initiate the formation of a DNA 
Holliday junction by a nucleophilic attack of the DNA backbone by a tyrosine. 
Isomerisation of the Holliday junction leads to a change in enzyme activity: the two 
protomers that have already catalysed a reaction are deactivated, while the other two 
become active. A second round of DNA cleavage and ligation reactions dissolves the 
Holliday junction and thereby completes the double-strand exchange. The 
recombination enables an excision, an insertion, an inversion or translocation of DNA 
sequences, depending on the position and orientation of the RT sites (Fig. 1-5). When 
two copies of an RT site are arranged as direct repeats, the corresponding enzyme 
excises the DNA sequence between the copies. The reverse reaction leads to an 
insertion of circular DNA containing one RT site. Due to thermodynamic reasons, the 
entropy-driven, monomolecular excision is favoured to the bimolecular insertion (Baer & 
Bode, 2001). When the RT sites are positioned in inverse orientation, the flanked DNA 
is inverted by the recombinase until a dynamic equilibrium is reached. Recombination of 
single RTs on two linear DNA molecules results in the translocation of distal sequences 
(Fig. 1-5).  
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The ΦC31 integrase, a serine recombinase, mediates recombination of two different 
RTs, attP and attB, resulting in the RTs attL and attR after recombination. Insertion 
reactions mediated by ΦC31 are unidirectional since excision would require the 
excisionase Xis for recombination between RTs attL and attR. Xis is not present in 
mammalian cells. ΦC31 recombination was commercialized for cell line development by 
Invitrogen (Jump-InTM system). However, there have been reported pseudo integration 
sites in mammalian genome for the Cre and ΦC31 mediated recombinations 
(Thyagarajan & Calos, 2005; Thyagarajan et al., 2000). These may cause unexpected 
integrations cumulating in genomic instability. Pseudo integration sites have not been 
reported for the Flp/FRT system, but as yet there is no absolute proof.     
  
 
Fig. 1-5: Schematic presentation of site -specific Flp/FRT recombination with 
different FRT sites arrangements. (A) Flp-mediated excision of a DNA sequence that is 
flanked by two FRT sites with the same orientation. The reverse reaction is the integration  
of the circular DNA molecule. (B) Inversion of a DNA sequence that is flanked by two FRT 
sites with opposite orientation. (C) Translocation of DNA sequences as a consequence of 
recombination of two FRT sites that are located on different DNA molecules.  
 
The wild-type Flp recombinase shows low activity at 37°C, where mammalian cells 
generally grow (Buchholz et al., 1996b). To enhance the efficiency, mutant versions 
were generated. First, the temperature optimum was modified which resulted in the 
mutant recombinase Flpe (enhanced Flp) (Buchholz et al., 1998). Based on Flpe a 
codon optimisation for mammalian cells resulted in the mutant FlpO (optimised Flp) and 
enhanced the efficiency further (Raymond & Soriano, 2007). In the past years, this 
development gave rise to the establishment of mammalian production cell lines by 
different Flp recombination strategies. Generally, these strategies combine tagging of 
expression hot spots with FRT sites and Flp-mediated targeting.  
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1.3.2 Flp-mediated excision in cell line development 
A procedure exploiting Flp-mediated excision for cell line development was described 
by Kaufman et al. (Kaufman et al., 2008). This approach combines the selection of 
highly and stably expressing GFP cell lines by preparative FACS with site-specific 
recombination to remove the GFP marker (Kaufman et al., 2008). The stably integrated 
GFP gene in the tagged cells was flanked by two homospecific FRT sites (Fig. 1-6). 
Upon transient expression of Flp, the GFP gene was excised by Flp-mediated 
recombination of the FRT sites. Thereby, a downstream located gene of interest 
became activated by the promoter. Besides avoiding any antibiotic selection, this cell 
line development approach is target independent, high yields are obtainable and the 
cells are spared from producing GFP along with the protein of interest. However, the 
tagging and excision steps have to be repeated for every new cell line.  
 
 
 
Figure 1-6: Scheme of Flp-mediated excision (FLEx) in cell line development. The 
pre-characterized genomic locus contained a GFP gene flanked by two FRT sites, while 
the promoter was located upstream of this gene cassette. The GOI was located  
downstream of the flanked GFP gene without an own promoter. By transfecting with a Flp 
expression vector, the GFP gene was excised by recombination of the FRT sites and the 
gene expression switched to the GOI and thus the new production cell line was 
established. In an authentic excision reaction the excised GFP construct got lost. Cones = 
FRT sites, P = promoter, pentagons = secreted protein product encoded by the GOI.   
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1.3.3 Flp-InTM cell lines 
The Flp-InTM system commercialized by Invitrogen is based on an Flp-mediated 
integration strategy (Fig. 1-7). Host cells (e.g. HEK293, CHO) were established by 
stably integrating one copy of a tagging vector into their genome. The tagging vector 
contains a FRT site and a fusion gene of lacZ and zeocin resistance which enabled the 
selection of tagged cells by antibiotics. Site-specific recombination occurs upon co-
transfection of an Flp expression vector and the Flp-InTM vector bearing the gene of 
interest and the required second FRT site. Since an insertion reaction is 
thermodynamically unfavoured compared to the excision, stringent selection systems 
are required (Francastel et al., 1999; O'Gorman et al., 1991; Schubeler et al., 1998). 
The Flp-InTM system employs a “selection trap” relying on an incoming, non-functional, 
ATG-deficient hygromycin resistance gene for selection. By correctly integrating the  
Flp-InTM vector at the tagged locus, the non-functional hygromycin resistance gene is 
complemented and thus transcriptionally activated. Consequently, resistance against 
hygromycin is exclusively conferred to correct recombinant daughter cells while 
resistance against zeocin and lacZ expression is lost. Due to the transgene integration 
at a pre-defined locus, the resultant daughter cell clones should be isogenic and should 
express the gene at the same level. Thus, an extensive screening for high and stable 
producers is avoided.  Moreover, tagged Flp-InTM cells only have to be established once 
and can be universally used for the integration of any GOI.    
Upon Flp-InTM recombination, the entire sequence of two plasmids is present in the host 
genome, although most genetic elements are not essentially required, such as the 
fusion gene, two copies of the bacterial selection marker beta-lactamase and the 
replication origins. Thus, properties of the expression locus may be changed upon 
recombination due to a higher probability of illegitimate recombination and possible 
interference with the transgene (Artelt et al., 1991).   
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Figure 1-7: Schematic representation of the Flp-In
TM
 system.  Host cells are tagged at  
an expression hot spot  by a simian virus 40 promoter  (PS V4 0) followed by an ATG start  
codon, one FRT s ite (F) and a lacZ-Zeocin fusion gene. Upon co-transfect ion of the     
Flp-In
T M
 vector and a recombinase expression vector, the Flp -mediated recombination is  
initiated. The cells become resistant against hygromycin by targeted integration of the   
Flp-In
T M
 vector due to the complementation of the ATG -defic ient incoming hygromycin 
resistance gene. Thus, correctly exchanged cells can be selected stringently. At the same 
time, the GOI is integrated at the tagged expression hot spot under a cytomegalovirus 
promoter (PCM V). ampR, PUCori = bacterial beta-lactamse gene and replication of origin, 
respectively. pA = poly adenylation site, GOI = gene of interest.     
 
1.3.4 Recombinase-mediated cassette exchange in cell line development 
An enhanced system for targeted cell line development is the recombinase-mediated 
cassette exchange (RMCE) presented by Schlake and Bode (Schlake & Bode, 1994). It 
circumvents the drawbacks of the Flp-InTM system and still enables the integration of 
user-defined DNA sequences at a tagged genomic locus (Fig. 1-8). A precondition of 
RMCE is the existence of heterospecific FRT sites that are recognized by Flp, but can 
not recombine with each other. By mutating the FRT spacer region, such FRT sites 
were engineered (Schlake & Bode, 1994; Senecoff & Cox, 1986; Turan et al., 2010). 
RMCE works well with a combination of the „F3‟ FRT mutant with the wild-type („F‟), 
since recombination of F3 sites is highly efficient, while recombination between F and 
F3 sites is negligible (Schlake & Bode, 1994). Other useful combinations of FRT 
mutants have been identified more recently (Turan et al., 2010).  
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Figure 1-8: Schematic representation of RMCE with the Flp/FRT system. The 
exchange of DNA sequences flanked by two heterospecific FRT s ites (F3 and F) is 
catalysed by the recombinase Flp.   
 
Similar to other Flp recombination systems, the establishment of a RMCE system 
requires two steps. First, a stable and high producing genomic locus is tagged by an 
exchangeable gene cassette. This can be achieved either by classical antibiotic 
selection (Kim & Lee, 2008) or preparative FACS with a fluorescent protein as reporter 
(Nehlsen et al., 2009; Qiao et al., 2009). In the second step, the reporter is exchanged 
against a gene of interest by a targeted cassette exchange (Fig. 1-8). This requires that 
both genes are flanked by the same set of heterospecific FRT sites (e.g. F3 and F). The 
tagged cells are co-transfected with the targeting vector bearing the flanked gene of 
interest and an Flp expression vector. The transient expression of Flp catalyses a 
double reciprocal crossover of compatible FRT sites whereby the DNA sequences 
between the FRT sites are exchanged. The transfection vectors and the Flp 
recombinase are lost after some time. Pre-defined chromosomal loci were reused and 
extensive screening procedures were circumvented by RMCE (Baer & Bode, 2001; 
Bode et al., 2000; Oumard et al., 2006). Thus, cell line development clearly profits from 
RMCE by high expression levels and predictable cultivation properties as well as a 
shortened development timeline.     
Stringent selection methods optimise the efficiency of cassette exchange and counter-
select random integration of the targeting vector. One strategy is the selection trap. 
Verhoeyen et al. (Verhoeyen et al., 2001) cloned a non functional neomycin 
phosphotransferase gene (∆neoR) lacking the start codon directly downstream of the 
FRT cassette. Upon recombination, a promoter and a start codon, located on the 
targeting vector, transcriptionally activated the incomplete ΔneoR gene at the tagged 
locus (Fig. 1-9). The selection trap allows selection for correct RMCE events with the 
antibiotic G418. Alternatively, a negative selection marker such as the thymidine kinase 
gene may be included in the initial tagging construct, thus allowing the specific 
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elimination of all cells without exchanged cassette by ganciclovir selection (Toledo et 
al., 2006; Wong et al., 2005).  
The promoter trap describes a combination of a FRT-cassette downstream of an 
activating promoter and a promoterless targeting vector. Thus, only RMCE, but not 
random integration, can lead to expression of the gene of interest on the targeting 
vector (Cobellis et al., 2005). 
 
    
Figure 1-9: Schematic presentation of RMCE with a neomycin selection trap and a 
promoter trap. The scheme summarizes the strategy for  selection of successfully 
targeted clones that was applied in the present work. The neomycin selection trap is  
based on the ATG-deficient neomycin resistance gene (∆neo
R
) in the tagged locus. Thus, 
parental cells are sensitive to G418. The missing promoter (or internal ribosomal entry 
site, IRES) and the start codon are located on the incoming targeting vector. Upon RMCE, 
these elements are posit ioned upstream of the neomycin resistance gene, which becomes 
activated and confers resistance against G418. The promoter trap requires a promoter 
upstream of the exchangeable gene cassette. The incoming gene does not need an 
additional promoter. Thus, GOI expression indicates a correct recombination.  Cones = 
FRT sites (F3 and F), P = promoter, pentagons = secreted protein product encoded by the 
GOI. 
   
Since its development, RMCE has been applied in different ways for generating cell 
lines producing viruses (Schucht et al., 2006), erythropoietin (Kim & Lee, 2008) or 
antibodies (Nehlsen et al., 2009). In this work, it was used to establish cell lines for the 
production of mammalian glycoproteins for structural analysis by crystallography.  
 
1.4 Mammalian proteins for structural analysis 
 
1.4.1 Regulation of recombinant protein production 
Recombinant protein production in mammalian cells is a complex process requiring 
transcription, mRNA processing and transport, translation, post-translational 
modification, protein folding and subcellular transport through the secretory pathway. 
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Although transcription is traditionally considered to be the most dominant factor 
controlling expression level and stability, all steps are tightly regulated in the host cell 
line and have an impact on the specific productivity of any producer cell line (Barnes et 
al., 2003). Strategies to augment productivity aim, for instance, at the architecture of the 
expression cassette. The choice of promoter, enhancer, poly-adenylation signal, as well 
as the order, orientation and distances between these elements contribute to the overall 
expression strength (Kim et al., 2009). Additionally, the sequence of the transgene itself 
can be optimised for higher production by adjusting codon usage and optimizing RNA 
secondary structure and stability (Kalwy et al., 2006). For secreted proteins, it has been 
recognized that the secretion capacity of a cell can become limiting in the presence of 
high recombinant mRNA levels (Peng & Fussenegger, 2009). For secretion, newly 
synthesized proteins pass through a series of compartments within the cell, including 
the rough endoplasmatic reticulum (rough ER) and the Golgi apparatus (Palade, 1975). 
Genetic engineering was applied at different points to enhance the secretion of 
recombinant proteins. First approaches altered the ER environment, an important region 
for glycosylation, folding and assembly of proteins. Overexpression of molecular 
chaperones assisting the folding of newly synthesized proteins was induced. However, 
overexpression of the chaperon BiP/GRP78 and the protein disulfide isomerase (PDI) 
led to contradictory results for different proteins. While PDI overexpression in CHO cells 
reduced the expression of a TNFR:FC fusion protein (Davis et al., 2000), the specific 
production rate of an antibody was increased by 40% (Borth et al., 2005). Further 
engineering approaches successfully focused on the overexpression of ceramide 
transport protein (CERT) which is involved in protein transport from Golgi apparatus to 
the plasma membrane (Florin et al., 2009) or the X-box binding protein 1 (XBP-1) which 
is a transcription activator affecting multiple key genes in the secretory pathway (Becker 
et al., 2008). However, it was demonstrated that XBP-1 expression enhanced apoptosis 
in CHO cells (Becker et al., 2010). A combinatorial approach co-expressing XBP-1 and 
the anti-apoptotic protein X-linked inhibitor of apoptosis (XIAP) achieved elevated 
specific productivities and final titres in fed-batch cultures of polyclonal cell lines when 
compared with control cells. 
Anti-apoptose engineering strategies are considered to be an important factor for viable 
cell density and thus protein yield and have already been applied before  (Mastrangelo 
et al., 2000). Most strategies focus on the overexpression of anti-apoptosis genes of the 
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Bcl-2 family (Lee & Lee, 2003) or caspase inhibitors such as XIAP (Sauerwald et al., 
2002). 
 
1.4.2 Glycoprotein production for X-ray structure analysis 
Beyond their production in sufficient amounts, glycoproteins pose another challenge for 
X-ray structure analysis. Though being required for folding and transport through the 
secretory pathway via endoplasmatic reticulum and the Golgi apparatus, the flexible and 
heterogeneous nature of N- and O-linked mammalian glycosylation generally hampers 
crystallisation (Butters et al., 1999). The glycans may also mask possible crystal 
contacts on the protein surface. Heterogeneity of the carbohydrate chains is determined 
by variable glycan composition (micro-heterogeneity) and non-uniformly occupied sites 
(macro-heterogeneity). Since O-linked glycans are often located in extended, unfolded, 
serine-, threonine- and proline-rich regions of a protein, they can generally be removed 
by mutagenesis or generating expression constructs without the corresponding domain 
(Nettleship et al., 2010). On the contrary, N-linked glycosylation of the Asn-X-Ser/Thr 
motif is generally necessary for protein folding and stability. Variably occupied sites are 
regarded as not essential for folding and stability and thus can be removed by genetic 
engineering (Nettleship et al., 2007). The composition of N-linked glycosylation can be 
classified in high-mannose, complex and hybrid type glycans of different length and 
branch number (Fig. 1-10 A). To circumvent the problems due to essential glycans, 
glycoproteins can be produced in the presence of glycosylation pathway inhibitors or 
directly by glycosylation mutant cell lines. The addition of glycosylation pathway 
inhibitors like N-butyldeoxynojirimycin (NB-DNJ), swainsonine and kifunensine to a 
production cell line results in glycoproteins with truncated carbohydrate chains (Fig. 1-
10 B) (Chang et al., 2007). Glycans of high-mannose type can be further truncated 
efficiently to a single N-acetylglucosamine (GlcNAc) by endoglycosidase H (endo H). 
Although all simplified glycans are sensitive to endo H cleavage, the truncation is most 
efficient with kifunensine treated glycoproteins bearing Man9GlcNAc2 sugar chains 
(Nettleship et al., 2010). Thus, for crystallisation projects, kifunensine has been used 
with endo H treatment (Bishop et al., 2009; Bowden et al., 2008a; Bowden et al., 2008b; 
Carafoli et al., 2009), but also without (Crispin et al., 2009). The inhibitory drugs can be 
combined with protein production in glycosylation mutant cell lines for an even higher 
stringency of glycan truncation. Various mutant CHO and HEK293 cell lines are 
available synthesizing glycoproteins with truncated carbohydrates. CHO Lec3.2.8.1 and 
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HEK293S cells, for instance, do not process N-linked glycans beyond the high-mannose 
type Man5GlcNAc2 (Fig. 1-10 C) (Reeves et al., 2002; Stanley, 1989). Their protein 
products are therefore more homogenous and more likely to crystallize (Davis et al., 
1993). For a further truncation, the N-linked glycans are amenable to endo H cleavage 
(Chang et al., 2007; Wilke et al., 2010). The use of mutant cell lines enabled the 
crystallization of various glycoproteins (Niemann et al., 2007; Reeves et al., 2002).   
 
 
Fig. 1-10: Diagramatic representation of the major N-linked glycans produced by (A) 
mammalian cel ls, (B) CHO and HEK293 cells in the presence of the N -glycan processing 
inhibitors N-butyldeoxynojir imycin (NB-DNJ), swainosine and kifunensine and (C) the 
mammalian mutant cell lines CHO Lec3.2.8.1 and HEK293S.    
 
1.4.3 Hepatocyte growth factor  
Human hepatocyte growth factor (HGF) acts as a mitogen in cultured primary 
hepatocytes (Nakamura et al., 1984; Nakamura et al., 1989). It was independently 
discovered and described as strong motility or scatter factor (SF) for epithelial cells 
(Stoker & Perryman, 1985). The identity of HGF and SF was demonstrated later 
(Weidner et al., 1991). By binding to the receptor tyrosine kinase c-Met, HGF/SF 
activates intracellular signalling pathways resulting in versatile biological responses 
(Fig. 1-11). These are involved in promoting cell proliferation, survival, migration, neurite 
extension, angiogenesis, wound repair and cell migration during development 
(Birchmeier et al., 2003; Chmielowiec et al., 2007; Funakoshi & Nakamura, 2003; Huh 
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et al., 2004). Deregulated activation of the HGF/SF receptor c-Met is associated with 
tumour invasion in many cancers with an aggressive phenotype and poor prognosis 
(Birchmeier et al., 2003; Eder et al., 2009). Thus, inhibition of Met activity, either by 
small molecule kinase inhibitors or by protein-based HGF/SF antagonists, has become 
an important strategy for developing anticancer therapeutics (Tolbert et al., 2010).   
 
 
Figure 1-11: Schematic representation of HGF/SF and cellular responses of c -Met 
signalling upon stimulation with HGF/SF. Mature HGF/SF is generated by proteolytic 
cleavage from its single-chain precursor pro-HGF. By binding to the receptor tyrosine 
kinase c-Met, HGF/SF activates various intracellular signalling pathways. N: N-terminal 
domain; K1-4: Kringle domains; SPH: serine protease homolog y domain. (Crystal  
structures of the NK1 and SPH domains derive from Birchmeier et al. , 2003). 
 
Structurally, human HGF/SF is a disulphide-linked heterodimer containing 698 residues 
and four N-linked glycosylation sites. The 57.3 kDa α-chain comprises an N-terminal 
loop domain and four kringle domains, while the 22.6 kDa β-chain contains a serine 
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protease like domain without enzymatic activity (Fig. 1-11) (Miyazawa et al., 1989). 
Despite the missing catalytic function, HGF/SF belongs to the family of serine protease 
growth factors. It is synthesised and secreted as a biological inactive single chain 
precursor (proHGF) which binds to Met, but is not capable to activate it (Gherardi et al., 
2006). A serine protease mediated cleavage at arginine-494 induces conformational 
changes leading to an active two chain form of HGF/SF (Stamos et al., 2004). Insights 
in this activation mechanism have been exploited by generating synthetic versions of 
proHGF that can not be activated. While one approach aimed at modifying the 
“activation pocket” of the HGF/SF β-chain (Kirchhofer et al., 2007), Gherardi et al. 
(Gherardi et al., 2006) mutated arginine-494 in the recognition site to glutamate which 
resulted in a non cleavable single chain variant of HGF/SF (scHGF). A detailed three 
dimensional structural analysis of the respective scHGF variant in complex with the c-
Met receptor may give further insights in conformational changes of HGF/SF upon 
cleavage and the activation process of receptor tyrosine kinases. 
 
1.4.4 LAMP-3 
The human lysosome associated membrane protein 3 (LAMP-3) comprises 416 amino 
acids and belongs to the family of lysosome associated glycoproteins. It is also known 
as DC-LAMP, since its mRNA is exclusively detected in dendritic cells (DC) in lymphoid 
organs (de Saint-Vis et al., 1998) and in lung type II pneumocytes (Akasaki et al., 2004). 
Its expression increases steadily during DC maturation and sharply and strongly upon 
DC activation by lipopolysaccharide, tumour necrose factor α or CD40L. Shortly before 
the MHC class II molecules are translocated to the cell membrane, LAMP-3 is 
detectable in the MHC class II compartment. Due to its localisation it is assumed that 
LAMP-3 function in lysosomes is related to presentation of peptide-MHCII complexes at 
the DC surface (de Saint-Vis et al., 1998). Overexpression of LAMP-3 in tumour cells 
was found to coincide with an increased potential of metastasis and thus may serve as 
a prognostic factor for diverse cancer types (Kanao et al., 2005; Ozaki et al., 1998).  
Members of the LAMP family are type I transmembrane proteins and thus have one 
transmembrane helix (Fig. 1-12). The helix connects the short cytoplasmic part 
containing a glycine-tyrosine motif with a luminal part, consisting of two domains. 
LAMP-3 is homologous to other family members such as LAMP-1 (28.9% sequence 
identity), LAMP-2 (26.9% sequence identity) and CD68/macrosialin (28.1% sequence 
identity). LAMP-1 and LAMP-2 are involved in lysosomal biogenesis, lysosomal fusion 
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of phagosomes and autophagy (Eskelinen & Saftig, 2009; Huynh et al., 2007). The two 
luminal domains of LAMP-1 and 2 contain four disulphide bonds each. LAMP-3 and 
human CD68/macrosialin (a dendritic cell/macrophage marker) differ from the other 
LAMP members, as they only contain four cysteines that may form disulphide bonds. 
These are located in the membrane proximal half of the luminal region. The membrane 
distal domains contain several serine, threonine and proline residues that are thought to 
be modified by O-linked glycans as it is the case in mucin-like proteins (Holness & 
Simmons, 1993). The LAMP-3 amino acid sequence also contains seven potential N-
linked glycosylation sites. Thus, the observed molecular mass in SDS-PAGE is around 
70-90 kDa, whereas the calculated mass for the polypeptide core is 44 kDa (de Saint-
Vis et al., 1998). Knowledge of the structure of the luminal LAMP domain is currently 
limited to the position of N-glycosylation sites and the disulphide bridge configuration. 
Structural analysis of LAMP-3 luminal domains would reveal its unknown three-
dimensional structure which could provide information about its molecular mode of 
action.  
 
 
Figure 1-12: Schematic presentation of LAMP-3. LAMP-3 is localized in lysosomes of 
dendritic cells. N- and O-glycans are indicated by tr idents and Ys, respectively. The 
position of the disulphide bonds is indicated. The larger part of the molecule resides in the 
lysosomal lumen.  
 
1.5  Aims of the thesis 
Structure determination of mammalian glycoproteins often calls for recombinant 
production in mammalian cells due to their complex processing. X-ray structure analysis 
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frequently requires generating several genetic constructs per protein to create well 
crystallisable material. However, establishing stable production cell lines remains time-
consuming and expensive. Additionally, the heterogeneous and complex glycosylation 
of mammalians complicates crystallisation of glycoproteins. Thus, strategies capable of 
dealing with the glycosylation problem and enabling straightforward cell line 
development are of essential interest. 
The primary aim of this work was the development of strategies simplifying the 
production and crystallization of glycoproteins. The glycosylation mutant CHO 
Lec3.2.8.1 cell line that produces more homogenous glycoprotein suitable for 
crystallisation was selected as host cell. The CHO Lec3.2.8.1 genome should be 
modified using Flp-mediated recombination in order to optimise cell line development 
towards higher-throughput and predictable expression strength. To this end, two 
strategies were available for evaluation, namely a GFP excision model  (Kaufman et al., 
2008) and RMCE (Schlake & Bode, 1994; Schucht et al., 2006). Possible target proteins 
were RFP, HygTk, human scHGF and a human luminal membrane-proximal domain of 
LAMP-3 (hLAMP3-prox). 
At the beginning of this work no member of the LAMP family had been structurally 
characterized and no homologous structure had been available for phase determination 
by molecular replacement. Thus, another aim of this thesis was the determination of the 
crystal structure of hLAMP3-prox domain as a representative for LAMP family members. 
Upon cell line development, procedures for the recombinant production, purification, 
crystallisation and crystal derivatisation were to be established. 
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2 Material and Methods 
 
2.1 Instruments 
 
Table 2-1: Instruments 
Instrument Model Company 
Autoclave 
Biochemical 
Analyser 
Blot chamber 
Cell counter 
Cell culture 
incubator 
 
Centrifuges 
 
 
 
Centrifuge rotor 
Clean Benches 
Cryostorage system 
 
Gel electrophoresis 
chambers 
Electroporator 
FACS 
 
Flow cytometer 
 
Fluorescence  
microscope 
FPLC system 
Incubator 
Incubation shaker 
Laboratory shaker 
Light microscope 
 
 
Luminometer 
pH meter 
Photometer 
Pipetting robot 
Power supply 
SDS-PAGE system 
Speed Vac 
Thermo cycler 
Thermo mixer 
UV-imaging system 
Steam-Sterilizer 9-6-9 
YSI 2700 select 
Trans-Blot SD 
CASY Model TTC 
BB15 
Forma Reach-In CO2 
Biofuge pico 
Multifuge 1S-R 
5417R 
4K15C 
RC6 
RC12BP 
SA-600, SLA-3000 
Hera Safe KS15 
10 K series cryostorage 
system  
Wide Mini Sub Cell GT 
Sub-cell Model 96 
GenePulser Nucleofector® 
MoFlo 
FACSAria 
Easy Cyte Mini 
LSR II 
Axiovert 1000 
Digital camera: DMX1200 
Äkta-FPLC (UPC-900, P-920) 
B20 
Multitron II 
WT12 
CKX4 
SZ40 
Digital camera: DP11 
LAS 3000 
S20-K Seven Easy pH 
NanoDrop ND-1000 
Mosquito 
Power-Pac 300 
Mini Protean III 
RC 1010 
T-Gradient 
5436 
Gel Logic212  
Belimed 
Yellow Springs Instruments 
BioRad 
Innovartis AG 
Heraeus 
Thermo Scientific 
Heraeus 
Heraeus 
Eppendorf 
Sigma 
Sorvall Instruments 
Sorvall Instruments 
Sorvall Instruments 
Thermo Electron Corporation 
Taylor-Wharton 
 
BioRad 
BioRad 
Amaxa 
Beckman Coulter 
Becton Dickinson 
Guava Technologies 
Becton Dickinson 
Zeiss 
Nikon 
Amersham pharmacia biotech 
Heraeus 
Infors 
Biometra 
Olympus 
Olympus 
Olympus 
FujiFilm 
Mettler Toledo 
PeqLab Biotechnology 
TTP Labtech 
BioRad 
BioRad 
Thermo Electron Corporation 
Biometra 
Eppendorf 
Kodak 
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Instrument Model Company 
Vortexer 
Water purifier 
X-ray generator  
Vortex Genie2TM 
Milli-Q Plus 
RU-H3R  
Scientific Industries 
Millipore 
Rigaku MSC 
 
2.2 Material 
 
2.2.1 Chemicals and cell culture material  
If not stated otherwise, chemicals were purchased from the following companies: 
Amersham, Bayer, Biolabs, Boehringer, Clontech, Difco, Fluka, Gibco, GE-Healthcare, 
Hampton Research, Hoechst, Invitrogen, Merck, Millipore, MoBiTec, Novagen, 
Promega, Qiagen, Riedel de Haen, Roche, Roth, Serva, Sigma-Aldrich and Stratagene. 
The quality standard was “pro analysis” (p.a.). Polystyrene, polycarbonat and glass cell 
culture materials were procured by Falcon, Greiner and Nunc. 
 
2.2.2 Enzymes 
 
Table 2-2: Enzymes 
 
2.2.3 Molecular weight standards 
 
Table 2-3: Molecular weight standards. 
Name Type Usage Company 
DNA Molecular Weight Marker II,    
   DIG-labeled 
λ BstP I digest 
DNA 
 
DNA 
Southern Blot 
 
Agarose gel 
electrophorese 
Roche 
 
Takara 
Precision Plus Protein Unstained Protein SDS-PAGE BioRad 
Precision Plus Protein All Blue  Protein  SDS-PAGE/Western 
Blot 
BioRad 
Name Company 
Benzonase 
CIP (Calf Intestine Phosphatase) 
Novagen 
New England Biolabs (NEB) 
Expand High FidelityPlus Polymerase Roche 
Restriction endonucleases 
RNase A 
T4 DNA-Ligase 
T4 DNA-Polymerase 
Taq Polymerase 
Trypsin/ EDTA 
New England Biolabs (NEB) 
Boehringer Mannheim 
New England Biolabs (NEB) 
New England Biolabs (NEB) 
New England Biolabs (NEB) 
PAA Laboratories 
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2.2.4 Media 
E.coli medium   
LB-medium (Luria-Bertani): Tryptone (Bacto) 10  g/L 
 Yeast extract (Bacto) 5 g/L 
 NaCl 5 g/L 
   
LB-agar: LB-medium +  
 agar (Bacto) 16 g/L 
   
SOC-medium: Tryptone (Bacto) 20 g/L 
 Yeast extract (Bacto) 5 g/L 
 NaCl 10 mM 
 KCl 2.5 mM 
 Glucose    2 mM 
 MgCl2 10 mM 
 MgSO4     10 mM 
 
If not stated otherwise, media for bacterial cultures were autoclaved 20 min at 
121°C. Heat instable components such as glucose and antibiotics were added 
after filtration (0.2 µm). 
 
Mammalian cell medium   
ProCHO5-medium: Lonza; supplemented with 7.5 mM L-
glutamine (Roth) and 11 mg/L phenolred 
(Sigma) 
   
ProCHO5 + ZKT-I [1:1]: ProCHO5 powder (Cambrex) 13.8 g/L 
medium ZKT-I powder (Biochrom)  6.1 g/L 
 NaHCO3 (Merck) 2.9 g/L 
 L-glutamin (Roth) 3.8 mM 
 NaOH 2 mM 
 Human Insulin (Cambrex) 0,1% (v/v) 
 2x CHO7 lipids supplement 
(Cambrex) 
0.04% (v/v) 
   
CD-Hybridoma medium: Invitrogen; supplemented with 8 mM L-
glutamine (Roth) and 5-10% FCS (Gibco) 
 
If not stated otherwise, supplements were filtered (0.2 µm) before addition to the 
medium. Powder media for mammalian cell cultures were sterilized after solving 
in purified water (MilliQ) by a filtration line (Pall) combining two nylon filter units 
with decreasing pore size (1 µm, 0.2 µm).     
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2.2.5 Antibiotics 
The following antibiotics were used for various cultured cells to ensure the selectivity of 
liquid and solid media. 
 
Table 2-4: Antibiotics. 
Name Stocking concentration Final concentration 
Ampicillin 100 mg/ ml 100 µg/ ml 
G418 100 mg/ ml 1.5 mg/ ml 
Hygromycin B 100 mg/ ml 150 µg/ ml 
 
2.2.6 Bacterial strains 
 
Table 2-5: Bacterial strains. 
E.coli 
strain 
Genotype Source 
Top 10 
F-, mcr A Δ(mrr-hsdRMS-mcrBC) Φ80 lacZ Δ M15 ΔlacX74 
recA1 araD139 Δ(ara-leu)7697 gal U gal K rpsL endA1nupG. 
Invitrogen 
XL1-
Blue 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ 
proAB lacIqZΔM15 Tn10 (Tetr)]. 
Stratagene 
DH5α 
F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZ ∆M15 ∆(lacZYA- argF)U169, hsdR17(rK- mK +), λ-. 
Invitrogen 
 
2.2.7 Mammalian cell line 
CHO Lec3.2.8.1 This line is a glycosylation mutant clone derived from the parental 
Chinese hamster ovary (CHO) clone Pro-5 (a proline auxotroph, 
ATCC no. CRL 1781) by selection for resistance to different 
lectins (Stanley, 1989). This clone was adapted to grow in 
suspension.  
 
2.2.8 Oligonucleotides 
Oligonucleotides were used as primers for polymerase chain reactions (PCRs) and 
DNA sequencing. They were purchased from MWG Eurofins Operon (desalted or HPSF 
purified). 
 
Table 2-6: Oligonucleotides. 
No. Name Length 
(bp) 
Sequence (5'  3') 
1 AY188393_F 17 AAGCAGCTGGCGCTGGA 
2 AY188393_R 17 TGGAGGCCACCTCCCGA 
3 BGH_rev 18 TAGAAGGCACAGTCGAGG 
4 CassettepEF_S 28 TCGGGAGATCTCGACCGAGCTTTGCAAA 
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No. Name Length 
(bp) 
Sequence (5'  3') 
5 CassettepEF_AS 30 TGCTCGAGCGGCCGCTCTAGAACTAGTGGA 
6 CMVfor 21 CGCAAATGGGCGGTAGGCGTG 
7 dneo1-AS 24 CAGTTCATTCAGGGCACCGGACAG 
8 dneo-pEF-FS-2 37 TAGATGCATGCTCGAGCGACTCTAGAGGATCCCC
CGA 
9 dneo-pEF-S-1 36 AGGAACTTCGGAATTCAGTGGATTGCACGCAGGT
TC 
10 flpo_as 24 GGAGGGAGAGGGGCGGAATTCTTA 
11 flpo_s 25 CGGCGGCTCTAGAATGGCTCCTAAG 
12 GFPKassette_AS 29 GCAGCCAGGGCGTGGAAGTAATTCAAGG 
13 GFPKassette_S 29 TCACATGGTCCTGCTGGAGTTCGTGACCG 
14 HygTk_771S 19 CGAGGTCGCCAACATCTTC 
15 HygTk_HpaI_as 30 GTATCCAATTGCGATTAGCCTCCCCCATCT 
16 HygTk_IRES_s 30 ACACGATAAGCTATGAAAAAGCCTGAACTC 
17 HygTk-pEF-1 36 CCGGTCGCCACCATGAAAAAGCCTGAACTCACCG
CG 
18 HygTk-pEF-2 39 ATCGCCAGTCACGCGTCAGTTAGCCTCCCCCATC
TCCCG 
19 IRES_as 38 GAGTTCAGGCTTTTTCATAGCTTATCATCGTGTTT
TTC 
20 IRES_s 27 ACTACCAATTGCAGGTAAGTATCAAGG 
21 IVS_as 18 TGAACTGGGAGTGGACAC 
22 KonkatemerGFP
Kassette_AS 
29 GCAGCCAGGGGCGTGGAAGTAATTCAAGG 
23 KonkatemerGFP
Kassette_S 
29 TCACATGGTCCTGCTGGAGTTCGTGACCG 
24 KonkatemerRFP
Kassette_AS 
28 CGGAGGAGGCCATGGTGGCGACCGGAAA 
25 KonkatemerRFP
Kassette_S 
30 CTGCCCGCGCGGTGTTCCGCATTCTGCAAG 
26 KonkatemerTest_
asPr 
30 TCGAGCGGCCGCTCTAGAACTAGTGGATCC 
27 KonkatemerTest_
s 
20 AAAGGAGTGGGAATTGGCTC 
28 pEF-F3/2-GFP-
MCS-for 
18 TCACTGCATTCTAGTTGT 
29 pEF-FS-AS2 25 GAATTCCGAAGTTCCTATACTTTCT 
30 pEF-FS-S 28 GTGTCGTGAGGAATTAGCTTGACCAAGC 
31 pEF_qPCR_F 17 CCCGAGGGTGGGGGAGA 
32 pFS-S 30 GGAGATCAGCTTGAAGTTCCTATTCCGAAG 
33 PGK_AS 28 CCTGGGGAGAGAGGTCGGTGATTCGGTC 
34 pgkatg-pfsrfp-1 65 GTTCCTGTAGCGGCCGCACGCGTATTTAAATGAT
CCAGACATGATAAGATACATTGATGAGTTTG 
35 pgkatg-pfsrfp-2 79 TAGATGCATGCTCGAGAAGTTCCTATACTTTCTAG
AGAATAGGAACTTCGGAATAGGAACTTCTCCATGT
TGGCGACCG 
36 SEAP_AS 40 CGATCAATTGAGATCTCTCAACCCGGGTGCGCGG
CGTCGG 
37 SEAP_S 50 CGATCTTCGAATTTCCGATCGATCCACCATGCTGC
TGCTGCTGCTGCTGC 
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2.2.9   Vectors 
The following vectors were used. 
 
C53  
 
 
pEFF3EGFPF3mcs 
 
 
 
 
 
pEFF3EGFPF3scHGF 
pBlueScript vector bearing scHGF cDNA. (Gherardi, 
E., MRC, Cambridge) 
 
Tagging vector of the GFP-excision system. The EGFP 
gene is flanked by two F3 FRT sites. A multiple cloning 
site is located downstream of the second FRT site. The 
gene cassette is under control of the human elongation 
factor 1-α (EF1-α) promoter (Kaufman et al., 2008). 
 
Tagging vector of the GFP-excision system to generate 
scHGF production cell lines. The scHGF gene 
including a C-terminal His6-tag and a mouse 
immunoglobulin signal peptide (Swissprot P01750) 
were cut out from C53 by XbaI and cloned into 
pEFF3EGFPF3mcs cut by SpeI.    
 
pEFF3EGFPF3LAMP3 
 
 
 
 
 
 
 
pEF-FS-EGFP 
 
 
 
 
 
 
 
Tagging vector of the GFP-excision system to generate 
hLAMP3-prox production cell lines. A sequence 
encoding a mouse immunoglobulin signal peptide 
(Swissprot P01750), amino acids 222-381 
(VKTG...SDYT) of LAMP-3 (GenBank AAH32940) and 
a His6-tag was cloned between the BamHI and NotI 
sites of pEFF3EGFPF3mcs.  
 
Tagging vector of a RMCE system expressing EGFP 
under control of the human EF1-α promoter. EGFP and 
a SV40 polyA site are flanked by F3 and wild type FRT 
sites. (Gossen, M., MDC, Berlin) 
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pEF-FS-EGFP-dneo 
 
 
 
 
 
 
pF3LMCSF_RFP_Express   
 
 
 
pFS-EGFP 
 
 
 
pFS-EGFP-IRES-HygTk 
 
 
 
 
 
 
 
 
 
 
 
pFS-GILT-PGK 
 
 
 
 
 
 
EGFP expressing tagging vector of a RMCE system 
with neomycin selection trap. An ATG-deleted 
neomycin phosphotransferase (∆neoR) gene was PCR 
amplified with primers 8 and 9 on ptagSVHTGdneodC 
and cloned between EcoRI and XhoI in pEF-FS-EGFP 
by the In-Fusion Cloning system (Clontech). 
 
Eukaryotic expression vector of DsRed Express under 
control of a CMV IE promoter. (Qiao, J., HZI, 
Braunschweig) 
 
EGFP targeting vector compatible with the pEF-FS-
EGFP RMCE system. The vector pEF-FS-EGFP was 
cut by BglII and HindIII, blunted and ligated.  
 
EGFP and HygTk targeting vector compatible with the 
pEF-FS-EGFP RMCE system. The IRES element was 
PCR amplified with primers 19/ 20 on pIRESneo3 
(Clontech) while the HygTk gene was PCR amplified 
with primers 15/ 16 on ptagSVHTGdneodC. The 
primers were designed to mediate a homologous 
recombination in a third PCR amplification (primers 15/ 
20) resulting in a 2.95 kb fragment. The third PCR 
product and the vector pFS-EGFP were cut by MfeI/ 
HpaI. The vector was dephosphorylated and ligated 
with the PCR product.      
 
GILT targeting vector compatible with the pEF-FS-
EGFP-dneo RMCE system. (Büssow, K., HZI, 
Braunschweig) 
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pFS-HygTk 
 
 
 
 
 
pFS-scHGF-PGK 
 
 
 
 
 
pFS-scHGF-IRES-HygTk 
 
 
 
pFS-FcεIα-PGK 
 
 
 
pFS-hLAMP2lum-PGK 
 
 
 
pFS-hLAMP3-PGK 
 
 
 
pFS-mLAMP2lum-PGK 
 
 
 
 
 
HygTk targeting vector compatible with the pEF-FS-
EGFP RMCE system. After EGFP excision in pFS-
EGFP by NcoI and MluI the PCR amplified HygTk 
gene from ptagSVHTGdneodC (primers 17/ 18) was 
inserted by the In-Fusion cloning system (Clontech).  
 
scHGF targeting vector compatible with the pEF-FS-
EGFP-dneo RMCE system. The vector pFS-RFP-PGK 
was cut by BstBI, blunted, cut by NotI and 
dephosphorylated. It was ligated with a 2.2 kb fragment 
of pEFF3EGFPF3scHGF cut by SmaI and NotI.   
 
scHGF and HygTk targeting vector compatible with the 
pEF-FS-EGFP RMCE system. (Duda, A., HZI, 
Braunschweig) 
 
FcεIα targeting vector compatible with the pEF-FS-
EGFP-dneo RMCE system. (Owens, R., OPPF, 
Oxford) 
 
hLAMP2-lum targeting vector compatible with the pEF-
FS-EGFP-dneo RMCE system. (Büssow, K., HZI, 
Braunschweig) 
 
hLAMP3-prox targeting vector compatible with the 
pEF-FS-EGFP-dneo RMCE system. (Büssow, K., HZI, 
Braunschweig) 
 
mLAMP2lum targeting vector compatible with the pEF-
FS-EGFP-dneo RMCE system. (Büssow, K., HZI, 
Braunschweig) 
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pFS-NALP3-H8-PGK 
 
 
 
pFS-RFP 
 
 
 
 
 
 
pFS-RFP-PGK 
 
 
 
 
 
 
 
 
 
 
pFS-rLAMP2dist-PGK 
 
 
 
pFS-rLAMPlum-PGK 
 
 
 
pFS-SEAP-IRES-HygTk 
 
 
 
NALP3-His8 targeting vector compatible with the     
pEF-FS-EGFP-dneo RMCE system. (Polle, L., HZI, 
Braunschweig) 
 
RFP targeting vector compatible with the                 
pEF-FS-EGFP RMCE system. The vector 
pF3LMCSF_RFP_Express was cut by NotI. The      
1.55 kb fragment was made blunt-end and cut with 
NcoI. The 0.63 kb fragment was ligated into the 2.5 kb 
fragment of a MluI/ NcoI cut pFS-EGFP vector.   
 
RFP targeting vector compatible with the pEF-FS-
EGFP-dneo RMCE system. The PGK promoter 
sequence and the ATG start codon were PCR 
amplified on pPGKMFGeGFP1. The primers 34/ 35 
were designed according to the In-Fusion PCR 
protocol (Clontech). An additional 5‟ tail of the 
antisense primer contained a wild type FRT sequence. 
The 1022 bp PCR product was cloned into the NotI/ 
XhoI cut vector pFS-RFP by the In-Fusion PCR 
system. 
 
rLAMP2-dist targeting vector compatible with the pEF-
FS-EGFP-dneo RMCE system. (Büssow, K., HZI, 
Braunschweig) 
 
rLAMP2-lum targeting vector compatible with the pEF-
FS-EGFP-dneo RMCE system. (Büssow, K., HZI, 
Braunschweig) 
 
SEAP and HygTk targeting vector compatible with the 
pEF-FS-EGFP RMCE system. The SEAP gene was 
PCR amplified with primers 36/ 37 on pSBC2SEAP 
(SB, HZI) and cut by BstBI/ MfeI. The vector pFS-
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pflpo-puro 
 
 
 
pPGKMFGeGFP1 
 
 
 
 
 
 
ptagSVHTGdneodC 
EGFP-IRES-HygTk was also cut by BstBI/ MfeI, and 
dephosphorylated to exchange the EGFP gene by the 
SEAP gene.   
 
Eukaryotic expression vector for the codon optimised 
recombinase FlpO and a puromycin resistance gene 
(Turan et al., 2010).   
 
EGFP targeting vector of a RMCE system. The gene 
cassette is flanked by a wt and a F5 FRT site. It bears 
an EGFP gene between MLV 5‟ and MLV 3‟ 
sequences and a human PGK promoter at the 3‟ end 
followed by an ATG start codon. (Wirth, D., HZI, 
Braunschweig)    
 
Tagging vector of a RMCE system expressing HygTk. 
The SV40 promoter, the HygTk gene and a SV40 late 
polyA site are flanked by a wt and a F5 FRT site. There 
is an ATG-deleted neomycin phosphotransferase 
(∆neoR) gene downstream of the F5 FRT site. (Wirth, 
D., HZI, Braunschweig)   
 
2.2.10  Software 
Text, graphic design and tables were generated by Microsoft software Word, 
Powerpoint and Excel and CoralDraw X3 (Adobe). Image editing was done by 
Photoshop 5.0 (Adobe). For the development of cloning strategies, PCR primer design, 
restriction- and sequence analysis Vector NTI suite 8.0 software (Invitrogen) was used. 
Pairwise and multiple sequence alignments were performed using CLUSTALW 
(Thompson, 1994) and EMBOSS (Rice et al., 2000). 
 
2.3 Molecular biology methods 
Molecular-biological methods used in this work are adapted from standard collections of 
methods and protocols (Ausubel et al., 2007; Coligan et al., 2002; Sambrook & Russell, 
2000).  
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2.3.1 Polymerase chain reaction (PCR) 
Target genes from genomic DNA or template plasmids were amplified by polymerase 
chain reaction (PCR) to allow cloning into the respective recipient plasmid, analysis of 
cloned plasmids (Colony PCR) and analysis of eukaryotic high molecular weight (HMW) 
DNA. Standard PCR mixtures contained: 
 
Table 2-7:  PCR reagent mixes. 
Component Expand HifiPlus 
polymerase reagent mix 
Taq polymerase                 
reagent mix (Colony-PCR)   
Primer forward (10 µM) 0.4 µM 0.3 µM 
Primer reverse (10 µM) 0.4 µM 0.3 µM 
Reaction buffer  20% (v/v) (1.5 mM MgCl2) 10% (v/v) (2 mM MgCl2) 
Betaine (5M) - 1.25 M 
dNTPs (10 mM) 0.2 mM 65.5 µM  
DMSO 5% (v/v) - 
Polymerase  2.5 U – 5 U  1 U  
Template 10 pg – 10 ng  (plasmid 
DNA) 
50 ng – 100 ng (HMW DNA) 
DNA from one E. coli colony  
Water (MilliQ purified)  add up to 20 – 50 µl add up to 20 µl 
 
The reaction was performed in a thermo cycler T-Gradient (Biometra). Typical runs 
were carried out as described in the polymerase manufacturer‟s protocol or as follows.  
 
Table 2-8: Thermo cycler program. The Annealing temperature depended on the primers‟ Tm. 
 
Amplificates were analysed by agarose gel electrophoresis (2.3.2). If necessary, they 
were purified by gel extraction (2.3.3).  
 
Program T (°C) Time Cycles (n) dT/dn(s) 
Heating 
rate 
Initial  
denaturation 
94 2 min 1   3°C/s 
Denaturation 
Annealing 
Elongation 
94 
Tm – 5 to 10 
72 
30 s 
30 s 
1 min/kb 
5-10 
  3°C/s 
  3°C/s 
  3°C/s 
Denaturation 
Annealing 
94 
Tm – 5 to 10 
30 s 
30 s 
 
10-20 
 
10 
3°C/s 
3°C/s 
Elongation 72 1 min/kb 3°C/s 
Final elongation 72 7 min 1  3°C/s 
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2.3.2 Agarose gel electrophoresis 
DNA samples were analysed by agarose gel electrophoresis using gels prepared from 
0.8 % (w/v) agarose in TAE, brought to boil in a microwave. After cooling to ~60°C, the 
agarose solution was supplemented with ethidium bromide (10 mg/mL stock solution, 
1:20.000) for DNA visualization and poured into an electrophoresis chamber. Plastic 
combs with teeth of different width were used to create sample pockets of desired 
volume. 
DNA samples were mixed with 6x DNA loading buffer before injection into the sample 
pockets. Gels were run in TAE buffer with 5-7 V/cm for 50-60 min and documented 
under UV illumination at 254 nm. 
 
TAE buffer:   40 mM Tris 
                       20 mM Sodium acetate 
                         1 mM EDTA 
                      adjusted to pH 8.2 with acetic acid 
 
6 x DNA loading buffer:      70% (w/v)  Sucrose 
                                           0.25% (w/v)  Bromphenol blue 
                                           0.1 M            EDTA 
 
2.3.3 Extraction of DNA from agarose gels 
Linearised vectors and PCR products were extracted from agarose gels using the “Gel 
extraction Kit” (Qiagen) or Plasmid Extract II Kit (Macherey-Nagel) according to their 
manuals. DNA was eluted with 20 µL TE-buffer or purified water (MilliQ). 
 
TE-buffer:    Tris-Cl, pH 7.5    10 mM 
                     EDTA                    1 mM 
 
2.3.4 Digestion of DNA with restriction endonucleases 
Plasmid DNA was digested by distinct combinations of restriction endonucleases as 
required for cloning and control purposes. Buffers and reaction conditions were adapted 
to the enzyme combinations, according to the New England Biolabs technical reference 
catalogue. 
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2.3.5 Dephosphorylation of linearised plasmid DNA 
Linearised plasmid DNA was 5'-dephosphorylated prior to ligation to prevent religation 
of the original vector without the target insert. 1-5 µg of linearised vector per planned 
ligation reaction were incubated with 10 U calf intestine phosphatase (CIP, NEB) at 
37°C for one hour prior to agarose gel-purification. 
 
2.3.6 Ligation of DNA fragments 
Target genes (inserts) were ligated into linearised, 5'-dephosphorylated vectors using 
30 ng linearised plasmid DNA and a 3-fold molar excess of insert. The mixture was 
incubated with 1 U of T4 DNA ligase (NEB) in the recommended ATP-containing 
ligation buffer (NEB) at RT for 4-5 h or at 22°C for 2 h followed by 16 h at 16°C.  
 
2.3.7 Ligation independent cloning 
Ligation independent cloning was performed using the In-FusionTM Dry-Down PCR 
Cloning kit according to its manual (Clontech). Briefly, a PCR reaction generated inserts 
bearing 15 bp extensions at both ends that are homologous to the ends of a linearised 
recipient vector. When the In-Fusion enzyme is incubated (15 min at 37°C followed by 
15 min at 50°C) with the linearised vector (100 ng) and the PCR product (2-fold molar 
excess) in a 10 µl reaction mix, the enzyme‟s exonuclease activity excises nucleotides 
from the 3‟ ends of the molecules. The exposed overlapping ends are free to anneal 
(single-strand annealing, SSA), forming non-covalently joined molecules that undergo 
final repair within the target E. coli strain after transformation (2.3.9). The resulting 
product is an assembled vector and insert. 
 
2.3.8 Preparation of electrocompetent cells 
Electro-competent cells were prepared using E. coli TOP10 cells freshly plated on LB-
agar. A single colony was picked, transferred to 100 mL of LB-medium, and incubated 
o.n. (37°C, 180 rpm). 5 mL of this starter culture were transferred to 500 mL LB-
medium. Bacteria were grown to an OD600 nm of 0.4, cooled rapidly and kept on ice for 
30 min. Cells were pelletized by centrifugation (4°C, 10 min, 5500 g), washed twice with 
ice-cold, sterile 1 mM HEPES buffer, once with ice-cold, sterile 10 % (v/v) glycerol and 
resuspended in a final volume of 1 mL 10 % (v/v) glycerol (concentration 1-3 x 1010 
cells/mL). 60 μL aliquots were transferred into pre-cooled 1.5 ml reaction tubes 
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(Eppendorf) and flash-frozen in liquid nitrogen. The electrocompetent cells were stored 
at -70°C. 
 
2.3.9 Transformation of competent bacteria 
Competent bacteria were transformed for plasmid amplification. Positive transformants 
were selected by plating the bacteria onto LB-agar plates containing antibiotics for 
which resistance was conferred by the respective plasmid. 
 
Electroporation 
1-2.5 μL of plasmid DNA, ligation- or In-FusionTM cloning mixture were pipetted into a 
cooled, sterile 0.2 cm electroporation cuvette. A slowly thawed 60 μL aliquot of 
electrocompetent cells was added and the mixture incubated for 1 min on ice. The 
cuvette was dried and placed into a Gene PulserTM (BioRad). An electric pulse at       
2.5 kV, 200 Ω and 125 μF was applied to the cells, followed by a rapid addition of 1 mL 
of room-tempered LB-medium. After incubating at 37°C with gentle shaking for 1 h, the 
transformants were plated on selective LB-agar and incubated at 37°C o.n.. 
 
Heat shock transformation 
5-10 μL of plasmid DNA or ligation mixture were added to 50 μL of chemically 
competent cells thawed on ice and incubated for 30 min on ice. A heat shock of 45 sec 
at 42°C was applied to the mixture, followed by a rapid cooling on ice for 2 min. 800 μL 
of SOC-medium were added to the cells followed by incubation for 1 h at 37°C with 
gentle shaking. The transformants were plated on selective LB-agar. 
 
2.3.10  Plasmid preparation 
Depending on the amount of plasmid DNA required, 5 (“Mini“) or 500 (“Maxi“) mL of LB-
medium were inoculated with freshly transformed E. coli TOP10, XL-1 blue or DH5α 
cells. Bacteria were grown o.n. at 37°C and 180 rpm and the plasmid DNA was isolated 
with the QIAprep Spin Kit (Qiagen) or EndoFree Plasmid Maxi Kit (Qiagen) basing on 
the alkaline extraction method by Birnboim and Doly (Birnboim & Doly, 1979). The latter 
kit was used, if the DNA was used for transfecting mammalian cells. Yields were 
determined spectro-photometrically (2.3.12). 
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2.3.11   Genomic DNA preparation 
Genomic DNA was isolated from CHO Lec3.2.8.1 cells in exponential growth phase with 
the AquaGenomicTM kit (MoBiTec). Yields were determined spectro-photometrically 
(2.3.12). 
 
2.3.12   Determination of DNA concentration 
Samples of isolated bacterial plasmid DNA were measured on a NanoDrop ND-1000 
photospectrometer to determine the yield and purity. The absorption at 260 nm (A260 nm) 
was determined, allowing the DNA concentration to be calculated using Equation 2-1 
and assuming that A260 nm = 1.0 is equivalent to 50 μg/mL DNA. 
 
  [
  
  
]   
        
  
                                                      Eq. 2-1 
 
A260 nm Absorption at 260 nm 
c concentration of DNA solution 
D dilution factor 
 
The ratio of A260 nm /A280 nm was used to check the sample for protein contamination. 
Ratios of 1.8 to 2.0 were assumed sufficiently pure to allow subsequent cloning and 
transformation/transfection experiments. 
 
2.3.13   DNA sequencing 
DNA sequencing reactions were performed by the company GATC or in the department 
of Genome Analysis at the HZI. The sequences were determined with the dye 
terminator method and provided as ABI chromatogram files for download. 
Chromatograms were analysed and compared using the programs AlignX and 
ContiqExpress from Vector NTI suite 8.0 (Invitrogen). 
 
2.3.14   Southern Blotting 
Genomic DNA was analysed by Southern Blotting in order to identify the copy number 
of the integrated transgene. 10 µg CHO DNA were digested with appropriate restriction 
enzymes and 0.25 µg/µL RNAse A. The digested DNA was separated in 0.8% agarose 
gels with a digoxigenin-labelled DNA molecular weight marker II (Roche) and 
transferred to Hybond N+ membranes (Amersham) o.n. by capillary transfer with 20 x 
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SSC buffer. After washing the membrane in 2 x SSC buffer, the transferred DNA was 
fixed to the membrane by UV-cross-linking. For hybridisation and immunological 
detection the DIG High Prime DNA Labelling and Detection Starter Kit II (Roche) was 
used according to its instruction manual.  
DIG-labelled DNA probes (Table 2-9) were generated by random prime labelling 
technique. 200-500 ng DNA probes in 16 µl purified water (MilliQ) were boiled 10 min at 
99°C, cooled on ice and filled up to 20 µl with DIG High Prime mix (Roche) for o.n. 
incubation at 37°C. The reaction was stopped by adding 2 µl 0.2 M EDTA (pH 8.0) 
before the labelled probes were stored at 4°C.  
 
Table 2-9: DIG-labled DNA probes. 
  
The membrane blots were pre-hybridized in DIG Easy Hyb solution (Detection Starter 
Kit II, Roche) for 1-2 h at 42°C. The denatured DIG-labelled DNA probe (5 min at 99°C, 
cooled on ice) was diluted in DIG Easy Hyb solution to 30 ng/mL and added without air 
bubble formation to the membrane. After o.n. incubation at 42°C, the membrane was 
washed under constant agitation - two times with 2 x SSC, 0.1% SDS buffer at RT and 
two times with pre-warmed 0.5 x SSC, 0.1% SDS buffer at 65°C for 15 – 30 min 
depending on the probe. For immunological detection the membrane was rinsed in 
water and unspecific binding sites were saturated for 30 min by Blocking Solution. The 
membrane was then incubated for 30 min in an anti-digoxigenin AP antibody solution 
(dilution 1:10,000 in Blocking Solution), washed three times for 15 min in Washing 
Buffer and equilibrated 5 min in Detection Buffer. To visualize the antibody on the blot 
about 3 ml CSPD ready-to-use substrate solution (Roche) were applied and the 
membrane was incubated 5 min at RT and 10 min at 37°C without drying. For 
documentation of the DNA bands, enhanced chemiluminescence (ECL) was detected 
by a luminometer.  
 
20 x SSC buffer:              Tri-Natriumcitrate-2-hydrate                  0.3 M 
                                          NaCl                                                         3 M 
 
 
 
Probe Origin 
EGFP probe 755 bp fragment (BglII/PstI) of pEpi-delCFGSARE 
IRES probe 457 bp fragment (KpnI/PacI) of pFlpO-puro 
PGK probe 667 bp fragment (NgoMIV/SacI) of  pFS-scHGF-pGK 
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Blocking Solution:         10x Blocking Solution (Roche) diluted in 
                                         Maleic acid                                             0.1 M 
                                         NaCl                                                     0.15 M 
                                         adjusted with NaOH (solid) to pH 7.5 
 
CSPD:                              0.25 mM Disodium 3-(4-methoxyspiro {l,2-dioxetane-3,2'-(5'- 
                                         chloro)tricyclo[3.3.1.13,7]decan}-4-yl) phenyl phosphate 
 
Detection Buffer:            Tris-HCl/ pH 9.5                                    0.1 M 
                                         NaCl                                                      0.1 M 
 
DIG High Prime mix:      0.5 mM dATP, 0.5 mM dCTP, 0.5 mM dGTP,  
                                         0.325 mM dTTP, 0.125 mM DIG-11-dUTP, random  
                                         hexanucleotides, DNA polymerase I (klenow enzyme large 
                                         fragment) (Roche) 
 
Washing Buffer:             Maleic acid                                           0.1 M       
                                         NaCl                                                   0.15 M 
                                         Tween 20                                           0.03 % (v/v)      
                                         adjusted with NaOH (solid) to pH 7.5      
 
2.4 Cell culture 
 
2.4.1 Maintaining cells in culture 
Mammalian cells were propagated in suspension cultures of ProCho5 medium (Lonza, 
Cologne, Germany) supplemented with 7.5 mM L-glutamine and 11 mg/mL phenolred at 
37°C in a humidified atmosphere of 5% CO2. 125 mL- spinner flasks (Techne) were 
filled with a volume of 35 - 40 mL and 1000 mL-spinner flaks were filled with a volume of 
200 - 250 mL and stirred at 80 rpm. 6-well plates were filled with a culture volume of 3 
mL, T-25 cell culture flasks (25 cm2, BD Falcon) were filled with 5 mL and T-75 cell 
culture flasks (75 cm2) were filled with 20 ml. These vessels were incubated at 37°C in a 
humidified atmosphere of 5% CO2 at 150 rpm on an Incutec K15-500 linear shaker. To 
maintain the cells in the exponential growth phase, they were subcultured in fresh 
medium every 3 to 4 days with a seeding cell density of 1.5-3 x 105 cells/mL. Cell 
numbers and viability were assayed by trypan blue dye exclusion method and/or Casy 
Counter (2.4.4).  
Cells were cultured adherent in CD-Hybridoma medium supplemented with 5% FCS 
and 8 mM L-glutamine at 37°C in a humidified atmosphere of 8% CO2. Cultures at 
about 80% confluence were split (1:5) or expanded as follows. After removal of the 
growth medium, cells were trypsinised 5 min at 37°C by 50 – 500 µL trypsin/EDTA 
solution (PAA laboratories) depending on the culture dish format. 0.2 – 2 mL medium 
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were added to the detached cells and the cells were pelletized at 180 g for 5 min and 
resuspended in a proper volume of medium.    
 
2.4.2 Cryopreservation 
For long-term storage mammalian cells were harvested and centrifuged at 180 g for      
4 min. The cell pellet was resuspended in freezing medium (80% (v/v) culture medium, 
10% DMSO and 10% Methylcellulose (1%)) at a cell density of 3 x 106 – 1 x 107 
cells/mL. Each cryo-tube (Nunc) was filled with 1.8 mL cell suspension and stored in a 
special freezing container (Nalgene) in isopropanol at -70°C for about 24 h. Then, the 
cryo-tubes were transferred in the vapour phase over liquid nitrogen.   
 
2.4.3 Revitalisation 
For revitalisation the cells were thawed in a water bath at 37°C. Cells were washed two 
times with 10 mL pre-warmed culture medium (180 g, 4 min). The final pellet was 
resuspended in 3 to 40 mL culture medium depending on the cell numbers that had 
been frozen. Cell numbers and viability were assayed by trypan blue dye exclusion 
method (2.4.4) and cell density was adjusted to 2-5 x 105 cells/mL. 
 
2.4.4 Determination of cell number and viability 
The cell number and viability was determined by the trypan blue exclusion method or by 
a CASY particle counter. 
For the trypan blue exclusion method cells were mixed 1:1 with 0.5% trypan blue 
solution (Roche). The cells were counted in four big squares of a Neubauer 
hemocytometer (BLB, Braunschweig) under a light microscope. The cell density (X) is 
calculated as follows: 
     
   
 
                                                           Eq. 2-2 
X = cell density [cells/mL] 
C = Cell numbers of four big squares 
D = Dilution factor 
 
While trypan blue can not enter the cytoplasmic membrane of viable cells, it stains 
selectively dead cells. The ratio of the viable cell number to the total cell number 
describes the viability of a culture: 
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                                                          Eq. 2-3 
Cv = viable cell density [cells/mL] 
Ct = total cell density [cells/mL] 
 
The CASY particle counter is an electronic device based on resistance measurements. 
The cell suspension was diluted in an isotonic buffer and drawn in a capillary with 
defined diameter. When a cell passed two platinum electrodes, the resistance rose and 
resulted in electric pulses which corresponded to the cell number. In terms of pulse 
height a cell size profile was generated. The viability was assessed based on the 
integrity of plasma membrane. Injured cell membranes lose their function as electric 
insulators thus dead cells appear smaller than viable ones.  
 
2.4.5 Quantification of glucose and lactate 
The glucose and lactate concentration of culture supernatants was determined by a 
biochemical analyser (YSI) based on enzymatic-amperometric processes.  
To quantify the glucose, 20-50 µl culture supernatant were pumped into a measuring 
cell.  The cell was bordered by a probe containing glucose oxidase (GOD) immobilised 
on a membrane. Thus, the glucose reacts as follows: 
                 
I                                      glucose + O2           
GOD              H2O2 + gluconic acid 
II                                                 H2O2    
platimum electrode     2H+ + O2 + 2 e
- 
 
The resulting two electrons induce an electric current proportional to the glucose 
concentration in the sample. 
 
For the determination of the lactate concentration the enzyme L-lactate-oxidase (LOD) 
was immobilised. The culture supernatant was pumped into the measuring cell and 
lactate was transformed as follows: 
 
I                                       lactate + O2            
LOD                H2O2 + pyruvate 
II                                                H2O2     
platimum electrode      2H+ + O2 + 2 e
- 
 
The resulting two electrons induce an electric current proportional to the lactate 
concentration in the sample. 
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2.4.6 Gene transfer methods  
Nucleofection (Amaxa) 
For stable transfection, 1.5 x 106 cells in 2 mL medium were transfected with SalI 
linearised plasmid DNA (5 µg) by using program U-24 of the Amaxa nucleofection 
device according to manufacturer‟s guidelines (NucleofectorTM Kit V, Lonza). 24 h post 
transfection the medium was exchanged and the cells were seeded into 6-well plates at 
37°C in a humidified atmosphere with 5% CO2 at 150 rpm on an Incutec K15-500 linear 
shaker. In the following days the transfected cell cultures were expanded before 
entering the stationary phase. 
 
Recombinase-mediated GFP excision  
Tagged cells were transfected with 5 µg of the optimized Flp expression vector 
pPGKFLPobpA by Amaxa nucleofection. 5 days later, the cells were analysed by flow 
cytometry and cloned by serial dilution in 96 well plates with CD-Hybridoma medium 
(2.4.7). After one week, the wells were screened for non-fluorescent single colonies on 
an Axiovert100 fluorescent microscope (Carl Zeiss) using an LP520 filter for GFP 
visualization. The detected colonies were expanded and recloned, if necessary. Clonal 
cell lines were adapted to suspension cultures in serum free ProCho5 medium by 
adding 10 U/ml heparin (Sigma) during the first 2 passages. 
 
Recombinase-mediated cassette exchange  
The cassette exchange in tagged CHO Lec3.2.8.1 cells was performed by Amaxa 
nucleofection. The cells were co-transfected with 1 µg, 2 µg or 2.5 µg of the targeting 
vector and 4 µg, 3 µg or 2.5 µg of the optimized Flp expression vector pPGKFLPobpA, 
respectively. 24 h post transfection the cells were seeded on a 100 mm culture dish in 
10 mL CD-Hybridoma medium and cultivated at 37°C in a humidified atmosphere with 
8% CO2. Depending on the RMCE system 2 mg/mL G418 or 150 µg/mL Hygromycin B 
was added 5 days post transfection to select for the targeted subcell clones. Medium 
was replaced every 3-4 days until the subcell clones were picked in 96 well plates after 
2-3 weeks. If necessary, the cells were recloned by serial dilution (2.4.7). Clonal cell 
lines were adapted to suspension cultures in serum free ProCho5 medium by adding  
10 U/ml heparin (Sigma) during the first 2 passages. 
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2.4.7 Single cell cloning by serial dilution 
Serial dilution in 96 well flat bottom microtiter plates was used to isolate clones of single 
cell origin. Initially, one well (A1) was inoculated with 0.5 x 104 cells/mL in 400 µL CD-
Hybridoma medium. These cells were diluted 1:2 along the first column resulting in    
200 µL per well. The second 1:2 dilution series was across the entire plate, so that all 
wells ended up with a volume of 100 µL medium and cells. The cells were cultured 
about one week at 37°C in a humidified atmosphere with 8% CO2 until they were 
expanded or recloned again.    
 
2.4.8 Flow cytometry and preparative FACS 
CHO Lec3.2.8.1 cells were transported and sorted at room temperature. GFP 
expression was analysed with a Guava EasyCyteTM Mini System (488 nm laser, 520 nm 
bandpass filter, Guava Technologies). Cells were diluted to 2-4 x 105 cells/mL in PBS 
and stained with 50 µg/mL propidium iodide (PI) to exclude dead cells from analysis. 
Preparative FACS was performed on a MoFlo high-speed cell sorter (Beckman Coulter). 
The sorter was equipped with an argon-ion laser tuned to 488 nm with 100 mW of 
power and an automated cell deposition unit for sorting into 96-well plates. GFP 
fluorescence was detected in FL1 through a 530/40-nm bandpass filter. Data analysis 
was performed using CytoSoftTM 4.2 and WinMDI 2.9 software. 
 
PBS-buffer:          NaCl                           140 mM 
                              KCl                                 3 mM 
                              Na2HPO4/ pH 7.4         10 mM 
                              KH2PO4                               2 mM       
 
2.4.9 Cell cycle analysis  
Cell cycle analysis by flow cytometric measurements on a LSR II cell analyser (BD) 
involved the determination of relative DNA contents. 2 x 106 cells were fixed o.n. in    
3.5 mL ~70% Ethanol at -20°C. To prevent clustering the cells were resuspended in 
PBS before the addition of 2.5 mL absolute Ethanol. After pelletizing (180 g, 5 min) the 
cells were incubated in 500 µl PI staining solution for 40 min at 37°C. 3 mL PBS were 
added, the cell suspension was centrifuged and the pellet was resuspended in 500 µl 
PBS for analysis. The flow cytometer was equipped with a laser tuned to 488 nm. PI 
fluorescence was detected in FL1 through a 685/35-nm PI filter using linear 
amplification. Data analysis was performed using FlowJo v8.8.7 software (TreeStar).  
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DNA index was calculated by taking the ratio of geometric mean PI fluorescence of the 
fitted G0/G1 peak in the sample to that in the internal control. 
 
PI staining solution:      Propidium Iodide            50 µg/mL 
                                         RNase A                       0.1 mg/mL 
                                         Triton X-100                0.05 % 
                                         in PBS buffer 
 
2.5 Protein production and purification 
 
2.5.1 Recombinant protein production in stirred tank reactors (STRs)  
Production cell lines were grown in batch or batch followed by perfusion mode in 
autoclavable stirred tank bioreactors with 2.5-L culture volume. The bioreactors were 
equipped with a double membrane stirrer for both bubble-free aeration via 8 m of 
hydrophobic polypropylene membrane tubing (Accurel® S6/2, Membrana, Wuppertal, 
Germany) and perfusion with internal cell retention via 8 m of hydrophilized, 
microporous membrane tubing of the same type (Lehmann et al., 1985, Blasey et al., 
1990, Figure 2-1). Cells were propagated in ProCHO5 + ZKT-I [1:1] medium at 37°C, a 
stirring speed of 45 rpm, pH 7.4 and a dissolved oxygen (DO) concentration of 40% air 
saturation. During the production phase, at a cell density exceeding 107 cells/mL, 
temperature was reduced to 32°C. The perfusion rate was adjusted to the metabolic 
consumption of glucose avoiding a drop below 2.5 g/L. 2-mL samples were taken daily 
for routine in-process control. Harvested cell-free supernatant was concentrated by 
ultrafiltration followed by diafiltration against PBS8 using a Pellicon 2 tangential flow 
system equipped with two 10-kDa cut-off cartridges (Millipore).  
 
PBS8-buffer:      NaCl                         300 mM 
                            Na2HPO4/ pH 8          50 mM      
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Figure 2-1: Flow diagram of a continuously perfused double membrane stirred tank reactor with 
bubble-free aeration for the production of recombinant glycoproteins by CHO cells.  
 
2.5.2 Cell lysis 
Intracellular proteins were extracted by the CytobusterTM protein extraction reagent 
(Novagen). 1 x 106 pelletized cells (180 g, 4 min) were resuspended in 150 µL 
CytobusterTM reagent. The cell suspension was incubated 45 min at room temperature 
and transferred to a 1.5 mL reaction tube for centrifugation (13,000 g, 5 min). The clear 
cell extract was transferred to a new reaction tube.  
 
2.5.3 Affinity chromatography 
The secreted human LAMP3-prox protein was fused to a hexa-histidine tag. Thus, the 
recombinant fusion protein was purified from the concentrated and diafiltrated culture 
supernatant (2.5.1) by immobilized metal ion affinity chromatography (IMAC) on a       
20 mL HisPrepTM FF 16/10 (GE Healthcare) column using Äkta FPLC systems (GE 
Healthcare). All used buffers and H2O were degassed and filtered (0.2 µm).  
The column was equilibrated with 5 column volumes (CV) of binding buffer before the 
protein solution was applied by a flow rate of 0.9 mL/min. Immobilized proteins were 
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washed by binding buffer and flow rates not exceeding 0.3 MPa. Elution of the protein 
was achieved with a linear gradient from 0 – 300 mM imidazole within 12 CV finishing 
with a final step to 500 mM imidazole in 2 CV. 5 mL fractions were collected and OD280 
was measured. Fractions absorbing stronger than buffer were analyzed by gel 
electrophoresis (2.6.2), pooled if appropriate and stored at 4°C.  
 
Binding buffer:     NaCl                         300 mM 
                               Na2HPO4/ pH 8          50 mM 
 
Elution buffer:      Binding buffer 
                               + 500 mM Imidazole 
 
2.5.4 Gel permeation chromatography 
Gel permeation chromatography (GPC) was used to separate molecules of different 
size in a porous gel matrix. GPC experiments were performed on ÄKTA FPLC Systems 
(GE Healthcare) with HiLoad Superdex 75 (formats 16/60, 120 mL and 26-60, 320 mL) 
columns in GPC buffer. All used buffers and H2O were degassed and filtered (0.2 µm). 
The recombinant proteins were concentrated to 1-10 mL (2.5.6) and applied to the GPC 
column after equilibration with 1.2 CV H2O and 1.2 CV GPC buffer. The protein 
separation was performed in 1 CV of GPC buffer with flow rates of 1 mL/min. Fractions 
of 1 – 5 mL were collected and OD280 was measured. Fractions absorbing stronger than 
buffer were analyzed by gel electrophoresis (2.6.2), pooled if appropriate and stored at 
4°C.  
 
GPC buffer:     HEPES/ pH 7.4       10 mM 
                         NaCl                      150 mM 
 
2.5.5 Deglycosylation of glycoproteins 
Recombinant glycoproteins were deglycosylated at 1 mg/mL over night at 37°C by 
adding sodium acetate to 100 mM and endoglycosidase H f to 10,000 U/mL (Endo Hf, 
NEB). Endo Hf is a fusion protein of endo H and maltose binding protein. Endo H f and 
contaminants were removed by GPC (2.5.4). 
 
2.5.6 Concentration of protein solutions 
Protein solutions were adjusted to desired concentrations by ultracentrifugation using 
Vivaspin-2, -6, and -20 concentrators (Sartorius Stedim) with appropriate MW cut-offs. 
The pore size was chosen to be at least 10 kDa smaller than the target protein. The 
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absorption at 280 nm was checked against the flow-through until the desired protein 
concentration was reached (2.6.1). 
 
2.6  Protein biochemical methods 
 
2.6.1 Photometric quantification of protein concentration 
Concentrations of purified protein solutions were determined via photometrical 
measurements of A280nm against buffer. The molar extinction coefficient ε280 for each 
protein was calculated in silico with the program Vector NTI (Invitrogen) (Table 2-10). 
The concentration was calculated according to the Beer-Lambert law: 
 
    
   
  
                                                           Eq. 2-4  
 
c      = concentration [mg mL-1] 
 Mr   = molecular mass [mg mmol-1]                       Table 2-10: molar extinction coefficient ε.      
A280 = absorption at λ = 280 nm                                                        
ε      = molar extinction coefficient [M-1 cm-1] 
d      = layer thickness of cuvette [cm] 
 
2.6.2 SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
Proteinaceous samples were analysed by SDS-PAGE with regard to their size and 
under denaturing conditions. The samples were mixed with 2 x Laemmli buffer and 
incubated for 5 min at 95°C to ensure complete unfolding. After a short centrifugation,   
1 – 20 µl of the samples were applied to a SDS-polyacrylamide gel. The composition of 
these gels is shown in Table 2-11. For native gel electrophoresis the SDS component 
was omitted in the gel, in the running buffer and in the 2 x Laemmli buffer. In the            
2 x Laemmli buffer β-Mercaptoethanol was omitted, too. 
 
 
 
 
 
 
 
Protein ε 280[M
-1 cm-1] 
hLAMP3-prox 9440 
scHGF 148300 
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Table 2-11: Composition of SDS-polyacrylamide gels. Volumes are listed for four gels.  
Solution Separating 
gel 
 Stacking gel 
10% 12% 5% 
Acrylamide/Bisacrylamide 10 mL 12 mL 1.5 mL 
30% (w/v)/0.8%(w/v)    
4 x Lower buffer 7.6 mL 7.6 mL - 
4 x Upper buffer 
10% SDS 
H2O 
TEMED 
40% (w/v) APS 
- 
300 µL 
12.4 mL 
40 µL 
60 µL 
- 
300 µL 
10.1 mL 
40 µL 
60 µL 
2.5 mL 
- 
5.9 mL 
30 µL 
30 µL 
 
Gels were run at 120 V for 5 min and 160 V for 40-60 min, depending on the 
polyacrylamide percentage and the expected range of MW of the proteins present in the 
samples.  
 
2x Laemmli buffer:                            4x Upper buffer                             1.25 mL 
                                                            10% SDS                                           1 mL  
                                                            Glycerol                                              2 mL 
                                                            β-Mercaptoethanol                          200 µL  
                                                            Bromphenol blue                             500 µL 
                                                            (5mg/mL in 50% Glycerol)      
                                                            H2O                                                     5 mL 
 
4 x Upper buffer:                                Tris-base adjusted with HCl, pH 6.8  0.5 M 
                                                             SDS                                                   0.4 % (w/v) 
 
4 x Lower buffer:                                Tris-base adjusted with HCl, pH 8.8  1.5 M 
 
10 x SDS-PAGE running buffer:       Tris-base                                          30.2 g 
                                                             Glycine                                           144.1 g 
                                                             SDS                                                    10 g 
                                                             add with H2O up to 1 L (pH 8.3) 
 
2.6.3 Coomassie staining 
Unspecific staining of proteins in SDS-gels was performed o.n. in 20 - 30 mL staining 
solution. The gels were destained by two to three washing steps for about 20 min with 
destaining solution and H2O before drying between cellophane films.   
 
Staining solution:                              Methanol                       50 % (v/v) 
                                                            Acetic acid                     10 % (v/v) 
                                                            Coomassie R-250        0.2 % (w/v) 
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Destaining solution:                           Methanol                        50 % (v/v) 
                                                              Acetic acid                     10 % (v/v) 
 
2.6.4 Western Blotting 
For detection of specific proteins from culture supernatant Western Blots were 
performed followed by Immunostaining (2.6.5). Protein samples in SDS polyacrylamide 
gels were transferred to and immobilized on polyvinylidene difluoride (PVDF) 
membranes (Millipore) by a semi dry procedure. Freshly run gels were equilibrated for 
15 min in transfer buffer, together with 2 pieces of gel-sized Whatman paper. The 
PVDF-membrane was activated in 100 % methanol for 1 min and briefly equilibrated in 
transfer buffer. For the transfer, the gel was placed onto the membrane, and both 
placed between two layers of soaked Whatman paper onto the anode of the blot 
apparatus. The blot was run with 15 V for 30 min. Success of the transfer was checked 
via reversible staining of the membrane with Ponceau red.  
 
Transfer buffer:                                  Tris-base/ pH 8.0            25 mM 
                                                             Glycine                          192 mM 
                                                             Methanol                            15 % 
                                                              
Ponceau red staining solution:        Ponceau S                         0.2 % 
                                                             Acetic acid                            2 % 
 
2.6.5 Immunostaining of Western Blots 
Immobilized target proteins were detected using specific antibodies directed against 
His6-tag of fusion proteins or directed against an epitope of human HGF/SF (Table       
2-12). After the Western Blot (3.6.4) unspecific binding sites for antibodies were 
saturated by incubating the membrane for 1 h with 50 mL of 5% (w/v) skim milk in TBST 
at 37°C and washed 3 times for 5 min in TBST. The membrane was then incubated with 
10 mL of the primary antibody diluted in TBST at 4°C o.n.. After antibody-binding, the 
membrane was washed 3 times for 5 min in TBST. Except for the membrane incubated 
with the peroxidase-conjugated antibody, a secondary antibody directed against the 
primary antibody and conjugated to an alkaline phosphatase (AP) was added. After 2 h 
incubation at RT, the membrane was washed 3 times for 5 min in TBST and 5 min in 
AP-buffer. To visualize the phosphatase-bound antibody 10 mL of a BCIP-NBT-solution 
were added (25 mg/mL BCIP, 50 mg/mL NBT in AP-Puffer; Applichem). After up to     
30 min the reaction was terminated by a further washing step in water.  
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The peroxidase-bound antibody was visualized on the membrane using Lumi-Light 
Western Blotting Substrate (Roche). For documentation, protein bands were detected 
by enhanced chemiluminescence (ECL) on a luminometer.  
 
Table 2-12: Primary and secondary antibodies for immunostaining of Western blots.  
Primary antibody Company D Secondary antibody Company D 
mouse α-His6-
Peroxidase 
Roche 1:1000 - - - 
mouse α-His  Novagen 1:1000 rabbit anti-mouse AP Promega 1:2000 
goat α-HGF  R&D 1:1000 goat anti-mouse AP Promega 1:1000 
 
TBST-buffer:                 Tris-base/ pH 8.0          20 mM 
                                       NaCl                            150 mM 
                                       TWEEN 20                 0.05 % (v/v) 
 
AP-buffer:                     Tris/ pH 9.5                  100 mM  
                                       NaCl                            100 mM 
                                       MgCl2                              5 mM 
 
2.6.6 Enzyme-linked immunosorbent assay (ELISA) 
scHGF product concentrations from cell culture supernatants were quantified with the 
human HGF DuoSet® ELISA Development System (R&D Systems) according to the 
manufacturers‟ protocol. Cells were seeded at 1.5 x 105 cells/mL in 3 mL in 6-well plates 
or 40 mL in spinner flasks. scHGF concentration was measured twice, one and four 
days after inoculation. Mean values were obtained from three parallel cultures. Daily cell 
culture supernatants from bioprocesses producing scHGF were analysed as a routinely 
in-process control, too. 
For the analysis 96-well immuno-plates (F96 MaxiSorpTM surface, Nunc) were coated by 
a capture antibody (mouse α-human HGF, 1 µg/mL in reagent diluent) o.n. at RT. The 
wells were washed three times with wash buffer before blotting the inverted plate 
against paper towels. The unsaturated binding sites were blocked for 1 h at RT by      
300 µL reagent diluents per well. The washing steps were repeated and 200 µL of the 
samples (1:2 diluted in PBS) and the HGF standard (42 ng/mL in PBS) were loaded in 
duplicate in the wells of the first line of the plate. Each sample and the standard were 
diluted 1:2 in PBS along the plate ending with 100 µL proteinaceous solution per well. 
After incubating 2 h, the wells were washed three times again and 100 µL detection 
antibody (biotinylated goat anti-human HGF, 200 ng/mL in reagent diluent) was loaded 
per well. The plates were incubated for 2 h, washed three times as before and 
incubated 20 min with 100 µL Streptavidin-HRP per well. Threefold washing removed 
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the excess of Streptavidin-HRP. For colour reaction 100 µL TMB plus ready-to-use 
substrate (KemEnTec Diagnostics) were added per well. After 2 min the reaction was 
stopped by 50 µL of 2N H2SO4. The plates were analysed at wavelengths of 450 nm 
and 540 nm (for correction) by a microplate ELISA reader (Infinite M200, Tecan). The 
scHGF concentration in the culture supernatant was calculated by the standard curve of 
HGF.              
After counting the cell number, the specific productivity qp [pg per cell per day; pcd] was 
calculated with the assumption of exponential growth by Equation 2-5 (Pirt, 1975). 
 
          
    ( 
     )
 
                                                Eq. 2-5 
 
p = product concentration at time t since inoculation [µg/mL] 
x0 = inoculum cell concentration [cells/mL] 
µ = specific growth rate [h-1]  
 
PBS:                        NaCl                            137 mM 
                                KCl                                2.7 mM 
                                Na2HPO4/ pH 7.4          8.1 mM  
  
Wash buffer:          PBS   
                                + Tween 20                    0.05 %     
 
Reagent Diluent:   PBS  
                                + BSA                                 1 % 
 
All buffers were filtered (0.2 µm). 
 
2.6.7 Fluorescence spectrometry 
The EGFP protein concentrations in CHO Lec3.2.8.1 cell extracts were quantified by 
fluorescence spectrometry with an Infinite M-1000 fluorescence spectrometer (Tecan). 
Cells were seeded at 1.5 x 105 cells/mL in 3 mL in 6-well plates or 40 mL in spinner 
flasks. Fluorescence from the cell extracts (3.5.2) was measured in duplicate (excitation 
470 nm, emission 510 nm) in non-fluorescent microtiter plates (Nunc) using several 
dilutions of the samples, and compared to a recombinant EGFP (BioVision). Linear 
regression of the values obtained for defined concentrations of recombinant EGFP       
(1 µg/mL, 0.8 µg/mL, 0.6 µg/mL, 0.5 µg/mL, 0.4 µg/mL, 0.2 µg/mL and 0.1 µg/mL) 
enabled the quantification of fluorescing protein in the cell extracts.  
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2.6.8 Mass spectrometry  
Protein samples were analysed by mass spectrometry (MS), by Dr. Manfred Nimtz and 
Undine Felgenträger (HZI, Braunschweig). 
Recombinantly produced, purified and eventually deglycosylated proteins were 
investigated by MALDI-TOF (Matrix Assisted Laser Desorption Ionisation – Time Of 
Flight) on an Ultraflex mass spectrometer (Bruker) or ESI-MS/(MS) (Electrospray 
Ionisation) on a QTOF II mass spectrometer (Micromass) regarding their glycosylation 
and/or intactness of the expected amino- and carboxy-terminal ends.  
 
Protein preparation for MS analysis 
To prepare desalted samples of native scHGF, 50 µL Ni-NTA superflow beads (Qiagen) 
were added to samples of His6-tag scHGF. scHGF was bound by shaking for 1 h and 
unbound material was removed upon centrifugation. Beads were washed three times in 
5 mM Tris-HCl, pH 8.0 and scHGF was eluted three times with 100-µL aliquots of 35% 
acetonitrile, 0.1% TFA and shaking for 10 min. Eluates were subjected to MALDI-TOF-
MS analysis. 
 
Protein crystals were desalted by three washing steps in 4 µL purified water (MilliQ). 
The crystals were dissolved by adding 2 µL methanol to the crystal in the water drop 
followed by mixing. The protein solution was subjected to MALDI-TOF MS analysis.    
Protein bands from Coomassie-stained gels were excised, five times washed in purified 
H2O (Milli Q) and tryptically digested by the group of Dr. Manfred Nimtz. Extracted 
polypeptides were desalted on reversed-phased C18 ZipTip pipette tips (Millipore 
Corporation) and subjected to ESI-MS/(MS).  
 
2.6.9 N-terminal sequencing 
Protein samples were identified and evaluated by N-terminal sequencing. All 
sequencing experiments were carried out by Rita Getzlaff (HZI, Braunschweig) as 
described (Edman & Begg, 1967). 
 
2.6.10   Dynamic light scattering (DLS) 
Dynamic light scattering (DLS) is used to measure hydrodynamic radii of proteins in 
solution based on their diffusion velocity. Particles scatter light in all directions resulting 
in intensity changes over time depending on the Brownian movement of the scattering 
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particles. These changes in light scattering intensity over time are evaluated with an 
autocorrelation function which allows calculation of the hydrodynamic radii of the 
analyzed proteins. 
Besides hydrodynamic radii, polydispersity was calculated. Monodisperse and 
homogenous protein samples for crystallization typically have a polydispersity <15 %. 
Protein solutions were centrifuged (20 min at 13,000 rpm), diluted with GPC buffer up to 
2 mg/mL and filtered with a 0.2 μm filter. All DLS measurements were performed at RT 
with a DynaPro Titan (Wyatt Technologies). 
 
2.7 Protein crystallization 
For X-ray diffraction experiments proteins had to be crystallized to obtain a regular 
arrangement of protein molecules in the three dimensional space. A crystal is set up by 
a regular arrangement of the unit cell, which is the smallest element to form a crystal 
based on translation along a crystal lattice. As the unit cell may contain symmetry 
elements itself, it can be divided into asymmetric units. The asymmetric units can be 
transformed into each other by the symmetry operations implied by the unit cell. The 
number of protein molecules per asymmetric unit may differ between different crystal 
forms and proteins. Unit cells are generally assigned to seven different crystal systems: 
triclinic, monoclinic, hexagonal, cubic, rhombic, tetragonal and orthorhombic. The 
packing is divided into one primitive and a number of centered ones (C: c-face centered; 
I: body-centered; F: all-face centered), such that combining both, the crystal systems 
and the packing, leads to 14 different Bravais lattices. 
There are 230 different crystallographic space groups. However, only 65 account for 
protein crystals as any space group that contains symmetry elements (e.g. mirror 
planes, inversion centre, etc.) which change the chirality of the molecules is not allowed 
for proteins. 
 
2.7.1 Initial screening for lead crystallization conditions 
LAMP-3 protein solution was initially screened for lead crystallization conditions using 
commercial screens (Table 2-13) for 96-well sitting-drop vapour diffusion method.      
200 nL drops composed of equal volumes of 10 mg/mL protein in GPC buffer and 
crystallization solution were pipetted using a MOSQUITO robot (TTP LabTech Ltd.). 
The plates were sealed with MancoTM Crystal Clear tape (Jena Bioscience) and 
incubated at 19°C.  
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Table 2-13: Crystallization Screens. 
 
2.7.2 Optimization of lead crystallization conditions 
Initial hit conditions were reproduced and optimized manually in 24-well hanging drop 
vapour-diffusion formats using 1-2 µL crystallization drops and 500 µL reservoir. 
Suitable crystals for X-ray diffraction experiments were obtained by varying physico-
chemical parameters of the initial condition 0.1 M citric acid pH 5, 5% PEG 6000. 
Different precipitant concentrations between 3 – 14 % PEG 6000, protein 
concentrations of 7.9 mg/mL, 10 mg/mL and 22 mg/mL, pH values between 4 – 6 and 
incubation at 4°C, 19°C and 26°C were tested. Additionally, co-crystallization with 
additives (additive screen, Hampton Research Corp.) was applied.   
 
2.7.3 Seeding 
Seeding is used to improve crystal quality by introducing small nucleation seeds into 
crystallization droplets, setting a starting point for crystal growth. This can be obtained 
either by streak seeding, or by micro-seeding. 
 
Streak seeding  
A horse hair was pulled through a crystallization droplet containing crystals of hLAMP3-
prox. Small crystal fragments stuck to the horse hair and were transferred to crystal free 
crystallization droplets by streaking through. 
 
Micro-seeding 
Some hLAMP3-prox crystals in 5 µL mother liquor were transferred to 45 μL reservoir 
and mixed thoroughly until the crystals were broken into small fragments. Serial 
dilutions from 10-1 up to 10-4 were set up from this stock solution. Crystallization droplets 
were then set up using 1 μL of the diluted micro-seeding solutions and 1 μL of purified 
protein (7.9 mg/mL in GPC buffer) and equilibrated against 500 μL reservoir in a 24 well 
crystallization plate (Greiner). 
Screen Company 
JCSG core I 
JCSG core II 
JCSG core III 
JCSG core IV 
The Classics  
Qiagen 
Qiagen 
Qiagen 
Qiagen 
Qiagen 
The Pegs Qiagen 
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2.7.4 Heavy atom derivatisation 
Heavy-atom derivatized LAMP-3 crystals were needed to solve the phase problem 
mentioned in 2.8. To find appropriate heavy atoms interacting with hLAMP3-prox a band 
shift assay was performed (Boggon & Shapiro, 2000). To this end, 1 µL of hLAMP3-
prox (7 mg/ml) was incubated in 1 mM heavy atom solution in 0.1 M citric acid pH 4.5 
and a final reaction volume of 10 µL for at least one hour. The reaction solution was 
analysed on a 15% native gel by electrophoresis (2.6.2). The following heavy atom 
compounds were screened: Kt2PtCl4, Hg(OOCCH3)2, (C2H5HgO)HPO2, 
(NH4)3IrCl6*xH2O, GdCl3*xH2O, Sm(O2C2H3)3*xH2O and AuCl3.  
 
The crystals were soaked in mother liquor supplemented with millimolar heavy-atom 
compound concentrations according to Table 2-14. Crystals treated with heavy atoms 
were flash-frozen in liquid nitrogen. 
 
Table 2-14: Heavy-atom compounds for derivatisation of hLAMP3-prox crystals. 
 
 
2.8  X-ray diffraction analysis  
X-ray crystal structure analysis was used to determine the electron density distribution 
within the unit cell from diffraction images. X-ray diffraction experiments are based on 
Bragg‟s law describing total reflection on a set of parallel planes with the Miller indices 
hkl (Bragg et al., 1913). The Miller indices hkl describe a set of parallel planes where hkl 
represent the number of parts into which the set of planes cut the a, b and c edges of 
the crystallographic unit cell. X-rays of wavelength λ are reflected at the angle θ only, if 
θ meets equation 2-6. 
 
           λ                                                             Eq. 2-6 
dhkl = interplanar spacing 
θ    = reflection angle 
λ    = wavelength 
n    = integer  
Heavy-atom compound Concentration in 
mother liquor 
Soaking time  
Potassium tetrachloroplatinate(II) 
(K2PtCl4) 
25 mM 5 min 
Ammonium hexachloriridate(III)hydrate 
((NH4)3IrCl6*xH2O) 
14 mM 0.5 – 10 min 
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X-rays are diffracted at the crystal lattice and Bragg‟s law is valid for all points of the 
reciprocal lattice on a sphere with the radius 1/λ around the origin of the real lattice, the 
so called Ewald sphere. Rotating the crystal during an X-ray diffraction experiment 
maximizes the number of points hitting the Ewald sphere causing more detectable 
reflexes on the X-ray detector. To result in a complete data set, crystallographic data 
have to be collected over an angular range that depends on the crystal‟s orientation and 
inherent symmetry.  
X-rays scattered at the atoms of a crystal are characterised by the three parameters of 
an electromagnetic wave: frequency, amplitude and phase. Both, frequency and 
amplitude of an emerging x-ray can be determined from the according Bragg peak‟s 
position and intensity. The phase, however, is not detected and not available for 
calculation of the electron density distribution ρ (xyz). The Fourier transform of the 
crystal‟s electron distribution function ρ (xyz) is its structure factor F (hkl) and vice versa. 
The structure factor can be expressed as a function of hkl: 
 
        ∭                               
 
 
                            Eq. 2-7 
Since Bragg diffraction occurs in discrete directions, the integration of the electron 
density calculation can be replaced by a summation of individual structure factors:    
 
         
 
 
∑ ∑ ∑ |      |    
                                         Eq. 2-8 
The lack of phase information makes the direct determination of the structure factors 
and hence the electron density impossible. The structure factor amplitude, however, is 
proportional to their intensity (Eq. 2-9) and can be determined.  
 
      |    |
                                                 Eq. 2-9 
In this study, the phase problem was solved by anomalous dispersion of heavy-atom 
derivatives of hLAMP3-prox crystals. Anomalous dispersion occurs when the energy of 
the incident X-ray photon is close to the absorption edge/transition energy required to 
promote an electron to an unoccupied higher orbital or to eject it completely from an 
atom. The absorption of incident energy by the crystal results in a reduced intensity of 
the coherent scattering and a slight change in the phase of the scattered X-ray beams. 
This is expressed by the atomic scattering factor f of the heavy atom comprising now 
the normal scattering component 0f and a non-negligible wavelength-dependent real 
(dispersive, f') and an imaginary (absorption, f'') correction term for the anomalous 
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scattering. The experimental determination of the actual shape of the absorption curve 
via fluorescence energy scan of the heavy atom-labelled crystal provides the precise 
values for f'' and of its derivative f'. As the absorption term f'' is always 90° advance in 
phase, the resonant/anomalous scattering causes a slight deviation from Friedel‟s Law 
(Friedel, 1913). Friedel pairs Fhkl and F-h-k-l (short F
+ and F-) are Bragg reflections 
related by inversion through the origin exhibiting the same magnitude of the structure 
factor intensity but opposite phase angles at normal scattering using wavelengths far 
from the absorption edge. In anomalous scattering, Friedel mates no longer have equal 
structure factor amplitudes (Bijvoet, 1954): IFhklI ≠IF-h-k-lI and their phase angles are no 
longer complementary. Near the absorption edge energy (“peak” wavelength), the 
imaginary anomalous component f'', which is proportional to the atomic absorption 
coefficient of the heavy atom, shows its largest value. The dispersive part f' of the 
anomalous signal shows its minimum at the inflection point of the scan. The structure 
factors of the derivative at these wavelengths differ significantly in their amplitudes 
compared to the native data (or the equivalent data of a derivative collected at a remote 
energy). It has been shown that even a single wavelength is sufficient to obtain good 
phase estimates and to solve novel structures (single-wavelength anomalous dispersion 
(SAD) (Dauter et al., 2002). In SAD, the phase ambiguity is broken by density 
modification protocols. The correct enantiomorph (handedness) of the anomalous 
scatterer substructure is thereby revealed by comparison of the electron-density maps 
treated by density modification. The incorrect enantiomorph contains no image of the 
macromolecule, whereas the correct map features clear solvent boundary and a 
macromolecular-like density histogram. The positions of the anomalously scattering 
heavy atoms in the unit cell can be deduced from an anomalous difference Patterson 
map (Patterson, 1935), which is calculated using only the coefficients ∆F2 derived from 
the anomalous structure factor amplitude differences of the Friedel pairs (and their 
symmetry mates) ∆F=IF+I – IF-I, also called Bijvoet amplitude differences. Significant 
non-origin peaks in the three dimensional Patterson map correspond to interatomic 
vectors between anomalously scattering atoms only that are related by crystallographic 
symmetry and are found in two-dimensional slices of the map (called Harker sections, 
(Harker, 1936)). From the Harker peaks (u,v,w), the coordinates of the heavy atoms 
(x,y,z) in the unit cell can be calculated. The normal scattering structure factor amplitude 
and phase, together with f'' and its derivative f', allows the estimation of the phases of 
the anomalous structure factors FA for the anomalous scattering substructure. This 
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allows a first approximation of the phase angles for the native protein structure factors 
FT. 
 
2.8.1 Cryoprotection of crystals 
Protein crystals are sensitive to X-ray radiation leading to severe damage and thus 
resulting in data loss, especially when using strong synchrotron X-ray radiation for data 
collection. To reduce this damage, X-ray diffraction data are collected under cryogenic 
conditions in a stream of liquid nitrogen at 100 K. Ice formation was prevented by quick-
soaks for 10 to 60 sec of the hLAMP3-prox crystals in cryo-protection solution 
containing mother liquor supplemented with 30% (v/v) PEG6000 or dehydrated oil 
(centrifuged in a SpeedVac o.n.). Crystals were stored in cap tubes filled with liquid 
nitrogen or mounted onto the goniometer using a pre-cooled cryo-tong and maintained 
at 100 K throughout the data collection using a nitrogen stream. 
 
2.8.2 Data collection  
X-ray diffraction data were collected on a rotating copper anode generator and an R-
AXIS IV++ image plate detector (Rigaku) and at synchrotron beamline X12 (EMBL, 
DESY, Hamburg) on charge-coupled device detectors (MarCCD, Marresearch). Data 
collection strategies were calculated by MOSFLM (Leslie, 1992). For single-wavelength 
and multiple-wavelength anomalous dispersion (SAD and MAD) experiments data sets 
of hLAMP3-prox derivatives were collected peak, inflection and high remote energies, 
respectively, of corresponding heavy-atom absorption L(III)-edges. The wavelengths 
were chosen from fluorescence scan data and are listed in Table 2-15.   
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Table 2-15: Data collection at different wavelengths. 
hLAMP3-prox 
derivatives 
Wavelength [Å] Light Source 
Sulphur 1.771 (high remote) Synchrotron beamline X12 (EMBL, 
DESY, Hamburg) 
Platinum 1.067870 (high remote) 
1.070450 (peak) 
1.070730 (inflection) 
Synchrotron beamline X12 (EMBL, 
DESY, Hamburg) 
Iridium 1.100090 (high remote) 
1.103710 (peak) 
1.104200 (inflection) 
Synchrotron beamline X12 (EMBL, 
DESY, Hamburg)  
 
2.8.3 Data processing 
hLAMP3-prox diffraction data were processed anomalously by MOSFLM (Leslie, 1992) 
or XDS (Kabsch, 2010b) determining the crystal parameters, assigning the space 
group, indexing and integrating the images‟ reflections. Twinning was analysed by the 
program SFCHECK (Vaguine et al., 1999). The intensities were scaled and partial 
reflections merged with XSCALE (Kabsch, 2010a). Finally the data were converted to a 
MTZ file by XDSCONV (Kabsch, 2010a).  
 
2.8.4 Phasing 
Initial phasing of 3-wavelength MAD experiments were performed by Dr. Jörn Krauße 
using the AutoSol program within the PHENIX suite software package (Adams et al., 
2010; Terwilliger et al., 2009) and Coot (Emsley & Cowtan, 2004). Figures were 
generated with Pymol (http://pymol.org).       
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3 Results 
The present work describes the development of different site-specific recombination 
strategies for cell line development, leading to a decisive improvement in the production 
of glycoproteins for structural studies. CHO Lec3.2.8.1 cells, which have a positive track 
record in X-ray crystallography, were chosen as expression hosts. Site-specific 
recombination systems facilitated the exploration of pre-characterized, favourable 
chromosomal loci for transgene expression in these cells. First, genetic loci were 
randomly „tagged‟ with a reporter gene and loci with a positive effect on reporter gene 
expression were identified. Depending on the strategy, the reporter gene was either 
excised (Flp-mediated excision, FLEx), activating a gene of interest located 
downstream, or exchanged against genes of interest by recombinase-mediated 
cassette exchange (RMCE). The chromosomal integration locus was not changed 
during the recombination step, except for the reporter gene coding sequence. 
Therefore, the expression ability of the resulting production subcell clones was highly 
predictable. This in turn essentially reduced the effort in screening for clones with 
appropriate expression level and genetic stability. Consequently, the time for developing 
production cell lines was greatly reduced. 
Site-specific recombination was applied for the first time for glycoprotein production in 
structural biology. Production, characterization and crystallization of various target 
proteins confirmed that X-ray structure analysis of glycoproteins benefits from site-
specific recombination with CHO Lec3.2.8.1 cells.  
 
3.1 Generation of master cell lines 
 
3.1.1 Tagging vectors   
Cell line development described in this work relies on the Flp/FRT recombination 
system from Saccaromyces cerevisiae. Chromosomal loci in the host cell genome were 
tagged with FRT sites. These sites were integrated in three different vectors flanking a 
GFP reporter gene (Fig. 3-1, 2.2.8). The tagging vector pEFF3EGFPF3MCS (Kaufman et 
al., 2008) (Gen-Bank GU983383) bears two identical FRT sites (F3) and thus confers 
FLEx. This resulted in a switch to expression of a GOI cloned into the downstream multi 
cloning site (MCS). Coding sequences for the single chain mutant of HGF/SF (scHGF) 
and the membrane-proximal domain of human LAMP-3/DC-LAMP (hLAMP3-prox) were 
cloned into this vector. The tagging vectors pEF-FS-EGFP and pEF-FS-EGFP-dneo 
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were designed for RMCE. Two heterospecific FRT sites (F3 and F) that can not 
recombine with each other flank the GFP gene. In the presence of a second, identically 
flanked DNA sequence, cassette exchange can be mediated by Flp. The vector pEF-
FS-EGFP-dneo additionally contains a selection trap, an ATG-deficient aminoglycoside 
phosphotransferase gene (∆neoR) downstream of the FRT cassette. The ∆neoR gene is 
complemented and activated by correct cassette exchange events in order to confer 
resistance to geneticin (G418). Further, a „promoter trap‟ is realized by the position of 
the EF-1α promoter upstream of the FRT cassette. An incoming promoter-less 
transgene can only be expressed upon correct cassette exchange.   
 
 
Figure 3-1: Schematic representation of tagging vector gene cassettes.  
pEFF3EGFPF3GOI is the tagging vector for the FLEx strategy; pEF-FS-EGFP and pEF-FS-
EGFP-dneo are tagging vectors for the RMCE strategy. They differ by the additional ATG -
deficient neomycin res istance gene (∆neo
R
)  downstream of the gene cassette on pEF-FS-
EGFP-dneo. The ∆neo
R
 gene is part of a selection t rap. F = wild type FRT site; F3 = F3 
mutant FRT site; PEF = human EF1-α promoter.    
 
3.1.2 Screening for expression loci in host cell genome  
The general strategy to establish master cell clones for site-specific recombination is 
outlined in Figure 3-2. CHO Lec3.2.8.1 cells were transfected with the NucleofectorTM 
system („nucleofected‟) with usually 5 µg linearised tagging vector. This created a broad 
spectrum of randomly tagged cells. Clonal „master‟ cell lines that integrated the 
transgene into favourable chromosomal loci were established by selecting GFP positive 
cells by two rounds of preparative FACS. The isolated cells contained genetically stable 
chromosomal loci, tagged with the reporter gene and conferring high transcriptional 
activity. This strategy avoided the use of antibiotics for selection which was reported to 
improve the establishment of cell clones of homogenous and stable transgene 
expression (Kaufman et al., 2008).  
In the first sorting step, 7 days post nucleofection, GFP positive cells of the highest 
fluorescent were selected, corresponding to 1% to 50% of the cell population. Sorting 
was repeated two weeks after nucleofection and 3% to 11% of the cells were isolated 
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as single cells. Upon expansion, individual GFP master cell clones were obtained 28 
days after nucleofection.  
 
 
Figure 3-2: Generation of master cells using a FACS selection strategy.  (A) Schematic 
representation of selecting tagged master cells for subsequent recombination. I: 
transfect ion of host cells with a GFP tagging vector. II: First sorting of top fluorescent GFP 
cells in a population by FACS one week post  transfection. III: Second sorting of top  
fluorescent single cells out of the sorted population two weeks post transfection. IV: 
Expansion of single cell  clones fol lowed by the analysis  of GFP fluorescence level.  (B) 
Representative presentation of FACS profi les of transfected and sorted CHO Lec3.2.8.1 
cells. Cells were transfected by pEF-FS-EGFP-dneo. Seven days post transfect ion the top 
2.6% fluorescent cells were sorted in a population. On day 14 the top 11% fluorescent 
cells were sorted as s ingle cells out  of the sorted population. 28 days post transfection the 
cells had been expanded and the fluorescence profile of a representative tagged cell  
clone is shown. 
 
3.1.3 Long term stability of tagged cell clones 
An essential criterion for a production cell line is long term stability of  transgene 
expression. Thus, potential master cells were cultured for 12 weeks and GFP 
fluorescence was analysed weekly by flow cytometry. Cell clones with stable GFP 
expression and favourable growth characteristics were eventually isolated for all tagging 
vectors (Fig. 3-3). Overlapping fluorescence profiles indicated stable expression. Cells 
with unstable GFP expression were usually identified within the first three weeks. 
3  RESULTS 67 
 
 
Unstable cell lines either segregated into GFP positive and negative populations, or 
GFP levels gradually shifted to lower fluorescence over time.     
 
 
 
Figure 3-3: Long term stability of master cells over 12 weeks. GFP  flow cytometer 
profi les of representative master cell clones tagged b y the vectors pEF-FS-EGFP (SWI2-
25), pEF-FS-EGFP-dneo (SWI3-26) and pEFF3EGFPF3scHGF (SWI4-25), respectively. Cell  
clones were analysed when they were two weeks in culture (grey line) and when they were 
12 weeks in culture (black line). CHO Lec3.2.8.1 cells served as negative control (grey 
plane). (B) Statistics of cell clones regarding their GFP expression stability.   
 
To quantitate production strength, GFP concentrations were measured in triplicate from 
cell lysates of four-day cultures by fluorescence spectrometry. GFP concentrations 
ranged from 11 to 30 mg GFP per litre of culture. The concentrations were normalized 
to the viable cell number for a better comparison of unequally grown cultures (Fig. 3-4). 
Assuming that these cells can produce other proteins in a similar scale, they were 
considered as adequate producers for glycoproteins in structural biology.  
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Figure 3-4: Representative GFP production level of ten master cell clones tagged by pEF -
FS-EGFP-dneo (SWI3 master cell  clones). The GFP concentration was determined by 
fluorescence spectrometry in tr iplicate from independent four day cultures. The 
concentrations were normalized to the viable cell number. A commercial GFP protein 
served as standard. Error bars = standard deviation.  
 
3.2 Flp-mediated excision 
The FLEx strategy facilitates cell line development without the traditional antibiotic 
selection. As described above, master cell clones were directly selected according to 
their GFP expression. In the following, the GFP gene was deleted for the expression of 
the genes of interest, scHGF and hLAMP3-prox. Due to the high efficiency of FLEx, no 
antibiotic selection was needed in this step, too. 
 
3.2.1 scHGF cell line generated by FLEx 
First, three stable GFP master cell lines (SWI4-18, SWI4-21, SWI4-25) established for 
scHGF with pEFF3EGFPF3scHGF were nucleofected with 5 µg pFlpO-puro encoding an 
optimized Flp recombinase (FlpO). FlpO is a codon improved version of Flpe, which is a 
variant of wild-type Flp from yeast created by molecular evolution (Buchholz et al., 
1998). FlpO is about five times more active than Flpe and its activity is similar to Cre in 
mammalian cells (Raymond & Soriano, 2007).  
Upon expression in the master cells, FlpO catalysed a double-reciprocal crossover of 
the FRT sites resulting in reporter gene excision (Fig. 3-5 A). Thereby, the scHGF 
transgene was transcriptionally activated. Five days post transfection, 16%, 18% and 
36% of the three transfected master clones were detected as GFP negative by flow 
cytometry (Fig. 3-5 B). Non-fluorescent cell clones were isolated for each of the three 
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master cell lines – one or two subclones per master cell line. Reporter gene excision 
was confirmed on the genomic level by PCR with the primers 30 and 5 (Fig. 3-5 C). 
Generally, two to three rounds of subcloning were necessary to obtain homogenous cell 
clones. Taken this into account, the cell line development from the first transfection to 
the pure production clone took about four months. 
 
 
 
Figure 3.5: Flp-mediated reporter gene excision.  (A) Schematic representation of the  
FLEx strategy. (B) Analytical FACS of a homogenous and stable GFP master cell clone 
(fi rst plot). The cel l line was transiently t ransfected with a Flp e xpression vector for GFP 
excision. Five days later, GFP excision led to a second, non-fluorescent cell population  
(second plot). Subcloning resulted in GFP-negative clonal cell lines expressing scHGF 
(third plot). (C) Confirmation of GFP excis ion by PCR. The chromosomally integrated gene 
cassette was amplified after two and three rounds of subcloning, respectively. The 
amplified gene cassette consists of 3.4 kb before and 2.4 kb after GFP excision. Cones = 
FRT sites (F3); P = EF-1α promoter; c  = master c lone number 18 before excision as 
negative control.  
 
3  RESULTS 70 
 
 
scHGF expression was detected in all tested cell lines by Western blot analysis. 
Subclones derived from the same master cell line expressed equal amounts of scHGF, 
due to their isogenicity (data not shown). Clones derived from different master clones 
had divergent expression levels in Western blot analysis (Fig. 3-6). The relative height 
of scHGF expression corresponded to the mean green fluorescence of their master 
cells in flow cytometry (348 a.u. for SWI4-18, 218 a.u. for SWI4-21 and 593 a.u. for 
SWI4-25).  
The most productive scHGF cell clone SWI4-25a1 was cultivated over 11 weeks (22 
passages) in a 40 mL spinner flask. Productivity and stability were analysed by ELISA 
after 7 passages and after 22 passages (Fig. 3-6). An average amount of 2.3 mg/L 
scHGF was produced in four days, and the mean specific productivity of triplicate 
measurements was about 1 pg per cell per day (pcd). The production was stable over 
this time, as product yield and specific productivity in batch culture did not change 
significantly (Fig. 3-6). 
A production cell line for wild type human HGF/SF (Gherardi et al., 2006) (provided by 
Ermanno Gherardi, MRC, Cambridge, UK) that had been established by conventional 
antibiotic selection produced significantly less under the same conditions (1.7 mg/L;    
0.5 pcd; Fig. 3-6). In percent, the increase in product concentration of the FLEx clone 
was lower than the enhancement in specific productivity due to slower cell growth. 
 
 
Figure 3.6: scHGF production and genetic stability.  scHGF was detected by W estern 
blot in the supernatants of stable cell lines established by cell sorting and FLEx. Lane 1: 
SWI4-18b, lane 2: SWI4-25a1 and lane 3: SWI4-21a. The cell clone yielding the most 
intense band (SWI4-25a1) was chosen for scHGF production. HGF/SF concentration in 
supernatants and specific productivit ies of stably transfected CHO Lec3.2.8.1 cell lines 
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were measured by ELISA. The productivity of the cell line SWI4 -25a1 was compared to a 
conventionally established cel l line for wi ld -type (wt) HGF/SF. scHGF production was 
constant over 22 passages. Dark grey = scHGF concentration, light grey = speci fic  
productivity, pcd = pg per cell per day.  Error bars = standard deviation . 
3.2.2 hLAMP3-prox cell line generated by FLEx 
The excision of the GFP reporter gene in stable hLAMP3-prox master cell lines was 
performed as described for scHGF. Homogeneously non-fluorescent clonal cell lines 
were derived from two distinct master cell lines. Western blotting showed that three cell 
clones derived from one of the hLAMP3-prox master clones produced equal amounts of 
protein, and considerably more than a cell clone derived from the second master cell 
line (Fig. 3-7). The hLAMP3-prox sequence has three N-glycosylation sites. Fig. 3-7 
shows that the protein is produced in different sizes with molecular mass differences 
corresponding to the mass of the high-mannose glycan unit, GlcNAc2Man5, of 1234 Da. 
This suggested that protein bearing three, two and one glycans was secreted, which 
was later confirmed by mass spectrometry of purified protein (see chapter 3.6.2 below).  
 
 
Figure 3-7: hLAMP3-prox cell lines.  The hLAMP3-prox product was detected by Western 
Blot analysis in the supernatant of hLAMP-3-prox cell lines which were established by cell  
sorting and FLEx. a, b, c = hLAMP3-prox with three, two and one occupied N-glycosylation 
sites. 
 
These results demonstrated that the excision strategy is a robust way to establish stable 
production cell lines. It circumvents the use of antibiotic selection which can lead to 
gene silencing (Liu et al., 2006). Production cell lines were repeatedly established within 
four months. However, the master cell lines were specific for a single gene of interest. 
That means, novel master cell lines had to be established for each glycoprotein 
construct, which was regarded as inefficient. Transfected CHO Lec3.2.8.1 cells did not 
always survive the procedure of preparative cell sorting for unknown reasons. 
Therefore, the system was developed further and new master cell lines, which could be 
employed for arbitrary genes of interest, were established.   
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3.3 RMCE systems 
Recombinase-mediated cassette exchange overcomes the limitations of the FLEx 
strategy described above. Once established, RMCE master cell lines can be converted 
to produce any protein of interest with heterologous exchange plasmids. Efficient RMCE 
requires master cell lines bearing only a single copy of the tagging vector, which avoids 
incomplete exchange and reduces the risk of illegitimate recombination leading to 
chromosomal rearrangements (Derouazi et al., 2006) and tandem-repeat induced gene 
silencing (McBurney et al., 2002).         
 
3.3.1 Characterisation of the vector integration locus 
Transgene copy number in the stable RMCE master cell lines described in section 3.1 
was analysed by Southern blots and PCR (Fig. 3-8). Southern blots of genomic DNA 
digested with BamHI, which cuts downstream of the RMCE cassette, were probed for 
GFP. A single copy integration of the vector pEF-FS-EGFP-dneo resulted in a single 
band of at least 3.25 kb, depending on the integration locus. If present, further bands 
indicated integration of the vector at additional genomic loci (Fig. 3-8 B). Altogether, 
three out of 15 cell clones that were tested (SWI3a-26, SWI3b-5, SWI3b-24) were found 
to contain a single copy of pEF-FS-EGFP-dneo (Figure 3-8 D). For pEF-FS-EGFP, eight 
out of 30 contained a single copy. The presence of tandem-repeat integrations 
(concatemers) was analysed by PCR with the primers 22/23 (Fig. 3-8 C). Concatemer-
specific PCR products were obtained from 14 multi-copy pEF-FS-EGFP cell clones (3.2 
kb) and five multi-copy pEF-FS-EGFP-dneo cell clones (3.9 kb). The proportion of 
single-copy transgene cell line obtained by nucleofection of CHO Lec3.2.8.1 cells was 
quite high, about 27 % for the tagging vector pEF-FS-EGFP and 20 % for pEF-FS-
EGFP-dneo, which compares well with previous studies on CHO and HEK293 cells 
(Nehlsen et al., 2009).  
To confirm completeness of the integrated transgenes, the human EF-1α promoter, plus 
the FRT cassette and the neomycin resistance gene were amplified by PCR with 
genomic DNA of the master cell clones (primer pair 4/5). In all tested 30 pEF-FS-EGFP 
and 15 pEF-FS-EGFP-dneo cell clones, the correct 2.5 kb and 3.3 kb fragments, 
respectively, were amplified (data not shown).  
 
3  RESULTS 73 
 
 
 
Figure 3-8: Determination of vector copy number integrated in the CHO Lec3.2.8.1 
genome. (A) Schematic representation of the tagging vector pEF-FS-EGFP-dneo. (B) 
Southern blot analysis of tagging vector pEF-FS-EGFP-dneo copy numbers in nine 
potential master cell  clones. The CHO Lec3.2.8.1 host cells were included as negative 
control (c). Genomic DNA was digested with BamHI and a 755 bp fragment of the GFP 
gene was used as probe. For a single copy cell clone, one band of at least 3.2 kb was 
expected, while multiple bands indicated multiple copies. (C) PCR analys is of 
concatemers in ten potential  master cell  clones and the CHO Lec3.2.8.1 (c, negative 
control). Pr imers are marked by horizontal  arrows in panel A. PCR products were 
amplified only in the presence of multiple tagging vector copies at the same integration  
site (D) The table summarizes the Southern blot results for cells  lines tagged with pEF -
FS-EGFP or pEF-FS-EGFP-dneo. Dark/light cones = F3/F FRT sites; P = promoter;       
∆neo
R
 = ATG- and promoter-deficient neomycin resistance gene.    
 
3.3.2 Initial RMCE attempts 
RMCE performance of the master cell lines tagged by pEF-FS-EGFP (SWI2 clones) 
was evaluated with a promoterless exchange vector encoding the red fluorescent 
protein (RFP). The RFP gene, lacking a promoter, is inactive until it is positioned 
adjacent to the EF-1α promoter present in the master cells. This promoter trap 
guarantees that the incoming transgene can only be expressed upon targeted 
integration (Qiao et al., 2009; Seibler & Bode, 1997). 
1.5 x 106 cells of four stable master clones were co-transfected in duplicate approaches 
with different amounts of the Flp expression vector pFlpo-puro (1, 2.5 and 4 µg) and the 
RFP exchange vector pFS-RFP (4, 2.5, 1 µg, respectively). According to the RMCE 
principle, exchange of GFP by the RFP cassette should result in the loss of GFP and 
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appearance of RFP fluorescence, serving as a marker to select targeted cells by FACS. 
The transfected cells were analysed two, three and five days after transfection by flow 
cytometry. However, no RFP+, GFP- cells were observed (data not shown), suggesting 
that the exchange efficiency was too low to isolate the events without antibiotic 
selection.  
To overcome this problem, the exchange vector pFS-HygTk was constructed containing 
a hygromycin thymidine kinase fusion gene (HygTk) flanked by F3 and F FRT sites (Fig. 
3-9 A). Thus, targeted cells gained resistance against hygromycin B. This strategy was 
tested with five single-copy master cell clones. 1.5 x 106 cells of each clone were co-
transfected with 1 µg pFS-HygTk and 4 µg pFlpo-puro. Two to about 600 colonies 
appeared under 12 days of hygromycin B selection in different experiments. However, 
all or most of the colonies were GFP+ in fluorescence microscopy and flow cytometry. 
Five to six GFP- colonies were subcloned and expanded for each of the three master 
cell clones (Fig. 3-9 B). Cassette exchange was confirmed by PCR with genomic DNA 
(Fig. 3-9 C) and the primer pair 4/5, which amplified the FRT cassette, resulting in 
different sizes before and after exchange. PCR on all tested targeted genomes gave 
rise to 3.8 kb bands, corresponding to the exchanged cassette as expected, thus 
confirming successful cassette exchange.  
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Figure 3-9: Generation of HygTk cell clones by RMCE. (A) Schematic representation of 
the RMCE system with promoter trap and integration of the hygromycin resistance gene 
fused to thymidine kinase for negative selection (HygTk). (B) Representative FACS profile 
of a SWI2-25 master cell clone and one subcell clone aft er RMCE and hygromycin B 
selection, demonstrating loss of green fluorescence. (C) PCR analys is of selected non -
fluorescent subcell  clones confirming RMCE. Six subcell  clones (a -f)  were analysed from 
master cell line SWI2-10 and -22 and five subcell clones (a-e) were analysed from master 
cell l ine SWI2-25. Dark/light cones = F3/F FRT sites; P = EF-1α promoter; c = master cells  
(SWI2-25) used as negative control.       
 
Further RMCE approaches with an exchange vector bearing the scHGF gene as GOI 
followed by an IRES element and the HygTk gene for selection, however, failed in 
growing GFP- colonies. In consequence, the HygTk strategy was not explored further. 
The HygTk subclones that were obtained could be used as master cells themselves. An 
exchange of HygTk by a GOI could be negatively selected by ganciclovir, which is a 
pro-drug excluding non exchanged parental cells from growing due to the viral 
thymidine kinase expression (Seibler et al., 1998). The tymidine kinase converts 
ganciclovir into a phosphorylated nucleotide analog, which incorporates into the DNA of 
replicating eukaryotic cells and causes their death (Tomicic et al., 2001).  
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3.3.3 RMCE with selection trap 
The second RMCE strategy used a selection trap in order to enhance the stringency of 
colony formation. To this end, the tagging vector pEF-FS-EGFP-dneo was designed 
with a non-functional ΔneoR gene lacking the promoter and the start codon (Fig. 3-10 
A). The ΔneoR gene is located downstream of the FRT sites and can only be activated 
by the incoming exchange vector upon recombination.   
For exchanging GFP against RFP, nine different master cell clones were co-transfected 
with 1 µg pFlpo-puro and 4 µg of the RFP exchange vector pFS-RFP-PGK. Upon 
recombination, a PGK promoter and a start codon located on the exchange vector 
activated the ΔneoR gene at the tagged locus. Two weeks after transfection, G418 
resistant colonies were obtained for all RMCE reactions at a frequency of about 3 x 10-5 
(40-50 colonies from 1.5 x 106 transfected cells). Two to six cell clones were isolated 
per transfection and their fluorescence was analysed by flow cytometry (Fig. 3-10 B). 
Eight master clones gave rise to exclusively red fluorescent cells, while two master cell 
clones resulted in populations with both red and green fluorescence, indicating 
incomplete RMCE. The exclusively red fluorescent subclones were propagated further. 
RFP expression was stable over at least five weeks, as tested by flow cytometry (Fig. 3-
10 C).  
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Figure 3-10: Generation of RFP production cell clones by RMCE.  (A) Schematic 
representation of the RMCE system with promoter trap and neomycin selection trap. The 
reporter gene is exchanged against RFP. (B) Green fluorescence profi les comparing a 
representative GFP tagged master cell clone (green) with a RFP targeted  cell clone (red) 
and CHO Lec3.2.8.1 cells (grey) as a negative control. (C) Red fluorescence profile 
showing the stable RFP expression of a representative targeted subcell clone after one 
week (orange) and 5 weeks (red) in culture. The fluorescence profi l es of the RFP subcell 
clone were compared to that of the corresponding master cel ls (grey). (D) PCR verification 
of RMCE on genomic level. The hybridization sites of the primers are marked in panel A 
by horizontal arrows. They amplified the FRT site flanked gene cassette. The size 
difference between the amplified GFP (1.9 kb) and RFP (2.7 kb) gene cassettes enabled 
the identification of correctly exchanged subcell clones.  Three of the five subcell  clones 
that were tested (a-e) had a complete exchange. (E) Identi fication of random targeting 
vector integrations by Southern blot analys is. Genomic DNA was digested by NotI and a 
667 bp fragment of the PGK promoter was used as probe. There were no extra bands 
indicating random integration of the targeting vector d etected in the five RFP subcell 
clones (a-e). Cones = FRT sites (dark = F3, l ight = F), P = promoter, ∆neo
R
 = ATG-
deficient, promoterless neomycin res istance gene, m = master cell clone.  
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Genomic DNA was prepared from the remaining seven subclones for PCR amplification 
of the exchanged cassette by primers 30 and 7 (Fig. 3-10 D). The expected 2.7 kb PCR 
product for the exchanged gene cassette was obtained for the tested single-copy 
subclones SWI3a-26 and SWI3b-5, confirming complete RMCE (Table 3-1). RFP 
cassette exchange was also detected in the multi-copy cell clones by PCR. However, 
three of the six tested multi-copy master cell clones resulted in a subset of clones with 
incomplete exchange; both the GFP and the RFP cassettes were detected by PCR in 
these subsets, as representatively shown in Figure 3-10 D lane a and c. The GFP gene 
copies that remained in these subcells were obviously inactive as green fluorescence 
was not detectable. Southern blot analysis proved that the RFP exchange vector did not 
integrate randomly (Figure 3-10 E). Moreover, PCR with Flp-specific primers 10 and 11 
did not detect random integration of the Flp expression vector for any of the subcells 
that were analysed (data not shown).  
 
Table 3-1: Recombination and production properties of different master cell clones 
with a RFP targeting vector.  Copy number of tagging vector was determined by Southern 
Blot analysis and concatemers were detected by PCR. GFP concentration was measured  
from cell ext racts of four day cultures by fluorescence spectrometry. The results were 
correlated to a standard curve of commerc ial GFP fluorescence in tensities of known 
concentration. conc. = concentration.  
Master cell clones  a-22  a-23 a-26 a-33 b-5 b-18 b-25 
Transgene copy number 2 2 1 3 1 3 2 
Concatemers yes yes no no no no no 
GFP conc. [mg/ L] 19.2 13.7 12.2 11.2 19.9 29.8 20.5 
Proportion of clones 
retaining GFP copies 
 6/6 3/5 3/3 0/6 2/2 2/2 3/3 
   
Establishing and analysing the RFP subclones from transfection to the first cryo-
conservation took seven weeks (Fig. 3-11). Upon transfection, the cells grew 3 weeks 
adherently in the presence of G418 until cell colonies were isolated. To ensure that the 
isolated colonies originated from a single cell, subcloning by serial dilution was 
performed. The single cell clones were then expanded by cultivation in suspension in 6 
well plates. These cells were the basis for flow cytometry, PCR, Western blot analyses 
and cryo-preservation.          
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Figure 3-11: Timeline for RFP cell line development by RMCE. Master cel ls were co-
transfected with Flp-expression and targeting vectors. Positively exchanged cell clones 
were selected by G418. Two weeks after transfection, RFP positive colonies were isolated  
and subcloned by serial dilution. S ingle cell clones were expanded to grow in 6 well  
plates. To confi rm the cassette exchange, the cel ls were analysed by flow cytometry and 
PCR analysis. The recombinant protein production was controlled by Western Blot 
analysis before cryopreservation of the cel l clones. It took 7 weeks from transfection of 
the master cel ls to cryopreservation of the first aliquot of RFP cel l clones. More time may 
be required, e.g., if an additional round of subcloning is required to obtain homogenous 
cell clones. WB = Western Blot, FC = flow cytometry.  
 
3.3.4 Evaluation of RFP production 
RMCE performance, expression strength and genetic homogeneity of subclones are 
important features of a good master cell line. Recombinant protein production of seven 
GFP expressing master cell lines and two to four corresponding RFP subcell clones 
was quantified (Fig. 3-12). The GFP productivity of master cells from four day cultures 
varied between 4 pg/ cell and 20 pg/ cell according to fluorescence spectroscopy     
(Fig. 3-4). The expression level distribution corresponded to flow cytometry intensities 
(Fig. 3-12).  
As expected from isogenic clones, subclones obtained by targeting the same master 
cell line produced RFP homogenously (Fig. 3-12). The two master cell lines containing 
transgene concatemers, SWI3a-22 and SWI3a-23, gave rise to cell lines with notably 
low RFP expression, which can be explained by the reduction of the concatemers to 
single copies during the recombination reaction. Absence of concatemers upon RMCE 
was confirmed by PCR with primers 9 and 12 (data not shown). RMCE with the 
remaining five master cell lines, although producing different amounts of GFP, resulted 
in subcell clones expressing a similar, saturating level of RFP. Thus, factors other than 
transcriptional activity might limit the maximal RFP concentration in this cell type.  
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Figure 3-12: GFP and RFP production levels. The fluorescence strength of seven GFP 
master cell clones (green) and the corresponding RFP targeted subcell clones (red) were 
measured by flow cytometry. Each cell c lone was analysed in tripl icate. Error bars = 
standard deviation. GFP fluorescence was scaled down by a factor of 10.  
 
Further experiments were mainly performed with the master cell clone SWI3a-26, which 
was genetically stable, carried a single transgene copy of high transcriptional activity 
and performed well in RMCE with 100% recombinant and highly fluorescent subclones. 
 
3.4 RMCE production cell lines 
To demonstrate the feasibility of the RMCE approach for producing protein for 
crystallography, production cell lines for nine different target proteins were established. 
Experimental work of this part was supported by Sarah Torkaski, Agathe Duda, Jörn 
Josewski and Lilia Polle. The proteins which are listed in Table 3-1 include 
glycoproteins, a GPI-anchored protein and an intracellular protein. The different LAMP 
constructs were chosen upon transient expression tests in HEK293 and CHO 
Lec3.2.8.1 cells (performed by Dr. Konrad Büssow).  
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Table 3-2: Recombinant proteins produced by RMCE derived from CHO Lec3.2.8.1 
cells.  The molecular weight was calculated from the amino acid sequence without signal 
peptides, glycosylation and GPI -anchors. MW = molecular weight, Glyc.  sites = N-
glycosylation sites as indicated by the sequon  Asn-X-Ser/Thr in the amino acid sequence. 
 
Symbol Construct Protein name Species Localisation 
MW 
(kDa) 
Glyc.  
sites 
FcεRIα  ectodomain 
High Affinity IgE 
receptor α 
Homo 
sapiens 
secreted 21 7 
GILT Full length 
Gamma-interferon 
inducible lysosomal 
thiol reductase 
Homo 
sapiens 
secreted 22 3 
mLAMP2-dist 
Membrane-
distal 
luminal d. 
Lysosome-associated 
membrane protein 2 
Mus 
musculus 
secreted 19 7 
mLAMP2-lum 
Luminal 
domain 
Lysosomal-associated 
membrane protein 2 
Mus 
musculus 
secreted 40 16 
hLAMP2-lum 
Luminal 
domain 
Lysosomal-associated 
membrane protein 2 
Homo 
sapiens 
secreted 39 7 
rLAMP2-dist 
Membrane-
distal 
luminal d. 
Lysosomal-associated 
membrane protein 2 
Rattus 
norwegicus 
secreted 19 8 
hLAMP3-prox 
Membrane-
proximal 
luminal d. 
Lysosomal-associated 
membrane protein 3 
Homo 
sapiens 
secreted 19 3 
NALP3 Full length 
NACHT, LRR and 
PYD domains 
containing protein 3 
Homo 
sapiens 
intracellular 118 0 
scHGF 
Single-
chain 
variant 
Hepatocyte growth 
factor/ Scatter factor 
Homo 
sapiens 
secreted 84 4 
shPrP Full length Prion protein 
Meso-
cricetus 
auratus 
Secreted, 
GPI-
anchored 
24 2 
 
3.4.1 Pilot expression test for LAMP constructs 
Proteins of the LAMP family are heavily glycosylated type I membrane proteins with a 
short cytoplasmic C-terminal domain. Their N-terminal region is localised in the 
lysosomal lumen. It is composed of two similar domains, which are connected by a 
proline rich, flexible hinge sequence. The aim of the pilot expression test was the 
identification of protein constructs with minimal flexibility for optimal crystal formation on 
the one hand and good protein yield on the other hand. 
A set of 33 LAMP domains of different species was cloned into the mammalian 
expression vector pEFFS-sigHA with a C-terminal HA tag. HEK293 and CHO 
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Lec3.2.8.1 were transiently transfected and secreted proteins were detected by Western 
blot (data not shown). Five proteins were secreted with relatively homogenous size and 
high yield and were selected for construction of stable cell lines: the complete luminal 
region of human and mouse LAMP-2 (hLAMP2-lum, mLAMP2-lum), the membrane-
distal domain of mouse and rat LAMP-2 (mLAMP2-dist, rLAMP2-dist) and the 
membrane-proximal domain of human LAMP-3/DC-LAMP (hLAMP3-prox). 
 
3.4.2 Generation of production cell lines  
RMCE for the production cell line development was generally performed as described 
for RFP. Adding selection pressure five rather than two days post transfection improved 
recombination frequency for the new constructs. Depending on the construct, the 
optimal mass ratio of co-transfected targeting vector and Flp-expression vector was 1:4, 
2:3 and 1:1, corresponding to a molar ratio of approximately 1:2. 
Stable production cell lines were derived from SWI3a-26 for scHGF, shPrPc, hLAMP2-
lum, mLAMP2-lum, FcεRIα, GILT and NALP3 and RMCE was confirmed by PCR in 38 
of 40 analysed subcell clones (data not shown). Random integration of the targeting 
vector could not be visualized in 10 subclones expressing scHGF by Southern Blot 
analysis (data not shown). This result was regarded as representative. Thus, this 
analysis was not performed for the other subclones. In addition, cell lines for hLAMP3-
prox, mLAMP2-dist and rLAMP2-dist were established with SWI3a-33. This master cell 
line bore three GFP gene cassettes and the cassette exchange was proved to be 
incomplete in all 12 analysed cell clones, though no green fluorescence was detected 
and the target proteins were found in the culture supernatant by Western blot analysis 
(Fig. 3-13).   
At least four subclones of average cell size were expanded for each construct with the 
exception of mLAMP2-dist where only one subclone was available. Recombinant 
protein production by targeted cell clones was analysed by Western blot (Fig. 3-13). 
Subclones derived from the same RMCE reaction expressed their transgene at a similar 
level, as expected for isogenic cells. With the exception of NALP3 cell clones, 
recombinant protein yield appeared adequate for producing sufficient amounts for 
crystallization. NALP3 is an intracellular protein that was solubly produced, but barely 
detectable by an anti-His antibody (Fig. 3-13) and by an anti-NALP3 antibody (data not 
shown) as well. 
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Figure 3-13: Expression test of a variety of production cell lines established by 
cassette exchange.  For all recombinant products, four representative, isogenic subcell  
clones were analyzed by Western blot. (A) Analysed supernatants or cel l lysates 
containing human scHGF, a variant of shPrP, human LAMP3 -lum, murine LAMP2-lum, 
FcεRIα ectodomain and a variant of GILT are illustrated. All subcell clones were derived  
from master cell clone SWI3a-26. (B) Supernatants of cell clones producing rat LAMP2-
dist, human LAMP3-prox and mouse LAMP2-dist are illustrated. These cell lines were 
derived from the SW I3a-33 master cell line. (C) Cell lysates of four NALP3 targeted 
subcell clones and the soluble lysate fraction of SWI3a-26 cells are illustrated. The 
subcells derived from master cel l line SWI3a-26. Small amounts of recombinant human 
NALP3 were detected in al l four soluble lysate fractions of the targeted cel ls and not in  
the negative control.  C = negative control (SWI3a-26 master cells),  i = insoluble, s  = 
soluble. 
 
3.4.3 Characterisation of scHGF subcell clones 
During the cultivation of five scHGF subcell clones, strikingly different growth curves 
and maximal cell densities were observed, while cell viability was generally high and 
glucose and lactate concentrations were not limiting (Fig. 3-14 A). Productivity of scHGF 
per cell correlated inversely with the maximal cell density - cell lines with weak growth 
produced more protein (Fig. 3-14 B). The scHGF product titres among the subclones 
varied between 1.4 mg/L and 4.6 mg/L. Cell size measurements revealed differences 
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between the cell lines that correlated with the divergent cell densities and productivities 
(Fig. 3-14 C). Some of the subclones had increased their size during RMCE and 
produced more protein than normal sized cells. This increase in size correlated with a 
higher content of chromosomal DNA (DNA index, Fig. 3-14 B), indicating chromosomal 
abnormalities like aneuploidy caused by the instability of the CHO genome (Barnes et 
al., 2003; Huang et al., 2007). The DNA index was determined by flow cytometry cell 
cycle analysis. The described heterogeneity for scHGF subclones was not observed in 
any of the other targets‟ cell lines. 
 
 
Figure 3-14:  Evaluation of growth and production properties of targete d scHGF 
subcell clones from one master cell line.  Five targeted subclones of master cell line 
SWI3a-26 were compared in parallel batch cultivations. (A) Course of viable cell  
concentrations (black), cell viabil it ies (grey), glucose concentration (black) an d lactate 
concentrations (grey) in the medium of five parallel cultured scHGF subclones. (B) 
Productivity and DNA index of the targeted subclones (a, b, c, h, i). Secreted scHGF in the 
medium was measured in mg/L and normalized to the viable cel l number. This resulted in 
the specific productivity of the cells presented in pg per cell per day (pcd, light grey). The 
DNA index was determined by cell cyc le measurements. To this end, the cells were fixed 
and their DNA was stained by propidium iodide which was fo llowed by flow cytometry 
analysis. (C) Cell s ize and morphology of the five subclones determined by phase contrast  
images (Axiovert100 fluorescent microscope, Carl Zeiss, Göttingen, Germany). Average 
cell sizes are indicated.  
 
A clone with high productivity and acceptable growth was chosen for further analysis 
(clone a). Its productivity in 40 ml spinner flasks (1.4 ± 0.4 pcd; 4.3 mg/L), compared 
favourably to a scHGF cell clone derived from the FLEx system (SWI4-25a;                 
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1.0 ± 0.2 pcd; 2.3 mg/L) and a conventionally established cell clone for wild-type HGF 
(EGT92/A20; 0.5 ± 0.1 pcd; 1.7 mg/L) which were described in chapter 3.2.1.  
 
3.4.4 Comparison of different scHGF cell lines in perfusion processes 
For structural studies, especially X-ray crystallography, milligram amounts of protein are 
required. Hence, the cultivation of targeted subcell clones was scaled up to 2.5 L 
perfusion bioreactors. Conditioned medium was continuously conducted from the 
bioreactor under cell retention, while fresh medium was added, until 20 L medium were 
perfused.  
To compare the cultivation and productivity of scHGF cell lines established by RMCE 
and FLEx (clones SWI3a-26a and SWI4-25a1, respectively), two 2.5 L perfusion 
processes were performed in parallel. Bioreactors were inoculated with                        
0.2 x 106 cells/mL and cultivated for 5 days in batch modus to viable cell densities of   
2.6 x 106 mL-1 (SWI3a-26a) and 4.4 x 106 mL-1 (SWI4-25a1) (Fig. 3-15). The 
corresponding product concentrations were 3.2 mg/L and 1.0 mg/L for SWI3a-26a and 
SWI4-25a1, respectively. Though having a lower cell density, the RMCE cell clone 
produced more scHGF than the reporter gene excision clone. As described in chapter 
3.4.3, this effect again correlates with the different cell sizes of the clones. The RMCE 
cells had an average size of 19.4 µm in diameter, while the FLEx cells were 13.5 µm in 
diameter.  
The cultivation temperature was shifted from 37°C to 32°C during the process (Fig. 3-
15). It had been reported that the decrease in temperature prolongs culture viability and 
thus lengthens production phase resulting in higher product yield (Kaufmann et al., 
1999; Moore et al., 1997). Moreover, the temperature shift may also increase the 
specific productivity, but this effect is variable among different recombinant CHO cell 
lines (Bollati-Fogolin et al., 2005; Kaufmann et al., 1999). 
After 10 days, 22.5 L conditioned medium were produced for both processes. The peak 
cell densities were 8.3 x 106 mL-1 for SWI3a-26a and 12 x 106 mL-1 for SWI4-25a1 (Fig. 
3-15). The final titre in the perfused culture supernatant was 1.44 mg/L and 0.9 mg/L for 
SWI3a-26a and SWI4-25a1, respectively.    
In conclusion, the final titre of the scHGF RMCE cell line SWI3a-26a outperformed the 
reporter gene excision cell clone SWI4-25a1, although the latter reached a higher cell 
density. Since the clone SWI4-25a1 was established earlier, it was used for producing 
scHGF for the studies described in the following.  
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Figure 3-15: Comparison of two scHGF cell lines in 22.5 L perfusion bioprocesses.  
(A) Photo of a 2.5 L bioreactor cultivating the cell clone SWI3a-26a. The upper panel 
shows the bioreactor at process start with a cell density of 5 x 10
5
 cells mL
-1
 (upper panel) 
and the lower panel shows the bioreactor at the end of the process with a cell density of 
83 x 10
5
 cells mL
-1
. 20 L perfused medium are located in the front. (B) Course of viable 
cell density ( rhombus), scHGF concentration (triangle) and perfusion rate (line) are shown 
for the paral lel cultivat ion of cel l clones SWI3a-26a (RMCE, black, line) and SWI4-25a1 
(FLEx, grey, dotted line). The vertical dotted line marks the start of perfusion and the 
arrows mark a temperature shi ft from 37°C to 32°C.  
 
3.5 Single-chain variant of HGF/SF  
Natural HGF/SF is secreted as a biologically inactive single chain (sc) precursor with 
four N-glycosylation sites and one O-glycosylation site. It is proteolytically cleaved into 
the mature, biologically active two chain form (Birchmeier et al., 2003). Stable CHO Lec 
production cell lines for wild-type HGF/SF and the ligand binding domain of its receptor 
Met have already been established (Gherardi et al., 2006). This work comprises the 
production and glycosylation analysis of a non-cleavable HGF/SF mutant (scHGF) 
bearing two mutations (K491D and R494E) in its natural cleavage site and a C-
terminally fused glycine followed by a hexa-histidine affinity tag. Table 3-3 summarizes 
important physico-chemical parameters of the scHGF construct.  
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Table 3-3: Physico-chemical parameters of human scHGF with C-terminal His6-tag as 
calculated with VectorNTI (Invitrogen). 
Parameter scHGF 
Length (aa) 704 
Molecular weight (kDa) a 80.5 
Molar extinction coefficient 148,300 
Isoelectric point (pI) 7.9 
a 
Molecular weight was calculated without signal peptide and glycosylat ion.  
 
3.5.1 Production and purification of scHGF 
scHGF was produced in 2.5 L batch cultivations of the CHO Lec3.2.8.1 clone        
SWI4-25a1. The protein was purified from the cultivation supernatant by heparin and ion 
exchange chromatography according to the purification protocols for natural HGF/SF by 
Dr. Jörn Krauße (Fig. 3-16). Typical yields amounted to 1 to 3 mg pure scHGF per litre 
of culture. scHGF was mainly obtained as a single protein chain due to the mutations at 
the protease cleavage site. However, small amounts of the cleavage products α- and β-
chain were detected by SDS-PAGE (Fig. 3-16) despite these mutations. This was 
confirmed by mass spectrometry and N-terminal sequencing which identified the natural 
N-terminus of the β-chain and thus the same cleavage position as in wt HGF between 
Arg494 and Val495 (Naldini et al., 1992). Adding 0.1 mM pefabloc SC plus 8 (Roche) to 
cultivation seems to reduce the cleavage products in Western blot analysis of cultivation 
supernatants, but not after purification (data not shown). 
 
 
 
 
 
 
 
3.5.2 Glycosylation analysis of scHGF 
The heterogeneous and flexible nature of glycan modifications generally influences the 
crystallisation of glycoproteins (Butters et al., 1999). To increase the chances of 
crystallisation, purified scHGF was deglycosylated with endoglycosidase H (endo H). 
scHGF was treated with different amounts of this enzyme over night (Fig. 3-17). Since 
no significant mass shift was detectable by SDS-PAGE, masses of the protein were 
measured before and after deglycosylation with 30 U/µg endo H at pH 5.2 by MALDI-
Fig. 3-16: scHGF purification.  scHGF was produced 
by a 2.5-L batch cultivation and purified with a 
heparin column (lane 1), fol lowed by ion exchange 
chromatography (lane 2). Proteins were analyzed by 
12% SDS-PAGE and Coomassie staining.  
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TOF mass spectrometry (Fig. 3-17 C), which confirmed the calculated mass shift of 
threefold glycosylated scHGF upon deglycosylation (84,129 to 81,090). Additional ESI-
TOF mass spectrometry of tryptic peptides indicated that position N402 was 
unglycosylated, while the others (N294, N566, and N653) bore GlcNAc2Man5 chains. 
 
 
Figure 3-17: Deglycosylation of scHGF. (A) Schematic representation of a high -
mannose type N-glycan as it is synthesized by the glycosylation mutant CHO Lec3.2.8.1 
cells. The cleavage site of endoglycosidase H (endo H) is indicated  by an arrow. (B) Endo 
H digestion of purified scHGF produced in CHO Lec3.2.8.1. Di fferent endo H 
concentrations (5 U/µg, 10 U/µg, 30 U/µg) were tested in over night incubations and 
analysed by a 12% SDS gel. No s ignificant size di fferences were observed b etween the 
glycosylated and deglycosylated scHGF. (C) Confirmation of enzymatic deglycosylation of 
scHGF by MALDI mass spectrometry. Molecular weights of 84,352 and 81,083 Da, 
respectively, were measured for glycosylated and deglycosylated scHGF. m/z = ion  mass/ 
ion charge; M
+ /2+
 = molecular ions with one/two positive charges; Man = mannose; GlcNAc 
= N-acetylglucosamine; Asn = asparagine; Control = scHGF without endo H.  
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3.6 hLAMP3-prox  
In this study, the structure of the luminal membrane-proximal domain of LAMP-3 
(hLAMP3-prox) consisting of the amino acids 222 to 381 was investigated. To this end, 
the domain was fused with a mouse immunoglobulin signal peptide (Swissprot P01750) 
and a C-terminally hexa-histidine affinity tag. It was recombinantly produced with CHO 
Lec3.2.8.1 cell lines (Fig. 3-18). hLAMP3-prox bears three N-glycosylation sequons and 
two disulphide bonds predicted by homology. After establishing a chromatographic 
purification protocol, as detailed below, the protein was deglycosylated and crystallised, 
resulting in first insights into the previously unknown structure of LAMP-3/DC-LAMP and 
the whole LAMP family. Table 3-4 summarizes physico-chemical parameters of the 
hLAMP3-prox construct.  
  
Table 3-4: Physico-chemical parameters of human hLAMP3-prox as calculated with 
VectorNTI (Invitrogen). 
Parameter hLAMP3-prox 
Length (aa) 166  
Molecular weight (kDa)a  19  
Molar extinction coefficient 9440 
Isoelectric point (pI) 5.7 
a Molecular weight is calculated without signal peptide and glycosylation. 
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Figure 3-18: Human hLAMP3-prox construct.  (A) Schematic representation of human 
hLAMP3-prox (amino acids 222–381 of LAMP-3, yellow) which is expressed with a mouse 
immunoglobulin signal peptide (Swissprot P01750, pink) and a His 6-tag (green). Positions 
of potential N-glycans and cysteines involved in disulphide bridges are indicated. (B) 
ClustalW alignment of hLAMP3-prox and the full- length sequence (hLAMP-3). The 
secondary structure prediction was performed by JPred (Cole et al. , 2008). The sequence 
annotation is according to Swiss-Prot entry Q9UQV4. E = strand (arrow); H = hel ix 
(cylinder). Colour code: signal  sequence = pink; threonine rich region = l ight grey;  
hLAMP3-prox domain = yellow; His6-tag = green; transmembrane region = blue;  
cytoplasmic domain = dark grey. Cysteines in the hLAMP3 -prox domain are marked pink 
and a natural variation between hLAMP3-prox and hLAMP-3 is highlighted at position 318. 
Numbers represent amino acid positions.  
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3.6.1 Production of hLAMP3-prox  
To evaluate the growth and production of two hLAMP3-prox-expressing cell clones 
established by FLEx and RMCE, parallel cultivations were performed in 2.5 L perfusion 
bioreactors similar to the scHGF processes described in 3.4.4. 
The bioreactors were inoculated with 0.4 x 106 cells/ mL and cultivated for 120 h in 
batch modus (Fig. 3-19). Within this time, both cell clones reached a viable cell density 
of 3.3 x 106 mL-1 and similar maximal growth rates of about 0.4 d-1. The perfusion rate 
was stepwise increased to one reactor volume per day (d-1) after 120 h of cultivation. 
The cultivation temperature was decreased from 37°C to 32°C after 260 h, followed by 
decreasing the perfusion rate to 0.5 d-1. Maximal cell densities were 8.9 x 106 mL-1 for 
the FLEx cell clone and 7.8 x 106 mL-1 for the RMCE cell clone, measured when the 
cultivations were stopped after 401 h and 429 h, respectively. Thus, the growth 
behaviour of the cell lines was similar in perfusion processes. However, the viability of 
the reporter gene excision clone dropped markedly in perfusion mode. For determining 
the hLAMP3-prox yield, the protein was purified from the culture supernatant.     
 
 
 Figure 3-19: Comparison of two hLAMP3-prox cell lines in 2.5 L bioreactors.  Course 
of viable cell density (rhombus), viabil ity (triangle) and perfusion rate (line) are shown for 
the parallel cultivation of LAMP-3 cell clones derived from RMCE (grey) and FLEx (black). 
The vertical dotted line marks the start of perfusion and the arrow marks a temperature 
shift from 37°C to 32°C.   
 
3.6.2 Purification of hLAMP3-prox  
hLAMP3-prox was purified from 22.5 L conditioned medium comprising 20 L perfused 
medium and 2.5 L culture supernatant from SWI3a-26a and SWI4-25a cells, 
respectively. The supernatant was separated from the cells by centrifugation and the 
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total medium was concentrated to 1 L by diafiltration with PBS, followed by purification 
of hLAMP3-prox by immobilized metal ion affinity chromatography (IMAC). A typical 
chromatogram is shown in Figure 3-20 A. Captured protein eluted in two separate 
peaks. The first peak predominantly contained unspecifically bound protein. The second 
peak contained three proteins with sizes corresponding to heterogeneously glycosylated 
hLAMP3-prox (20 – 25 kDa). Additional proteins were still present. Since all unspecific 
bound proteins were larger than hLAMP3-prox, a second purification step was 
performed by preparative gel permeation chromatography (GPC, Fig. 3-20 B). To this 
end, the fractions of the second IMAC peak were concentrated to 10 mL and subjected 
to GPC in 10 mM HEPES pH 7.4 and 150 mM NaCl, resulting in three peaks. Pure 
protein was identified by SDS-PAGE in the third peak, which was concentrated to        
7-10 mg/mL for further analysis. The overall yield of hLAMP3-prox was ~1.2 mg per litre 
cell culture for the RMCE cell clone (SWI3a-26a) and ~0.4 mg per litre for the FLEx cell 
clone (SWI4-25a). The higher hLAMP3-prox yield of the RMCE line indicated superiority 
of the RMCE expression locus over the FLEx locus. 
 
 
Figure 3-20: Purification of hLAMP3-prox. (A) hLAMP3-prox was produced in a 
bioreactor by a RMCE cell line. The perfused medium was concentrated tenfold and 
exchanged to phosphate buffer by diafiltration. The first puri fication step was an IMAC. 
Absorbance at 280 nm is indicated by a l ine in the chromatogram. Horizontal bars indicate 
fractions that were analyzed by SDS-PAGE. Fractions 14 to 21 contained hLAMP3-prox 
and were pooled (light blue bar). The main peak of the chromatogram (fractions 1 to 13, 
dark blue bar) contained unspecific bound protein from the culture supernatant. (B) Upon 
IMAC, hLAMP3-prox from pooled fractions was puri fied by GPC. Fractions 8 to 12 
contained the pure protein. Proteins were analysed by 12% SDS -PAGE and Coomassie 
staining.  1 = hLAMP3-prox with one occupied N-glycosylation site; 2 = hLAMP3-prox with  
two occupied N-glycosylation sites; 3 = hLAMP3-prox with three occupied N-glycosylation 
sites.  
3  RESULTS 93 
 
 
Mass spectrometric peptide mapping of the three hLAMP3-prox SDS-PAGE bands 
between 20–25 kDa (Fig. 3-20 B) identified GlcNAc2Man4-5 at one (predominantly at site 
N291), two (predominantly at sites N266 and N291) or all of the three predicted N-
glycosylation sites.  
 
3.6.3 Deglycosylation of hLAMP3-prox 
The deglycosylation of hLAMP3-prox was analysed by incubating the protein in the 
presence of different activities of endo H at pH 7.4 and pH 5.2, respectively, for different 
lengths of time. The digested protein was analysed by SDS-PAGE (Fig. 3-21). The 
lowest amount of endo H resulting in a complete deglycosylation was 2.5 U/µg when 
incubating over night at pH 5.2. However, aggregation of hLAMP3-prox in the acidic 
buffer condition was observed. hLAMP3-prox was therefore digested with 30 U/µg at pH 
7.4 over night.    
 
 
Figure 3-21: Optimization of hLAMP3-prox deglycosylation. hLAMP3-prox was 
incubated with different activit ies of endo H, for di fferent lengths of time and at two pH 
values (7.8 and 5.2). a = 30 U/µg; b = 10 U/µg; c = 5 U/µg; d = 2.5 U/ µg; C = hLAMP3-
prox before deglysylation; o.n. = over night. Protein digestion  was analysed by 12% SDS-
PAGE and Coomassie staining. 
 
Upon deglycosylation, hLAMP3-prox was purified by preparative GPC to remove endo 
H (Fig. 3-22). Endo H was identified in the fractions of the first peak, while the second 
peak consisted of pure, deglycosylated hLAMP3-prox, which was concentrated to       
22 mg/mL.     
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Figure 3-22: Purification of deglycosylated hLAMP3-prox. Upon deglycosylation, endo 
H  was separated from deglycosylated hLAMP3 -prox by GPC. Horizontal bars indicate 
fractions that were analyzed by SDS-PAGE. Fractions 1 to 6 contained endo H  (dark blue 
bar); fractions 7 to 15 contained deglycosylated hLAMP3 -prox (light blue bar). Lane 16 = 
deglycosylated hLAMP3-prox and endo H before chromatography; lane 17 = 
heterogeneously glycosylated hLAMP3-prox. Fractions containing protein were analysed  
by 12% SDS-PAGE and Coomassie staining.   
 
Before crystallisation setups, the concentrated solution of purified and deglycosylated 
hLAMP3-prox in 10 mM HEPES pH 7.4 and 150 mM NaCl was analysed by dynamic 
light scattering (DLS) in order to check for aggregation and heterogeneity. Only one 
signal corresponding to a hydrophobic radius of 2.3 nm and a molecular weight of       
23 kDa was obtained by DLS, which proved that the protein sample was monodisperse 
and free of aggregates (Fig. 3-23). However, it was observed that the deglycosylated 
protein was temperature sensitive that is to say it aggregated after a few minutes on ice 
or a few days at 4°C while it was soluble at RT for about two weeks. The glycosylated 
protein was stable at 4°C and RT over several weeks. 
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Figure 3-23: DLS measurement of purified and deglycosylated hLAMP3 -prox. The 
presence of a s ingle sharp peak around 2.3 nm indicated the absence of high -molecular-
weight aggregates.  
 
3.6.4 Crystallization of hLAMP3-prox 
Initial screening of crystallization conditions for hLAMP3-prox was performed by sitting 
drop vapour diffusion using the following commercially available screens: JCSG core I, 
II, III and IV, the classics and the Pegs. 39 conditions yielded small, needle-like crystals 
after three to seven days at 19°C. Three representative conditions are shown in Figure 
3-24 A to C. Crystals of 13 conditions were reproduced using an increased sample 
volume and hanging drop vapour diffusion in 24-well format (Table 3-5). This led to the 
crystals shown in Fig. 3-24, panels D-E, which diffracted X-rays to a maximal resolution 
of about 9 Å.    
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Figure 3-24: Initial hLAMP3-prox crystals. (A-C) hLAMP3-prox crystals were obtained  
from various crystallisation conditions using 96-well format crystall ization screens. (D-F) 
Crystals from conditions presented in panels A to C were reproduced in 24 -wel l format. 
Reservoirs contained (A, D) 0.2 M calc ium acetate, 0.1 M MES, pH 6.0, 20% (w/v) PEG 
8000; (B, E) 0.1 M citric acid, pH 5.0, 5% (w/v) PEG 6000; (C, F) 0.2 M ammonium 
sulphate, 20% (w/v) PEG 3350. Proteins were crystallized in drops of equal volumes of 
reservoir solutions and 22 mg/mL protein. 
 
Table 3-5: Conditions that reproducibly yielded hLAMP3 -prox crystals in 3 to 7 days.  
No. Conditions 
1 0.1 M Na-acetate pH 4.6, 30% PEG2000, 0.2 M ammonium sulphate 
2 0.1 M Na-acetate pH4.6, 25% PEG4000, 0.2 M ammonium sulphate 
3 0.1 M Citric acid pH 2.5, 20%(w/v) PEG 6000, final pH 4.0 
4 0.1 M Citric acid pH 5.0, 10% (w/v) PEG 6000 
5 0.1 M Citric acid pH 5, 5% (w/v) PEG 6000 
6 0.2 M Calcium acetate, 0.1 M MES pH 6, 20% (w/v) PEG 8000 
7 0.2 M Ammonium sulphate, 20% (w/v) PEG 3350 
8 0.1 M Sodium acetate anhydrous, pH 4.6, 20% PEG10000 
9 0.1 M Sodium acetate anhydrous, pH 4.6, 15% PEG20000 
10 0.2 M Magnesium chloride hexahydrate, 20% (w/v) PEG 3350 
11 0.2 M Calcium chloride dihydrate, 20% (w/v) PEG 3350 
12 0.2 M Ammonium sulphate, 20% (w/v) PEG 3350 
13 0.2 M Ammonium dihydrogen phosphate, 20% (w/v) PEG3350 
 
Optimization of the crystallization with 0.1 M citric acid pH 5, 5% (w/v) PEG 6000 was 
performed in 24 well plates in order to improve crystal quality and X-ray diffraction. The 
influence of varying the pH between 4.0 and 6.0, the concentration of the precipitant 
PEG 6000 from 3% (w/v) to 20% (w/v) and temperatures of 19°C and 26°C was tested. 
The first needle shaped crystals appeared again after three days and diffracted X-rays 
3  RESULTS 97 
 
 
up to 7 Å. Interestingly, in the following three months some crystals grew further while 
smaller ones dissolved according to a phenomenon called Oswald ripening (Ng et al., 
1996). Best diffracting crystals (up to 2.5 Å) appeared with the conditions 0.1 M citric 
acid pH 4.5 to pH 5 and 7% to 12% PEG 6000 at 19°C. Examples of various optimized 
crystals up to 750 µm in the longest dimension are shown in Figure 3-25. Streak or 
microseeding techniques in optimised conditions did not accelerate or improve the 
formation of the well diffracting crystals.    
 
 
Figure 3-25: Optimized hLAMP3-prox crystals.  Crystals were obtained through 
optimizing the screening condition 0.1 M citric acid pH 5, 5 % (w/v) PEG 6000 by varying 
pH and precipitant concentration. (A) 0.1 M citric acid pH 5, 7 % PEG 6000;                  
(B) 0.1 M citric acid pH 4.5, 8 % PEG 6000; (C) 0.1 M citric acid pH 5, 14 % PEG 6000; 
(D) 0.1 M citric acid pH 4.9, 9 % PEG 6000; (E) 0.1 M citric acid pH 5,  12 % PEG 6000; 
(F)  0.1 M citric acid pH 5, 8 % PEG 6000. 
 
Due to the long period of crystal growth, the intactness of the hLAMP3-prox construct 
building the crystal was analysed. To this end, crystals were dissolved and subjected to 
MALDI mass spectrometry (Fig. 3-26). The resulting molecular weight corresponded to 
the intact hLAMP3-prox construct bearing N-acetylglucosamine residues at two or three 
N-glycosylation sites. The glycoform with only one occupied site was not detected within 
the dissolved crystal solution.          
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Figure 3-26: Characterization of hLAMP3-prox from a dissolved crystal by MALDI 
mass spectrometry.  The molecular weight of 9,622 Da was assigned to a twofold  
positively charged standard molecule and 5000 -7000 Da corresponds to PEG 6000 (upper 
panel) and molecular weights of 19,027 and 19,243, respectively, were measured for 
hLAMP3-prox modified by two GlcNAc residues and three GlcNAc residues, respectively 
(lower panel). m/z = ion mass/ ion charge; GlcNAc = N-acetylglucosamine.  
 
3.6.5 Data collection and processing 
Several optimized hLAMP3-prox crystals were used for X-ray diffraction data collection 
to determine the protein‟s three-dimensional structure. The number of recorded images 
and the oscillation range per dataset varied between different crystals. Both parameters 
were chosen based on the data collection strategy calculated by iMOSFLM (Leslie, 
1992).  
The crystals diffracted up to 2.7 Å at beamline X12 at the DESY (EMBL Outstation, 
Hamburg, Germany, Fig. 3-27). Indexing, integrating and scaling of the diffraction data 
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was performed by the programs XDS (Kabsch) and XSCALE (Kabsch). Ice rings were 
excluded from the calculation. Trigonal symmetry (P3) with similar unit cell dimensions 
of a = b = 52 Å and c = 141 Å was determined for all isomorphous crystals. Moreover, 
the diffraction data indentified systematic absences along 00l. Only every third reflection 
was visible. The absences arose from destructive interference of X-rays in relation to a 
screw axis along c as it is present in the enantiomorphic space groups P31 or P32 (No. 
144 or 145, P3x) (Hahn, 1993). The complete data set statistics are shown in Table 3-6 
at the end of this chapter.  
 
 
Figure 3-27: Diffraction images of hLAMP3-prox crystals. All diffraction images were 
collected at beamline X12 at DESY (EMBL Outstation, Hamburg, Germany). The resolution  
limits are indicated in the pictures. (A) Diffraction image of a sulphur SAD data set. (B) 
Diffraction image of a peak energy data set of an i ridium derivat ive crystal. (C) Diffraction  
image of a peak energy data set of a platinum derivative crystal.   
 
To estimate the number of protein molecules in the asymmetric unit, the Matthews 
coefficient was determined (Matthews, 1968). It indicated the presence of either two  
(VM = 3.06 Å
3/ Da, solvent content: 59.87%, probability 36%) or, more likely, three     
(VM = 2.04 Å
3/ Da, solvent content: 39.8%, probability 64%) monomers per asymmetric 
unit. The calculation of a MOLREP self-rotation function (CCPN4, 1994; Vagin & 
Teplyakov, 1997) revealed twofold axes in the xy-plane perpendicular to the 
crystallographic z-axis and a threefold axis parallel to the z-axis (Fig. 3-28). The 
threefold axis is identical to the crystallographic symmetry axis of space group P3x, 
whereas the twofold axes correspond to a twofold non-crystallographic symmetry 
(NCS). This finding together with the Matthews coefficient indicates the presence of two 
hLAMP3-prox monomers as a C2 dimer (Schönflies, 1886; Schönflies, 1887) in one 
asymmetric unit.  
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Figure 3-28: MOLREP self rotation function calculated from a data set of hLAMP3 -
prox.  Stereographic projection of the coordinate surface of the spherical coordinates (r,  
ω, Φ) along the z-axis. Contour lines indicate the intersection point of a rotation axis. Left  
panel: search for twofold (χ= 180°) rotational symmetries, right panel: search for threefold  
(χ= 120°) rotational symmetries. One non -crystallographic twofold and one 
crystallographic threefold axis were found.  
 
Upon scaling, corresponding data were converted with XDSCONV (Kabsch, 2010a; 
Kabsch, 2010b) to a MTZ file for further phasing analysis.  
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3.6.6 Phasing 
Since no appropriate model of LAMP-3 or the other LAMP family members was 
available, phasing by molecular replacement was not possible. Instead, anomalous 
dispersion was used to determine the phases of X-ray reflection experimentally.  
 
Sulphur-single anomalous dispersion (S-SAD) phasing 
First attempts to solve the phase problem by intrinsic sulphur SAD phasing failed due to 
macromolecular twinning (Fig. 3-29). The twinning fractions of the analysed crystals 
were measured to be 5% to 40% by SFCHECK (Vaguine et al., 1999). Consequently, 
the anomalous signal-to-noise ratio (0.65) did not reach an arbitrary threshold of 1.3.  
 
 
 
Multi-wavelength anomalous dispersion (MAD) phasing 
Since phasing by S-SAD failed to solve the structure, multi-wavelength anomalous 
dispersion was used. Commonly, selenomethionine (SeMet) derivatized protein is 
produced and crystallized in such a situation. The SeMet derivatization in CHO 
Lec3.2.8.1, however, is impeded by the cytotoxicity of SeMet. Therefore, hLAMP3-prox 
crystals were derivatized by heavy-atom compounds. To screen for appropriate heavy-
atom compounds for derivatization, native PAGE was performed by Vitali Maffenbeier 
which separates proteins on the basis of net charge, size and conformation (Boggon & 
Shapiro, 2000). The gel was loaded with soluble protein which had been incubated with 
different heavy-atom compounds. Two of these compounds potassium 
tetrachloroplatinate(II) (K2PtCl4) and ammonium hexachloriridate(III)-hydrate 
((NH4)3IrCl6*xH2O) were identified to interact with hLAMP3-prox and thereby altering the 
protein‟s charge and thus the protein‟s electrophoretic behaviour. This is illustrated in 
Fig. 3-30 by the observed band shifts in lane two and four. 
Figure 3-29: Diffraction image of a hLAMP3-prox 
crystal with a twinning fraction of 40%. The 
diffraction image was collected at beamline X12 at the 
DESY (EMBL Outstation, Hamburg, Germany). The 
resolution limits are indicated in the picture.  
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Figure 3-30: Native PAGE screening for heavy atom derivatization. 7 µg  of the protein 
hLAMP3-prox were incubated at least one hour in 1 mM heavy atom solution in 0.1 M citric 
acid, pH 4.5. The reaction solution was  analysed by a 15% native gel electrophoresis and 
coomassie staining.  
 
The soaking of protein crystals with both components, however, easily provoked crystal 
cracking and loss of diffraction. To reduce the osmotic stress, back soaking in mother 
liquor for removal of the unbound heavy atom compounds was omitted. To determine 
the optimal wavelength for anomalous data collection, X-ray fluorescence energy scans 
of the soaked crystals near the Pt and Ir absorption edges was performed (Fig. 3-31 A). 
The resulting fluorescence data were used by the program CHOOCH (Evans & Pettifer, 
2001) to calculate the anomalous scattering curve including the real (f') and imaginary 
(f'') part of the anomalous scattering factor (Fig. 3-31 B). To efficiently exploit the 
anomalous signal, three datasets were collected for each derivatized crystal at the 
wavelenghts marked in Fig. 3-31 A. Peak datasets were collected at the wavelengths of 
maximal f'', λIr=1.103710 Å and λPt=1.070450 Å for the Ir and Pt-derivatized crystals, 
respectively. A second dataset was collected at the inflection point (λIr=1.104200 Å, 
λPt=1.070730 Å), where the real part (f') of the signal reached its minimum (Fig. 3-31 B). 
Therefore, structure factors at this wavelength should strongly differ from structure 
factors at a wavelength which was chosen for the high-energy remote dataset 
(λIr=1.100090 Å, λPt=1.070730 Å). The gain of information from the latter two datasets 
alone (inflection/remote) is equivalent to two independent datasets collected from a 
native crystal and an isomorphous heavy metal derivative. The advantage of the MAD 
phasing is that all datasets were collected from the same crystal and therefore are 
perfectly isomorphous to each other. Non-isomorphism would have introduced 
systematic errors in the later phasing procedures.  
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Figure 3-31: X-ray energy fluorescence scan of a hLAMP3-prox crystal derivatized 
with the iridium compound hexachloriridate(III) -hydrate. (A) The black line indicates 
the fluorescence intensity at a given energy of incident X -rays. Coloured vertical lines 
indicate the energies which were used for data col lection. (B) P lot for the real ( f' ) and 
imaginary (f '')  part of the anomalous scattering fact or at the L(III)-absorption edge of 
iridium. The values of f' and f'' at the inflection point and the peak are depicted in red and 
blue, respectively.  
 
Following data collection and processing, experimental phasing calculations were 
performed by Dr. Jörn Krauße using the AutoSol tool of the PHENIX package (Adams et 
al., 2010; Terwilliger et al., 2009). Initial phases were eventually obtained by exploiting 
the anomalous signal of the iridium data set up to a resolution of 2.8 Å where the 
anomalous signal-to-noise ratio reached the threshold 1.3. In contrast, the platinum data 
set could not successfully be used for phasing due to a too small anomalous signal. 
Thus, the initial model was obtained by the iridium data set having incorporated one 
iridium atom per molecule (Fig. 3-32). It is coordinated with the nitrogen of S346 
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(distance 4.1 Å), the carbonyl oxygen atoms of Q320 (distance 3.9 Å), A347 (distance 
4.0 Å), H348 (distance 3.6 Å) and probably the oxygen atoms of two water molecules.   
 
Initial hLAMP3-prox structure 
In the presented model hLAMP3-prox appears as a monomer. Most of its amino acids 
were built with the exception of a loop region comprising seven amino acids (V230 to 
L236 referring to their position in the full length protein) near the protein‟s N-terminus. 
Here, the electron density was poorly defined which might be improved by further 
refinement and new crystals with higher resolution.  
The model in Figure 3-32 is in agreement with the secondary structure prediction (Fig. 
3-18) and reveals a high β-strand content. Anti-parallel β-strands form a sandwich of 
two β-sheets. Hydrophobic interactions between the β-sheets (Fig. 3-32 B) and two 
disulphide bonds (C237-C274 and C339-C376, Fig. 3-32 A) stabilize the domain. 
Moreover, electron density corresponding to GlcNAc residues was measured at 
glycosylation sites N266 and N291 whereby the electron density around N266 was not 
well defined. This can be due to heterogeneous occupation of this glycosylation site or 
the flexible nature of the carbohydrate residue. The GlcNAc bound to amino acid 
residue N291 forms a crystal contact over its C3-hydroxyl group to the nitrogen of a 
crystal neighboured G287 backbone and vice versa (Fig. 3-33). Thus, this hydrogen 
bond stabilized the crystal. The third glycosylation site at N232 is localized in the loop 
that had not been built yet.  
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Figure 3-32: Initial model of hLAMP3-prox. Cartoon representat ion of the overall  
structure. Two views are shown related by a 90° rotation around the horizontal -axis. (A) 
Positions of cysteines 237, 274, 339 and 376 involved in disulphide bonds are marked and 
the sulphurs are indicated in yel low. (B) Hydrophobic amino acid side-chains inside the 
sandwich fold are shown in stick representation. Loop regions are shown in grey and β-
strands in red. Iridium atoms are represented by brown spheres. Figures were generated  
with Pymol (http://pymol.org).   
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Figure 3-33: Crystal contact in hLAMP3-prox crystals. A hydrogen bond (2.7 Å) is 
formed between the C3-hydroxyl  group of the GlcNAc bound to res idue N291 and the 
nitrogen of the G287 residue located in a crystal neighboured molecule. The figure was 
generated with Pymol (http://pymol.org).       
 
To gain further information about hLAMP3-prox, the presented model was used to 
search for structurally related proteins in the protein data bank using the DALI server 
(Holm & Sander, 1999). Significant similarities have a Z-score above 2 and usually 
correspond to similar folds. Strong matches even have a Z-score above a cut-off that is 
empirically set to n/10 – 4, where n is the number of residues in the query structure 
(Holm et al., 2008). The protease VII of E. coli had the highest Z-score of 5.2 but no 
obvious similar fold. Thus, no convincing structural homologue was found. Further 
refinements leading to an improved electron density and a more complete model might 
improve the DALI search. Beyond that, the presented model is the basis for further 
experiments resulting in a more detailed structural insight into this protein and other 
members of the LAMP family.  
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4 Discussion 
 
4.1 Site-specific recombination systems in cell line development for 
structural studies 
A variety of approaches have been evolved to enhance recombinant protein production 
in mammalian cells. However, stable cell line development is still restrained by time-
consuming and expensive screening procedures for high and stable production clones. 
Defined genomic engineering by heterologous site-specific recombination systems has 
been described before (Kaufman et al., 2008; Nehlsen et al., 2009; Qiao et al., 2009; 
Schlake & Bode, 1994). Published reports have so far focused on the proof of principle 
and optimization of the technology. This work describes for the first time the application 
of recombination systems to establish glycosylation mutant cell lines for protein 
production for crystallography. To this end, glycosylation mutant CHO Lec3.2.8.1 cells 
were chosen as host cells. These cells express glycoproteins with truncated and more 
homogenous carbohydrate side chains which have a beneficial effect on crystallisation. 
Two different recombination strategies were pursued: an Flp-mediated excision (FLEx) 
and a recombinase-mediated cassette exchange (RMCE). In both approaches, 
chromosomal loci were tagged by Flp recombination target (FRT) sites and a GFP 
gene. The GFP gene was used to enrich and clone highly expressing cell clones using 
fluorescence activated cell sorting (FACS). Upon generation of so-called master cell 
clones, the GFP reporter was either exchanged against another gene (RMCE) or 
excised (FLEx) whereby a gene of interest was put under control of the promoter at the 
pre-characterized locus. By this means, production cell lines were established for 
different recombinant products, and they were successfully used for bioreactor 
cultivations.  
 
In the following the results of the RMCE and the FLEx system are discussed and 
compared regarding their applicability for glycoprotein production in crystallography. 
 
4.1.1 Isolation of genomic loci with stable and high transgene expression  
An important characteristic of a good production cell line is its highly active and stable 
expression locus. Conventional identification of an expression hot spot is based on 
random integration of the transgene resulting in unpredictable integration sites and 
transgene copy numbers due to chromosomal position effects. This explains the highly 
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variable gene expression among isolated cell clones, requiring an extensive screening 
procedure. Moreover, the selection procedure has to be repeated for every new 
recombinant product which in turn impedes a higher throughput. Hence, new strategies 
are of great interest.  
 
Various strategies have been applied before to identify expression hot spots. They 
include antibiotic selection, multiple rounds of FACS and combinations of both (Kim & 
Lee, 2008; Nehlsen et al., 2009; Qiao et al., 2009; Verhoeyen et al., 2001). FACS 
enables high-throughput selection of high-yield GFP tagged clones out of millions of 
cells and facilitates an easy long-term screening of cell clones for homogenous 
expression (Kaufman et al., 2008). Thus, this method was well suited for establishing 
master cell lines in this work. After nucleofection of CHO Lec3.2.8.1 cells a two-round 
sorting strategy resulted in stable, high-yield expression in 38% of the analysed clones 
after 12 weeks in culture and in the absence of any antibiotics (Fig. 3-3 B). The 
observed reduction in productivity in some clones may be a consequence of 
chromosomal rearrangements (Yoshikawa et al., 2000) or epigenetic mechanisms 
occurring by interactions between the integrated DNA sequence and the chromosomal 
surroundings (Emerman & Temin, 1984; Whitelaw et al., 2001). Besides an emphasis 
on position effect, tandem-repeat integration of the transgene may lead to gene 
silencing (McBurney et al., 2002). The transgene copy number influences the cassette 
exchange, too. While “head-to-tail” tandem integrations result in the excision of 
additional transgenes by recombination of identical FRT sites, more complicated 
architectures may result in unpredictable deletion, inversion or translocation (Bode et 
al., 2000). To circumvent this unpredictability, transgene copy numbers and tandem-
repeat integrations of RMCE master cell clones were investigated by PCR and Southern 
Blot analysis. Among the analysed 34 cell clones, 8 (26 %) and 3 (20 %) were identified 
with a single integration of pEF-FS-EGFP and pEF-FS-GFP-dneo, respectively (Fig. 3-8 
D). This result suggests that nucleofection is a feasible DNA transduction method for 
CHO Lec3.2.8.1 cells in order to obtain single copy integrations. Similar single copy 
integration rates of about 30 % were obtained for CHO K1 cells by Nehlsen et al. 
(2009).    
 
With regard to the cell sorting strategy itself, it is often recommended to use a 
destabilized, short-lived GFP or RFP variant (Turan et al., 2011). This is advantageous, 
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if the enhanced GFP variant reaches saturation and prevents resolution of the top 
fluorescent cells. Figure 3-2 B shows, however, that only a minor part of the GFP cells 
reached saturation in this work. The maximal GFP expression levels ranged between  
11 mg/L and 30 mg/L. These cells were considered to be adequate master cells for 
glycoprotein production in structural biology. Altogether, 12 and 18 FLEx master cell 
lines were generated for the target proteins scHGF and hLAMP3-prox. 8 and 3 single 
copy master cell lines were generated for the RMCE strategies based on the plasmids 
pEF-FS-EGFP and pEF-FS-EGFP-dneo, respectively. 
 
4.1.2 How to efficiently isolate recombination events upon RMCE   
The cassette exchange that was applied in this work based on the Flp/FRT system of 
Saccharomyces cerevisiae. Here, a gene cassette is flanked by two FRT sites, a wild-
type and a mutant sequence, that cannot recombine with each other but are recognized 
by Flp (Schlake & Bode, 1994). This architecture enables the precise exchange of one 
gene cassette against another. However, the exchange rate is low. The simplest 
selection approach aimed at sorting the exchanged events by FACS. Since the GFP 
reporter is exchanged against another gene, the cells should lose GFP fluorescence 
and can be isolated. Four master cell clones with different integration loci were 
investigated for an exchange of GFP against RFP. However, no RFP+, GFP- cells were 
obtained. This regative result led to the introduction of antibiotic selection strategies.  
Exchanging GFP against a hygromycin resistance thymidine kinase fusion gene 
(HygTk) in five different master cell clones resulted in two to 600 mostly GFP+, but also 
GFP- colonies after hygromycin B (hyg B) selection. Though being leaky, the 
hygromycin selection system was adapted to generate scHGF production clones. The 
exchange vector bore the scHGF gene followed by an IRES element and the HygTk 
gene for selection. However, this approach failed in growing GFP- colonies. The high 
number of selected GFP+ colonies indicated that the master cells became resistant 
against hyg B on another way than RMCE. The exchange vector might have been 
randomly integrated downstream of an endogenous promoter and thereby conferring 
resistance. Due to the high frequency of this event interfering with RMCE, a more 
stringent selection system was needed. A combination of a positive and negative 
selection strategy was for example conceivable. One possibility would have been the 
use of generated HygTk clones as master cells. An exchange of HygTk by a GOI could 
be negatively selected by ganciclovir, which is a pro-drug excluding non-exchanged 
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parental cells from growing due to the viral thymidine kinase expression (Seibler et al., 
1998). The tymidine kinase converts ganciclovir into a phosphorylated nucleotide 
analog, which incorporates into the DNA of replicating eukaryotic cells and causes their 
death (Tomicic et al., 2001). A published approach in BHK-A cells made use of a 
combined positive and negative selection strategy by puromymicin and ganciclovir, 
respectively (Karreman et al., 1996). In that work, 62 cell clones were established for 
two integration sites, but in many cases they bore random integrations of the exchange 
vector, too. Only one was identified as an authentic RMCE event. Thus, the negative 
selection strategy was not followed further in this work. 
 
Higher recombination efficiencies were obtained by integrating a selection trap in form 
of a non-functional selection marker like the neomycin resistance gene (∆neoR) 
(Verhoeyen et al., 2001). The ∆neoR gene is cloned directly downstream of the FRT 
cassette in the master cells and lacks a promoter and a start codon. Upon 
recombination, the missing elements, located on the targeting vector, transcriptionally 
activate the incomplete ΔneoR gene at the tagged locus (Fig. 1-9). The complemented 
selection trap allows selection for correct RMCE events with the antibiotic G418. 
Verhoeyen (Verhoeyen, 2000) analysed 165 subcell clones upon RMCE and confirmed 
a correct exchange in all of them. Schucht (Schucht, 2006) used the ∆neoR selection 
trap in three cell lines (HEK293, BHK-21 and CHO-K1) and also found nearly 100% 
exchange efficiency. Only three of 122 analysed subclones contained additional 
integrations of the exchange vector. Thus, this selection system facilitated a stringent 
selection of authentic cassette exchanges.  
 
This work combined the ∆neoR complementation strategy with a promoter trap (Fig.     
1-9). No targeting vector integrated randomly in 15 of 15 analysed non-fluorescent 
subcell clones. Furthermore, RMCE resulted in a complete exchange in 43 of 45 
subclones derived from two different single-copy master cell clones (SWI3a-26 and 
SWI3b-5). Thus, the cassette exchange in CHO Lec3.2.8.1 cells was regarded as 
reliable and obviously resulted in extremely high selection stringency.  
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4.1.3 RMCE frequency 
Besides selection stringency, recombination frequency contributes to an efficient RMCE 
experiment. The latter is influenced by the recombinase activity, the exchange vector 
and the position effect of tagged chromosomal loci in the master cells.  
 
As the activity of the natural thermo-instable Flp was low in mammalian cells, the 
thermo-stable mutant Flpe was evolved by cycling mutagenesis (Buchholz et al., 
1996a). The recombinase that was used throughout this work based on a mouse codon 
optimized Flpe variant (FlpO) whose efficiency is comparable to Cre (Raymond & 
Soriano, 2007). Recently, it was reported that the exchange efficiency is directly related 
to the amount of transferred Flp expression plasmid (Schebelle et al.). The following 
amounts of Flp expression vector per 5x106 cells were transferred in other studies:    
170 µg for murine ES cells (Seibler et al., 1998), 40 µg for CHO cells (Qiao et al., 2009) 
and 25 µg for NIH3T3 cells (Turan et al., 2010). In this work, however, the transferred 
DNA amounts were limited to 5 µg and a maximum volume of 5 µl by the DNA delivery 
method nucleofection. The corresponding recombination frequencies varied between 7 
and 50 subcell colonies per 1.5x106 transfected cells dependent on the used exchange 
vector. Best results were obtained by transfecting the Flp expression vector and the 
exchange vector in a molar ratio approaching 2:1. The excess of the Flp enzyme is 
necessary regarding the stoichiometry of the recombination reaction. Four Flp 
protomers have to associate with the DNA strands of both reaction partners for 
catalysing the recombination (Chen & Rice, 2003). Moreover, the protein dissociation 
step limits the turnover of Flp reactions (Waite & Cox, 1995). Thus, Flp remains 
unavailable for further reactions for extended time periods and higher amounts of the 
enzyme can compensate for the deficiency.  
 
A prerequisite for an Flp-mediated recombination is a random collision of two identical 
FRT sites (Qiao, 2009). In case of RMCE, one FRT cassette is anchored as a single-
copy in the host chromatin, while its counterpart is located on the exchange vector. 
Thus, the amount of the incoming FRT cassette on the exchange vector can be varied. 
By increasing its amount to a large molecular excess, the rate of random collisions 
possibly leading to RMCE events is raised. Higher recombination efficiencies may be 
achieved by optimizing other DNA delivery methods for the hard-to-transfect CHO 
Lec3.2.8.1 cells. DNA transfer by polyethyleneimine (PEI) could be a solution as it is 
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cheap and the DNA amounts can be increased. The ratio of DNA to PEI for CHO 
Lec3.2.8.1 cells was optimized in small scale and adequate transfection rates of up to 
29% were obtained with 1.6 µg of an GFP reporter plasmid and 20 µg PEI per 5x105 
cells (Duda, 2009). However, it has to be taken into account that a transfer of increased 
DNA amounts might also raise the probability of random secondary integrations of the 
Flp and the exchange vector. 
 
The most obvious difference between RMCE runs was the transgene size and therefore 
the size of the exchange vector. While transfection with an exchange vector bearing a 
RFP gene (0.68 kb) resulted in 40-50 colonies, transfection with an exchange vector 
bearing a scHGF gene (2.2 kb) resulted in 7 colonies. This led to the assumption that 
the distance between two FRT sites might influence the rate of collisions between the 
respective FRT sites. For Flp-mediated excision approaches, where both FRT sites 
were located on one DNA molecule, it was shown that increased distances between the 
FRT sites led to an asymptotic decrease in recombination frequency (Ringrose et al., 
1999). Nevertheless, Wallace et al. (Wallace et al., 2007) described the replacement of 
a large segment (> 100 kb) of the mouse genome by the equivalent human synthetic 
region. This shows RMCE being a multi-factorial process that can be optimized at 
different levels to enable reproducible results.        
 
No significant variation was observed when master cell clones with different integration 
loci but similar high GFP fluorescence were transfected by the same RFP exchange 
vector. The recombination frequency was uniformly 40 to 50 colonies per approach. 
This supports the observations of Verhoeyen (Verhoeyen, 2000) and Schucht (Schucht, 
2006) that RMCE frequency is similar for different high expression integration sites. 
Highly producing cells were more amenable for site-specific recombination than lower 
producing cells in their studies. It appears that tagged chromosomal loci located in 
easily accessible heterochromatin conferring a high transcriptional activity also support 
success of RMCE. 
 
4.1.4 RMCE of multiple transgenes is possible 
Diverse studies have shown before that the co-expression and co-purification of protein 
complexes for structural studies are often more successful than their separate handling 
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(Romier et al., 2006; Strong et al., 2006). Thus, a system facilitating the co-expression 
of multi protein complexes in mammalian cells would be of great interest.  
 
In this work, RMCE was performed with five multi-copy master cell lines (Table 3-1) and 
resulted in a complete exchange of all reporter copies against RFP in three lines. This 
suggests that simultaneous exchange of two to three reporter gene copies against 
different target genes for co-expression in the same cell would generally be possible. 
However, the selection of subcells expressing all desired transgenes might be 
challenging using the master cells of this work, as all loci bear the ∆neoR trap. The 
integration of different selection traps such as a hygromycin trap or puromycin trap 
might improve selection specificity. Further considerations have to be made before 
establishing a robust RMCE system for the expression of multi-protein complexes at 
different chromosomal loci (multiplex RMCE). For example, mutual recombinations  
between the FRT sites of different tagged loci have to be ruled out. Recently, a 
multiplex Flp-RMCE approach was described that relies on a set of novel heterospecific 
FRT site mutants (Turan et al., 2010). The authors designed novel pairs of synthetic 
FRT site variants and evaluated simultaneous exchange of two separate target 
cassettes in one master cell. The new F13/F14 site pair was similarly effective in RMCE 
as the F3/F sites used in this work. 
 
Besides the three multi-copy master cell clones that exchanged all FRT-cassettes, two 
multi-copy clones did not. False subclones were usually identified by their GFP 
fluorescence. However, one master cell line, SWI3a-33, always resulted in subcell 
clones with incomplete RMCE events, though their subcell clones lacked green 
fluorescence and produced glycoproteins with good yield. This may be explained by a 
transcriptionally silenced copy of the reporter gene present in the heterochromatin, not 
accessible for recombination. In summary, unpredictable RMCE results can be 
expected when using multi-copy master cells with identical FRT-cassettes. 
 
4.1.5 Homogenous expression by isogenic subcell clones 
According to the RMCE principle, isogenic subcell clones of one master cell line should 
have a uniform expression profile after cassette exchange. Previous studies showed 
this for the production of retroviral vectors and antibodies in HEK293 and CHO cells 
(Nehlsen et al., 2009; Schucht et al., 2006).      
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The genomic homogeneity that was found in subclones of master cells with single copy 
transgenes corresponded to homogenous RFP levels (Fig. 3-12). Interestingly, the RFP 
levels are quite similar throughout all analysed subclones, though the GFP levels of 
different master clones varied. Regarding the position effect, there are no differences 
between master cells and their daughters except for the transgene itself (Fig. 1-9). 
Thus, there is the possibility that particular features of the transgene like its nucleotide 
composition or its product might limit the RFP concentration in mammalian cells. For 
bacterial hosts it is for example discussed that the RFP variant DsRed-Express, which 
was also used in this work, is cytotoxic due to aggregation (Strack et al., 2008).  
 
Close analysis of five RMCE-derived scHGF cell clones revealed deviations in their 
production level determined by ELISA, although immunoblotting resulted in similar 
scHGF expression. These discrepancies coincided with differences in cell size, growth 
and DNA content. Non-uniformity of scHGF cell clones was likely caused by 
chromosomal abnormalities like aneuploidies of the CHO genome, which is known to be 
instable (Barnes et al., 2003; Pilbrough et al., 2009). All other cell lines obtained by 
RMCE in this study, apart from scHGF, appeared to be isogenic and interchangeable on 
protein level. Thus, CHO Lec3.2.8.1 hosts were generally well amenable for the Flp 
RMCE strategy. Nevertheless, the size of subclones obtained by RMCE should be 
taken into account. Subclones of similar size to the master cells should be selected to 
ensure predictable production and cell growth. 
 
In the following, another aspect leading to heterogeneity of subclones in other 
heterologous recombination systems will be discussed. The Cre/lox system from 
bacteriophage P1 has been reported to cause decreased cell growth, cytopathic effects 
and chromosomal aberrations (Schmidt et al., 2000; Silver & Livingston, 2001). 
Explanations for these observations were illegitimate recombinations based on the 
presence of multiple cryptic lox sites on the one hand. On the other hand illegitimate 
endonuclease activity contributed to DNA damage and growth inhibition by inducing 
nicks that can be converted to double strand breaks and led to non-homologous DNA 
repair (Loonstra et al., 2001). The illegitimate endonuclease activity can arise, as 
recombination intermediates are prone to be attacked by unauthorized nucleophiles like 
water molecules. In case of the Flp/FRT system this side reaction is conf ined by the 
architecture of the recombination synapse and its conformational dynamics as identified 
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by three dimensional structures of Flp (Ma et al., 2009). Furthermore, a long term study 
proved the stability of an FRT flanked gene cassette in a BHK cell line continuously 
expressing Flp (Seibler & Bode, 1997). This strongly indicated the absence of cryptic 
FRT sites in mammalian genomes. Taken together, the Flp/FRT system confers highly 
specific and non-toxic recombination (Turan et al., 2011). Thus, the heterogeneous 
scHGF expression levels found in this work are more likely to be caused by 
characteristics of the CHO Lec3.2.8.1 cells.  
 
4.1.6 Flp-mediated cassette exchange versus excision 
In this work, stable high producer cell lines for two target proteins, hLAMP3-prox and 
scHGF, were successfully established by RMCE and FLEx. Their establishment relied 
on two steps. The first step was the same for both systems: integration loci conferring 
high and stable GFP reporter gene expression were tagged. This procedure took 
advantage of two subsequent rounds of FACS efficiently selecting the top fluorescent 
cells within one month (4.1.1, Fig. 4-1). To ensure that the tagged single cell clones 
mediated stable transgene expression, only those cells were used as master clones 
whose fluorescence did not vary over at least three months. Depending on the 
architecture of the GFP tagging vector, the reporter was either excised or exchanged by 
another transgene.           
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Figure 4-1: Timeline comparison of different cell line developme nt strategies.  (A) The 
conventional strategy needs a minimum of 12 months from gene transfer over screening 
for high and stable producer cell clones to develop large-scale production processes 
(Wurm, 2004). (B) The FLEx strategy relies on GFP expressing master  cell clones that 
were selected by two rounds of FACS (1 month). The selected high producers were 
screened for their stabi lity (3 months) and the best master cell clones were subjected to 
Flp-mediated recombination resulting in the excision of GFP and acti vation of the desired 
transgene. First cryo-preserved production cell  clones were available after another subcell  
cloning step (1 month). Altogether 5 months were needed for this strategy . This could be 
shortened to 4 months, when the FLEx reaction is performed in parallel to the last weeks 
of screening. (C) The generation of the RMCE master cel ls is  analogous to the FLEx 
system and took 4 months. The RMCE reaction exchanging the GFP gene against another 
transgene resulted in the production cell lines. This  step took 6 weeks for scHGF 
subclones and 7 weeks for RFP subclones depending on the number of subcloning rounds. 
Altogether the whole process took about 5.5 months for the first production cell line and 6 
to 7 weeks for the following ones, as the master cell clones could be reused.         
 
While FLEx is a monomolecular reaction and therefore thermodynamically favoured, 
RMCE is a rare event. Recombination frequencies were up to 36% for FLEx and only up 
to 0.003% for RMCE. Thus, RMCE needed a stringent selection by the ∆neoR selection 
trap to isolate the recombined cell clones (4.1.2). The additional antibiotic selection 
explains why RMCE took six to seven weeks, while the FLEx step took only one month 
and was easier to establish. Moreover, the latter strategy completely circumvented the 
use of antibiotic selection. According to published data, the prokaryotic neomycin 
resistance gene acts as a transcriptional silencer in eukaryotic cells (Artelt et al., 1991). 
However, this was not observed in this work. To minimize the risk of instabilities, a 
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combined use of RMCE and FLEx would be conceivable that would eliminate the 
selection trap after successful RMCE.   
 
An important factor of cell line development by FACS and recombination strategies is 
the short and predictable timeline. Dependent on the strategy the first cryo-preserved 
cells were available after 4 months and 5.5 months for the FLEx and the RMCE 
strategy, respectively (Fig. 4-1). This is a big advantage compared to conventional cell 
line development requiring about 12 months (Wurm, 2004). The RMCE system is even 
more convenient, as the master cells are universal and only have to be established 
once. They can be converted to express any desired transgene, which shortened the 
timeline further. The expansion of first subclones started three weeks post transfection, 
followed by cryo-preservation after six to seven weeks depending on the number of 
subcloning cycles. Altogether, 10 different production cell lines were rapidly established 
from selected master cells. The recombinant products include glycoproteins, an 
intracellular protein and a GPI-anchored protein.  
 
The RMCE cell lines for scHGF and hLAMP3-prox were cultivated in parallel to their 
FLEx counterparts in 2.5 L bench top bioreactors to compare their productivities. It is 
worth noting that the scale up from 6 well plates to 2.5 L was a straightforward process 
for all stable cell lines using a standard protocol for the bioreactor process. In contrast, 
the scale up for transient transfection approaches is currently still connected to 
laborious optimization and the preparation of large DNA amounts. Thus, stable cell lines 
are the favoured expression system especially for low yield glycoproteins that have to 
be purified from larger culture volumes.  
 
The purified hLAMP3-prox yields derived from the RMCE and the FLEx system were    
1 mg and 0.4 mg per litre cell culture, respectively. A direct comparison of scHGF titres 
in the culture supernatants also resulted in a higher specific productivity for the RMCE 
cells (1.4 pcd) than for the FLEx cells (1 pcd). The measured productivities are in 
accordance with the relative GFP fluorescence levels of the respective master cell 
clones.      
 
In summary, RMCE with a suitable, well characterized master cell line was found to be 
faster and more predictable than FLEx. Using RMCE, fewer clones had to be analysed 
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and preparative cell sorting equipment was not required after the master cell clones had 
been established. Due to these facts, RMCE was an ideal system to produce 
mammalian glycoproteins.      
 
4.2 Production of glycoproteins for X-ray crystallography  
 
4.2.1 The glycosylation dilemma  
Structural information of mammalian glycoproteins gained an increased attention in 
recent years, as they often have key functions in the human body. However, their 
production is challenging and requires eukaryotic expression systems though being cost 
and time intensive. Moreover, crystallography projects often necessitate the production 
of a variety of different constructs per protein to find well crystallisable protein. As 
discussed above, the RMCE system in CHO cells is an excellent choice to enhance 
mammalian cell line development for glycoprotein production.  
 
Another challenge for X-ray structure analysis is the heterogeneous and flexible nature 
of mammalian protein glycosylation which often hampers the formation of well diffracting 
crystals (Butters et al., 1999). In contrast, the production of completely deglycosylated 
glycoprotein may lead to folding problems and instable products. Glycosylation mutant 
cell lines like CHO Lec3.2.8.1 are a good alternative producing glycoproteins with 
truncated carbohydrate chains of high-mannose type (Stanley, 1989). Moreover, they 
have the advantage of the mammalian machinery for protein folding and processing. 
Yeasts also synthesise glycans of the high-mannose type, but fail to efficiently secrete 
certain classes of mammalian proteins (Chang et al., 2007). If glycoproteins with high-
mannose type side chains remain not crystallisable, a further deglycosylation often 
results in improvement (Chang et al., 2007).  
 
4.2.2 CHO Lec3.2.8.1 cells are beneficial for X-ray crystallography 
In this work, two glycoprotein constructs, scHGF and hLAMP3-prox, were analysed 
regarding their glycosylation homogeneity. They were produced in glycosylation mutant 
CHO Lec3.2.8.1 cells upon RMCE. The production process could be kept quite simple, 
as no additional inhibitors of the glycosylation processing pathway, like NB-DNJ, 
swainosonine or kifunensine, had to be added to gain shorter and more homogenous 
glycosylation. The high-mannose type glycans added by CHO Lec3.2.8.1 cells          
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(Fig. 1-10) can be efficiently digested by endoglycosidase H (endo H). Endo H cleaves 
between GlcNAc residues in the di-N-acetyl-chitobiose core of high mannose and 
hybrid-type N-glycans, leaving single GlcNAc units at each glycosylation site (Chang et 
al., 2007). The single GlcNAc is known to shield hydrophobic regions of the protein 
surface (Petrescu et al., 2004). Proteins bearing these GlcNAc residues were found to 
be more stable than those completely deglycosylated by PNGase F (Davis et al., 1995). 
Deglycosylation of purified scHGF with 30 U/ µg endo H at pH 5.2 followed by mass 
spectrometry indicated that three of the four predicted glycosylation sites were 
occupied. The positions were identified as N294, N566 and N653, all bearing 
GlcNAc2Man5 chains. N402 was found non-glycosylated. That proved the high 
homogeneity of glycoproteins concerning glycan composition and occupied sites when 
using CHO Lec3.2.8.1 cells.  
 
In case of pure hLAMP3-prox, however, non-uniformly occupied glycosylation sites 
were identified. One (predominantly N291), two (predominantly N266 and N291) or all 
three sites (N232, N266 and N291) of the protein bore GlcNAc2Man4-5 chains. Total 
hLAMP3-prox recovery following endo H digestion was higher at pH 7.4 than pH 5.2, 
signalling pH sensitivity of the deglycosylated protein. Nevertheless, all one to three 
occupied glycosylation sites were efficiently shortened to one GlcNAc residue conferring 
a suitable homogeneity for crystallisation (4.3.2). Before crystallisation, endo H was 
separated from hLAMP3-prox by GPC. The deglycosylated protein was soluble for at 
least two weeks. As the stability of glycosylated hLAMP3-prox was even higher, 
deglycosylation was applied in several batches depending on the need for 
crystallisation. Digestion by endo H can be easily adapted to different scales.  
 
Taken together, these observations confirm that glycoproteins produced by CHO 
Lec3.2.8.1 cells are well susceptible for endo H digestion resulting in soluble 
homogenous protein with a minimal amount of flexible sugars. Thus, these hosts are an 
excellent expression system for X-ray crystallography.   
 
4.3 Structural analysis of hLAMP3-prox 
LAMP-3 belongs to the family of lysosome accociated glycoproteins. It was suggested 
that LAMP-3 is involved in processing of exogenous antigens restricted to MHC class II 
presentation, as it is associated with the intracellular MHC class II compartment in late 
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mature dendritic cells (de Saint-Vis et al., 1998). LAMP-3 may facilitate the translocation 
of MHC class II molecules to the cell surface. However, direct information about the 
function of LAMP-3 is still awaited, for example by generation of knock out animals. 
The sections below discuss the progress towards a crystal structure of the membrane-
proximal domain of human LAMP-3 in lysosomes. This structure is the first among all 
LAMP family members. Production, purification and crystallisation conditions were 
established. The initial model from the crystal structure was finally determined using 
multi-wavelength anomalous dispersion. It revealed a β-sandwich fold of two β-sheets.   
 
4.3.1 Production and purification of hLAMP3-prox 
Since hLAMP3-prox is a mammalian glycoprotein with three predicted N-glycosylation 
sites, it was produced in CHO Lec3.2.8.1 cell lines secreting the protein with a C-
terminal hexa-histidine (His6) tag for purification. The production cell lines were 
established by FLEx and RMCE as described before in this work. Perfusion processes 
routinely resulted in 22.5 L conditioned medium which was concentrated to 1 L followed 
by a buffer change and IMAC purification. The affinity chromatography should 
specifically purify the tagged protein and should concentrate it further upon elution. 
However, this step was not as specific as expected. Many proteins secreted by CHO 
cells were unspecifically bound to the Ni-NTA column and eluted together with hLAMP3-
prox. This phenomenon was also observed when purifying other LAMP constructs by 
the same protocol (Dr. Konrad Büssow, personal communication). In case of hLAMP3-
prox the contaminants were removed by GPC due to sufficient size differences. This 
two-step procedure yielded pure monodisperse protein which could be concentrated to 
at least 10 mg/ mL. As unspecific bound proteins in the culture supernatant of CHO 
Lec3.2.8.1 cells seem to be a general problem for purifying His6 tagged proteins, 
alternative strategies are discussed in the following. One possibility would be the 
increase in length of the polyhistidine tags from His6 to His10 which usually coincides 
with increased recovery and purity, but may in some cases reduce the expression 
(Grisshammer & Tucker, 1997; Mohanty & Wiener, 2004). Alternatively, other tags can 
be added at either terminus for an initial affinity chromatography step. They include for 
example Strep II tag, OneSTrEP, Flag-tag, GST-tag, MBP-tag, Fc-tag, and myc-tag. 
These tags differ substantially in purity, yield and cost (Lichty et al., 2005). The choice 
of the tag depends on the requirement of an experiment. A comparative study using a 
tagged dihydrofolate reductase (DHFR) construct produced in HeLa cells revealed that 
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GST tags as well as His tags are favoured for low-cost purification of large quantities of 
partial purified protein (Lichty et al., 2005). The highest purity was obtained by epitope 
tags such as the FLAG-tag, though being a cost intensive method. The study further 
found the Strep II tag to be an excellent candidate for affinity purification of DHFR, since 
it is a short tag resulting in pure protein in good yields and at a moderate cost.  
 
For structural studies it may be important to remove large affinity tags like GST or MBP 
after purification to obtain natural protein without unstructured, flexible residues. This 
can be realized by integrating a protease recognition sequence. It has been shown that 
TEV protease cleavage was efficient to remove N-terminal MBP and C-terminal 
thioredoxin-His6 tags for example from the neurotoxin receptor (White et al., 2004). It 
should be noted that polyhistidine tags are often fused to the C-terminus of a 
recombinant protein to maintain expression (Massotte, 2003) and that protease 
recognition sites generally leave between four and six additional residues behind upon 
cleavage when placed at the C-terminus. In case of hLAMP3-prox, the domain is 
naturally connected to a trans-membrane domain at its C-terminus, and thus the C-
terminal His6-tag was not expected to alter the fold of the construct.     
 
Crystallisation approaches with glycosylated hLAMP3-prox failed (data not shown). 
Therefore, the protein was deglycosylated by endo H. This procedure included another 
GPC purification, followed by concentrating up to 22 mg/ mL without any noticeable 
precipitation at room temperature. DLS measurements proved the monodispersity 
before crystallisation.  
 
4.3.2 First insights into X-ray structure of hLAMP3-prox 
After purification and crystallisation of hLAMP3-prox, its initial structure was obtained to 
a resolution of 2.8 Å by MAD. To this end, a screening for heavy atom derivatization 
was required which was performed by native SDS-PAGE. This technique successfully 
identified a compound for phasing and thus represents a practical alternative to 
selenomethionine labelling, which was impaired in this study by the toxicity of 
selenomethionine to CHO Lec3.2.8.1 cells (data not shown).  
 
The model of the membrane-proximal luminal domain of LAMP-3 provided first insights 
into its previously unknown three-dimensional structure. Only seven amino acid 
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residues near the N-terminus could not be located, possibly due to their high flexibility 
(Fig. 3-32). Further attempts to improve the electron density map and thus the initial 
model might include screening for crystals with higher resolution.  
 
In accordance with secondary structure prediction, the initial model reveals a high β-fold 
content with two anti-parallel β-sheets forming a sandwich. Comparative structural 
analysis using the DALI-Server did not find any convincing homologue. This indicates 
that the hLAMP3-prox domain contains new structural features. Interestingly, the C- and 
N-terminus of the crystallised domain are located in close proximity (Fig. 3-32 B). In the 
full length protein, the C-terminus of the membrane-proximal domain is connected to a 
transmembrane helix followed by a short cytoplasmic domain. The N-terminus is 
connected to a serine/proline-rich region followed by a highly glycosylated mucin-like 
domain. Hence, the mucin-like domain seems to be located near the lysosomal 
membrane and may protect the membrane and other membrane proteins from the 
acidic conditions of the lumen.   
 
4.3.3 GlcNAc-stabilized crystal packing 
Two of three expected GlcNAc residues (N266 and N291) were visible in the electron 
density map of hLAM3-prox. The third glycosylation site at position N232 was located in 
the flexible loop region and thus could not be built into the model. The GlcNAc residue 
connected to N291 stabilized the crystal packing by contacting the crystal neighbour‟s 
backbone at position G287. Crystal contacts by single GlcNAc residues have been 
reported before (Petrescu et al., 2004). This feature might explain why hLAMP3-prox 
bearing high-mannose glycans did not crystallize in this condition.       
 
4.3.4 Structure of hLAMP3-prox as phasing model 
The LAMP membrane-proximal domain is the most conserved region among all LAMP 
family members. Separate amino acid alignments of this domain showed that human 
LAMP-3 shares 31% sequence identity with CD68, 27% identity with LAMP-1 and 25% 
identity with LAMP-2 (de Saint-Vis et al., 1998). It would be worth trying to use hLAMP3-
prox as a phasing model to determine the domain structures of other LAMP family 
members, although the success rate of molecular replacement decreases sharply when 
the sequence similarity between template and target proteins drops below 40% identical 
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residues. However, there are examples of structures solved using molecular 
replacement with phasing models of less than 20% sequence identity (Jones, 2001).  
 
4.4 Outlook 
The combination of FACS and Flp-recombination for cell line development in CHO 
Lec3.2.8.1 cells has improved the production of glycoproteins for X-ray crystallography. 
RMCE paved the way for structure determination of hLAMP3-prox in a minimal amount 
of time and was used to establish a number of other cell lines stably expressing protein 
in mg-per-litre scale with less effort. The system is currently being used to facilitate the 
production of further recombinant glycoproteins for their structural analysis. Thus, it has 
the potential to standardize the glycoprotein production in mammalian cells.  Moreover, 
the described strategy is not limited to the glycosylation mutant cell line, but can also be 
applied on other cell lines like CHO K1, BHK, HEK293 or PER.C6 commonly used in 
pharmaindustry to produce therapeutic proteins.   
 
A possible advancement would be the parallel expression of different recombinant 
proteins in the same cell for assembling of multi-protein complexes, as already 
discussed in 4.1.5. Besides the establishment of a multiplex system (Turan et al., 2010), 
another strategy would be a simultaneous cultivation of a subclone mixture producing 
different glycoproteins. The recombinant protein complexes could assemble in the 
culture supernatant and thus could be co-purified. If the cultivated subclones derived 
from the same master cell clone by RMCE, they should be isogenic except for the 
transgenes. Hence, the result would be a heterogeneous production culture with 
homogenous cultivation abilities.   
 
To allow for even stronger expression of challenging proteins, the presented RMCE 
system has potential for further enhancements. One approach might aim at 
transcriptional augmentation of hard to express proteins by RMCE. This might be 
achieved by integrating cis-acting DNA sequences. The addition of S/MARs at the 
borders of a target cassette resulted in a larger proportion of master cells with high 
reporter gene expression (Qiao et al., 2009). This indicated that S/MARs alleviated 
silencing and increased transfection-mediated integration events. Due to the sorting 
strategy for master cell selection, a larger proportion of high producers is not 
necessarily needed. However, based on their DNA strand separation potential, it is 
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further argued that S/MARs support recombination events like RMCE (Qiao et al., 
2009). Another study suggested, however, that S/MARs integrated upon RMCE at a 
weak expression locus was not able to significantly improve the expression level 
(Nehlsen et al., 2009). Thus, the value of S/MAR elements might be more pronounced 
in increasing low recombination frequencies.  
 
Another strategy to increase the expression level of hard-to-express proteins is 
metabolic engineering by using multiplex RMCE. Thereby, positive effects of the co-
expression of transcriptional activators, anti-apoptotic proteins or secretion supporting 
proteins can be analysed individually and more easily. Former studies revealed 
increased expression levels by co-expression of the transcription activator XBP-1 
(Becker et al., 2008), the caspase inhibitor XIAP (Sauerwald et al., 2002) or the 
modulator of protein secretion CERT (Florin et al., 2009).   
 
Unfortunately, some structurally interesting proteins are toxic for the host cells in high 
concentrations. Thus, a regulated recombinant expression is desired and can be 
achieved by using inducible promoter systems. Commonly used is a tetracycline-
regulated gene expression system (tet system) (Corbel & Rossi, 2002; Gossen & 
Bujard, 1992). Basically, a repressor binds to a tet operator within a modified promoter 
and prevents the assembling of the transcription initiation complex. In the presence of 
the antibiotic tetracycline, the repressor dissociates and the transcription is induced. 
Depending on the tetracycline concentration in the culture medium, even the expression 
strength can be regulated to minimize deleterious effects of cytotoxic proteins.   
 
Insect cells are another excellent expression system to produce proteins for structural 
studies (Nettleship et al., 2010). Establishing the RMCE system in these cells would be 
beneficial. By designing exchange vectors that can be used in both hosts, selection of 
the best suited expression system would be facilitated. Generally, cytosolic proteins are 
favourably produced in insect cells, while for secreted proteins mammalian cells are 
preferred (Aricescu et al., 2006). Hence, a RMCE system for both expression hosts 
would be complementary for efficient protein production.  
 
In conclusion, RMCE in mammalian cells can overcome the production bottleneck for 
glycoproteins. The established system can be routinely used by structural biologists to 
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enhance determination of three-dimensional glycoprotein structures. Time that is saved 
for the production step can accelerate the functional analysis of proteins involved in 
pathogenic pathways and thus drug discovery.  
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